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Abstract 
 
 
 During clathrin mediated endocytosis (CME) cargo molecules are transported across 
the plasma membrane from the outer cell surface into the cytosol. In this process, the 
plasma membrane undergoes massive local remodeling events as well as local changes in 
lipid composition mediated and regulated by the interplay of over 40 proteins that bind at 
specific time points at the membrane.  
 One of these proteins is Epsin1. It is highly conserved across eukaryotic evolution 
and its structure reveals a tightly folded N-terminal ENTH (Epsin N-terminal homology) 
domain and an unstructured C-terminus. The ENTH domain has a compact globular 
structure mainly composed of helices. It is the membrane binding module and specifically 
binds to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). The binding to PtdIns(4,5)P2 
causes the formation of an amphipathic helix, which is associated with membrane 
deformation. 
 In this thesis, the roles of additional phospholipids beside PtdIns(4,5)P2 in ENTH 
domain induced membrane deformation were investigated. Especially, phosphatidylserine 
(PtdSer) was identified to promote ENTH domain induced membrane tubulation by analysis 
of liposome morphology. Solid-state NMR studies revealed that the ENTH domain 
undergoes conformational changes in presence of PtdSer in the membrane.   
 The generation of membrane tubules was accompanied by the formation of ENTH 
domain homo-oligomers. By mutating an arginine within the loop between helix 6 and helix 7 
to an alanine (R114A) oligomerization as well as membrane deformation was inhibited. The 
ENTH domain was demonstrated to form homo-oligomers in presence of PtdSer by FRET 
studies and this particular loop was identified as the location for ENTH domain interprotein 
interaction site by MS/MS. 
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1. Introduction 
 
1.1 The plasma membrane 
Cells are enclosed and defined by the plasma membrane (PM), composed of lipids 
and membrane proteins. This membrane maintains the physical integrity of the cell and 
serves as barrier between the cytosol and the outer environment. The cell membrane is 
selectively permeable for certain particles and protects the cytosol from intrusion of 
nanoparticles. It is also a place for signal transduction, nutrient uptake, sensing 
environmental changes and cell to cell communication. To adapt to all these functions the 
cell membrane is highly dynamic and changes the shape either globally, or locally to 
respond to cellular demands. The cell membrane undergoes permanently local remodeling 
events (Figure 1). Molecules are transported across the membrane by vesiculation. 
Therefore, the membrane must invaginate deeply and form areas of high curvature. But what 
is the physical behavior of a cell membrane? And what are the energetic barriers that keep 
the integrity and must be overcome to bend the membrane? 
 
 
Figure 1: Schematic illustration of a eukaryotic cell. The cell and several organelles are enclosed by lipid 
bilayers. Communication between membranous organelles and environmental sensing are established by 
vesicular transport. 
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The matrix of cellular membranes is formed by phospholipids. These molecules are 
amphipathic and possess a hydrophilic headgroup and hydrophobic fatty acid residues. They 
spontaneously self-assemble into bilayers in an aqueous solution due to their physical 
characteristics. The lipid composition of mammalian plasma membranes is highly diverse 
and tissue dependent. However, there is a distinct tendency of lipid species that are 
enriched in plasma membranes. The most abundant lipids are phosphatidylcholine (PtdCho) 
with nearly 50% and phosphatidylethanolamine (PtdEtn) with up to 30% in different tissues 1, 
2, 3. PtdCho has a cylindrical shape and tends to self-organize into planar bilayers. PtdEtn 
induces negative membrane curvature due to its intrinsic inverse conical shape and thus 
classified as a non-bilayer lipid. A certain lipid portion is represented by phosphatidylserine 
(PtdSer) and phosphatidylinositides (PtdIns). Both lipid species are negatively charged and 
phosphatidylinositides are critical lipids for signaling due to their property of being multiple 
phosphorylated. Phosphatidylinositol(4,5)bisphosphate (PtdIns(4,5)P2) for example is a key 
player in endocytic pathways. Additionally, mammalian plasma membranes are enriched in 
sterols and sphingolipids which are densely packed and resist to mechanical stress 4. The 
lipids of two bilayer leaflets of the plasma membrane are asymmetrically distributed. The 
outer leaflet is enriched in PtdCho as well as sphingolipids and the inner leaflet contains 
higher portions of PtdSer, PtdEtn and different species of phosphatidylinositides 5. 
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1.2 General view on the endocytic process 
In mammalian cells, endocytic membrane trafficking has a pivotal role in the delivery 
of membrane components, solute molecules and receptor associated ligands to several 
intracellular destinations (Figure 2). Endocytosis is also used by toxins, viruses, and 
symbiotic microorganisms to enter the cell 6. Earlier models described endocytosis as a 
simple route, with the main pathways thought to lead to degradation in lysosomes or 
recycling back to the plasma membrane. However, more recent models present this process 
as more complex and multifunctional.  
It has been now almost 20 years since the publication of the first report 
characterizing the recycling of receptors back to the plasma membrane, which demonstrated 
the crucial role of clathrin mediated endocytosis (CME) on the control of the signal cascade 
of Epidermal Growth Factor Receptor (EGFR) 7. Receptor mediated endocytosis is the best 
characterized endocytic process and it is known to be involved in the internalization of 
receptors and their ligands by clathrin coated pits (CCPs) 6. Several ligands are then 
degraded in late endosomes or lysosomes, while receptors are re-used several times. 
Such clathrin-dependent regulatory and trafficking pathways not only occur at the 
plasma membrane, but also between intracellular organelles. In general, they are essential 
for the maintenance of the right composition of organelles as well as for returning crucial 
molecules to the appropriate compartments. Moreover, endocytic recycling is also essential 
for keeping the distinction between apical and basolateral membranes in polarized cells 8. 
Different types of sealed endocytic compartments originate from the plasma 
membrane, and the better characterized of these starts with the formation of a CCP6. 
Commonly, endocytosed molecules are then delivered to early endosomes, where sorting 
takes place 9. Sorting endosomes are tubular-vesicular structures that have a luminal pH of 
~ 6.0 10, 11 and accept material only for 5-10 minutes 12. After this, they translocate onward 
microtubules, stop fusing with freshly endocytosed vesicles and its lumen becomes more 
acidic. At this time point, endosomes start to gain hydrolases and acquire the characteristics 
of late endosomes. This process is called endosomal maturation. After the sorting 
endosome, there are three destinations for cargo, which are the plasma membrane, late 
endosomes and the endocytic recycling compartment. 
CME is a major endocytic pathway of the plasma membrane however, several 
studies demonstrated that other endocytic pathways can also take place in mammalian cells.  
 
 
Introduction: Endocytosis 
 
4 
 
 
Figure 2: Schematic illustration of the endosomal trafficking (adapted from Elkin S. R. et al. 13). Vesicles 
are internalized into the cytosol and fuse with the early endosome. The cargo is sorted to be transferred back to 
the cell surface by exocytosis or to the late endosome. The cargo is then transferred to the TransGolgi network or 
degraded in lysosomes. The endosome undergoes continuous acidification which is indicated by the darker color 
of the compartments. 
 
1.2.1 Clathrin independent endocytosis 
Endocytosis is a basic process which is used by cells to incorporate an assortment of 
molecules. Since these molecules can be quite diverse, it is important to understand the 
different pathways that mediate their internalization and how these pathways are regulated. 
The discovery of clathrin mediated endocytosis and of the main players involved in this 
complex process provides a fundamental model for the investigation of membrane trafficking 
in cells 13, 14. Some of these pathways are fundamental, although others are triggered by 
specific stimuli or even used by pathogens to infect cells 15. Moreover, they differ in the 
composition of the molecular machinery, the associated cargo destination, as well as in 
mechanism and kinetics of formation 16. 
Several endocytic pathways that do not require clathrin begun to be recognized as 
distinct clathrin independent endocytic pathways (CIEs). These pathways can be divided into 
those which require dynamin and those that are dynamin-independent. Another way to 
distinguish is related to the presence or absence of a proteinatious coat 16. 
The plasma membrane, in different cell types (excluding neurons and leukocytes) contains 
small flask-shaped invaginations of 60 to 80 nm 17 and depending on the cell type, these so 
called caveolae play different roles. It has been observed that these structures internalize 
glycosphingolipids as well as integrins 18. In addition, caveolae play a role in lipid and 
cholesterol regulation in adipocytes 19. Finally, they participate in mechanosensing by 
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counteracting cell membrane swelling, working as a membrane reservoir 20. The formation of 
caveolae strongly depends on the presence of Caveolin1, or Caveolin3 in skeletal muscle 
cells 21, 22. They bind or form special lipid rafts at the plasma membrane composed of 
sphingomyelin and glycosphingolipids as well as cholesterol 23, 24. Caveolins possess an 
intramembrane domain, a scaffolding domain and a domain that undergoes palmitylation 
during protein maturation 25  
The GEEC pathway (Figure 3) is a novel coat and dynamin independent endocytic 
pathway 26, 
27. Originally, GPI-anchored proteins were thought to be internalized via the 
caveolae dependent pathway. However, this idea was changed by data collected in several 
studies, which demonstrated that GPI-anchored proteins are not actively enriched in 
caveolae 27, 28, 29. In the absence of cross-linking, GPI-anchored proteins form nanoscale 
clusters on the plasma membrane, and are internalized through the GEEC pathway. 
 
 
Figure 3: The diversity of endocytic pathways in metazoan cells (adapted from Mayor S. et al. 31). The 
caveolae endocytic pathway and clathrin mediated endocytosis are associated with a characteristic protein coat 
and depend on dynamin. The GEEC pathway is dependent on the actin cytoskeleton. 
 
 
 
 
 
 
 
Introduction: Endocytosis 
 
6 
 
1.2.2 Clathrin mediated endocytosis 
So far, clathrin mediated endocytosis is the best described endocytic pathway and 
since the discovery of clathrin as the lattice forming coat molecule in CME by Pearse B. M. 
F. in 1976 30, extensive studies were performed to elucidate the mechanisms of this process. 
The plasma membrane locally invaginates, encloses the cargo and is released into the 
cytosol as a clathrin coated vesicle (CCV) (Figure 4). Clathrin dissociates from the CCV and 
finally fuses with the endosome. The plasma membrane undergoes massive local 
remodeling events as well as drastic changes of the local lipid composition during the events 
of CME. These processes are mediated and regulated by over forty proteins that bind at 
specific time points to the membrane. 
 
 
Figure 4: The different stages of clathrin mediated endocytosis (adapted from McMahon H. T. et al. 
31
). The 
nucleation is initiated by a complex of FCHo, Eps15 and intersectin. Cargo selection is characterized by the 
recruitment of cargo specific adaptors, AP-2 and clathrin. The pit gets a more defined vesicular shape, and the 
complete clathrin lattice is formed in the coat assembly step. The neck region still connects the CCV and the 
plasma membrane. Dynamin is then recruited by BAR domain proteins to the neck. Finally, the clathrin coated 
vesicle is released off the membrane by dynamin activity and clathrin starts to disassemble. 
 
Clathrin mediated endocytosis is classically subdivided into several stages that were 
determined by morphological studies. However, the key proteins and the processes within 
the stages remain controverse. The nucleation is the initial step, in which the membrane pit 
starts to get a defined shape by local invagination of the plasma membrane. Three 
components play a key role in the nucleation of the plasma membrane by assembling to a 
nucleation module 31. FCH domain only (FCHo) proteins, Eps15 (Epidermal growth factor 
receptor substrate 15) and intersectins define this nucleation module, thus the depletion of 
one of these proteins inhibits the formation of the clathrin coat 32, 33. Especially FCHo 1,2 are 
believed to be key proteins in this model. They initially bind to PtdIns(4,5)P2 containing 
membranes with a low curvature and recruit intersectin and Eps15 that in turn recruits AP-2 
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(Adaptor protein complex 2) 33. In contrast, another model was proposed, in which nucleation 
is mediated by AP-2 34 which is the main adaptor protein in CME. This protein binds to 
PtdIns(4,5)P2 
35 and recruits clathrin to the membrane 36, 37. In addition, AP-2 interacts with 
nearly all proteins involved in clathrin mediated endocytosis. The interactions are mediated 
by the α-Ear of AP-2 and DPW/F motives 38. In 2012 it was demonstrated, by total internal 
reflection fluorescence microscopy (TIRFM) that AP-2 initiates the nucleation in BSC1 cells 
followed by the recruitment of FCHo proteins39.  
Subsequent to nucleation, cargo selection is the next stage of CME and is defined by 
the interactions of AP-2. AP-2 interacts directly with cargo, but also indirectly through its 
binding to the corresponding adaptor proteins. One example is stonin2 that binds AP-2 and 
the cargo molecule synaptogamin 40. It was shown that the nucleation complex still 
assembles in AP-2 depleted cells, but clathrin was not recruited to the membrane and the 
CCVs did not mature 41, 42. 
In the next stage, the membrane gets a more pronounced invaginated shape as 
more clathrin triskelia are recruited by AP-2 and other adaptor proteins. As clathrin triskelia 
assemble into a scaffold, membrane curvature is stabilized. In cells without clathrin, AP-2 is 
recruited to the nucleation complex, but invagination of these patches is depleted 43. It still 
remains controversial if clathrin polymerization induces membrane curvature, as the budding 
of clathrin coated pits was induced by using clathrin triskelia together with truncated adaptor 
proteins that were not able to induce membrane deformation by themselves 44. However, 
clathrin binds to the flexible parts of the adaptor proteins which is thought to transmit the 
potential polymerization force in an inefficient way to the membrane 31. Clathrin, if bound by 
adaptor proteins to flat membranes, does not form the characteristic alternating pentagonal 
and hexagonal lattices with an intrinsic curvature of a CCP. Instead, it assembles only in 
hexagons forming flat lattices 45. The stage of clathrin coat assembly is accompanied by the 
displacement of adaptor proteins like Eps 15 and curvature generating adaptors like Epsin 
proteins 46, 47. 
Later, when the clathrin coated pit gets the characteristic shape and size of a vesicle, 
a neck region is formed, which connects the CCV with the plasma membrane. This stage of 
CME is characterized by two types of key proteins. The N-BAR domain proteins 
amphiphysin and endophilin have intrinsically highly curved shapes 48. These proteins are 
able to sense and induce high degree membrane curvature 49. Ultimately, it was 
demonstrated, by the use of GUVs (Giant unilamellar vesicles) coupled to optical tweezers, 
that amphiphysin1 preferentially binds to curved membranes than to flat membranes 50. As 
they bind to the neck region of the CCP in late stages of endocytosis 51, BAR domain 
proteins assemble into a neck-surrounding helical ultrastructure generating and stabilizing 
high membrane curvature 52. The second key protein is dynamin that promotes the fission of 
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the CCV from the plasma membrane. Dynamin is recruited by BAR domain proteins of CME. 
Meinecke M. et al. showed that dynamin is not efficiently recruited to CCPs in endophilin and 
amphiphysin knocked down SK-MEL-2 cells 53. In addition, they showed that amphiphysin 
recruits dynamin to GUVs which ultimately induces membrane vesiculation in the presence 
of GTP. The binding between both proteins is established by the SH3 (Src-homology 3) 
domain and the proline-rich domain of dynamin 54. The actual mechanism of how dynamin 
promotes fission is not completely elucidated. After its recruitment to the neck and self-
assembly to a ring 55, dynamin promotes the hydrolysis of GTP (Guanosine triphosphate) 
leading to a conformational change of this protein 56, 57. It is implicated that dynamin then 
constricts the neck which leads to the release of the CCV 58. Dynamin activity plays a crucial 
role in membrane fission because inhibiting its GTPase activity or knocking it down arrests 
CCVs on the plasma membrane 59, 60. 
After the release of the CCV from the plasma membrane, clathrin rapidly dissociates 
into triskelia. This process is induced by the ATPase activity of the Heat Shock Cognate 70 
(HSC70) 61 in cooperation with its cofactor 62. The uncoated vesicle travels through the 
cytosol to fuse with the endosome.  
 
1.2.3 Cargo and tissue modulation of clathrin mediated endocytosis 
 The cellular function of clathrin mediated endocytosis strongly depends on the tissue 
where it takes place. The ubiquitous function is the internalization of plasma membrane 
bound receptors. The Transferrin receptor (TfR) and Low Density Lipoprotein receptor 
(LDLR) are both internalized constitutively by CME 30, 63, whether their ligands are bound or 
not. The TfR binds transferrin-iron complexes, thus it is crucial for cellular iron internalization 
64 and binds AP-2 directly 65, 66. The LDLR plays a crucial role in the uptake of cholesterol by 
Low Density Lipoproteins (LDLs) 67. This receptor binds CME adaptor proteins ARH 
(Autosomal Recessive Hypercholesterolemia) or Dab2 (Disabled homolog 2) 66.  
Several receptors that are CME cargoes are only internalized after their stimulation 
by the corresponding ligands. So far, two receptor families are well characterized for CME 
after stimulation: the G protein-coupled receptor family (for example the adrenergic receptor 
68) and the receptor tyrosine kinase family (Insulin receptor 69, Epidermal Growth Factor 
receptor 70).  
The binding of the EGFR to its ligand leads to the dimerization, ubiquitination and 
autophosphorylation of the receptor. These events induce a signal cascade associated with 
cell growth and inhibition of apoptosis 71, 72. In several tissues CME function is extended to 
regulate signaling pathways, like the Wingless pathway. This pathway was studied in 
Drosophila melanogaster and plays a role in embryonic development of the body axis, cell 
fate, cell proliferation and migration 73. The Wingless ligands bind to the membrane receptor 
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Frizzled. Activated Frizzled is the cargo protein for Dishevelled, an endocytic adaptor 
protein, and finally internalized 74. By this process, CME regulates signal transduction 
pathways only by physically removing used receptors from the cell surface 75. 
The main role of CME in the brain is the recycling of synaptic vesicles proteins and 
lipids after the release of the neuro transmitter into the synaptic cleft 40, 76. The composition 
of associated adaptor proteins of synaptic CCVs also differs from the composition of CCVs 
in other tissues. For example, AP180 replaces CALM in synaptic vesicles31. 
 
1.2.4 Clathrin mediated endocytosis in yeast 
Yeast endocytosis takes place at plasma membrane subdomains which are called 
actin patches 77, 78. At yeast endocytic sites, the proteins that are first detected are the 
ubiquitin binding protein Ede1p (EH domain-containing and endocytosis 1) and the F-BAR 
protein Syp1p 79, 32. Syp1p (Septin-associated protein 1) induces the formation of endocytic 
sites at the bud neck, in a polarized way, however its deletion does not inhibit patch 
formation in buds. After the arrival of early proteins, accumulation of cargo molecules at the 
nascent actin patch takes place. At this point, several other proteins are recruited to the 
endocytic site. Among them are Sla2p (actin cytoskeleton-regulatory complex protein SLA2) 
and Ent1/2p (extended version), which have domains that specifically bind to PtdIns(4,5)P2 
80, 81. Later, coat proteins arrive, together with members of the WASP/Myo (Wiskott–Aldrich 
syndrome protein/myosin) module. Lsb5p (LAS seventeen-binding protein 5) and Gts1p 
(protein GTS1) promote the uncoating, whereas Lsb3p (LAS seventeen-binding protein 3) 
and Lsb4p/Ysc84p (LAS seventeen-binding protein 4 ) are involved in actin polymerization 
and bundling 82, 83. The proteins that arrive at later time-points are probably involved in the 
link between the early coat, actin and the scission machinery. At the end of the endocytic 
process, the vesicle pinches off from the plasma membrane and moves towards the center 
of the cell, where the endocytic coat disassembles.  
 Among the 60 yeast proteins that are known to localize at endocytosis sites, 
approximately 85% are homolog to mammalian proteins involved in the endocytic process. 
As an example, intersectin in mammals possesses two Eps15 homology domains and five 
SH3 domains and it is believed that it plays a role similar to the one of the yeast proteins 
Pan1p and Sla1p 51. 
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1.3 Membrane curvature 
To understand the mechanisms of membrane curvature it is necessary to understand 
the mechanics and thermodynamics of lipid membranes. One measure to predict the 
behavior of lipids in a membrane is the packing parameter introduced by Israelachvili J. et al. 
in 1977 84. It defines, in a simplified way, the intrinsic geometry of a lipid depending on the 
headgroup, the volume of the lipid and the fatty acid chain length. The packing parameter 
determines the shape of the membrane. Cylindrical shaped lipids tend to form bilayers, while 
inverted conical shaped lipids govern micelles. Conical shaped lipids tend to form reverse 
micelles (splayed chain confirmation) in which the headgroups form the core and the acyl 
chains form the continuous phase 85.  
The motion of lipids within a bilayer is explained by the bilayer phase behavior 86 
(Figure 5). At low temperatures bilayers are in the liquid ordered phase (Lo) that is displayed 
by a highly ordered lipid fatty acid chains 87. At higher temperatures the bilayer phase 
transits into the lamellar gel phase (Lβ for lipids similar to PtdEtn, or Lβ’ for lipids similar to 
PtdCho). The lipids are still highly ordered, but their fatty acid residues are slightly tilted 
organized. The next phase is the fluid phase (liquid disordered, Lα) 
87, which is 
physiologically the most relevant 86. The transitions between the phases are known as the 
melting temperature. The length of the fatty acid chains has a great impact on the melting 
temperatures because of the Van der Waals interactions between them 88. The degree of 
fatty acid chain saturation also impacts the melting temperature.  
 
 
Figure 5: Schematic illustration of various bilayer phases (adapted from Kranenburg M. et al. 
86
). Lipids are 
highly ordered in liquid ordered phase (L0). The fatty acid tails are oriented in a tilted manner in the lamellar gel 
phase (Lβ) and unordered in the fluide phase (L). 
 
In 1972 Singer S. J. et al. introduced the fluid mosaic model to describe the 
properties of the bilayer components in cellular membranes 89. Although, the classic fluid 
mosaic model became obsolete and has been replaced by different complex models, it can 
still be used to understand the basic properties of the membrane. Lipids and integral 
membrane proteins are free in lateral diffusion within the membranous matrix, so they 
behave like a two-dimensional fluid in the liquid disordered phase. Lipids are also able to 
perform transversal diffusion (flip-flop) although Singer S. J. assumed this as a rare event. 
Furthermore, the membrane viscosity is increased as a consequence of high cholesterol 
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concentrations. The restriction of the fluid mosaic model is that it does not explain the 
formation of subdomains within the lipid bilayer, since the single components of a membrane 
are assumed to behave independently 90. One example for these subdomains are lipid rafts 
91. They are described as regions within the membrane that are enriched in cholesterol and 
glycosphingolipids. Lipid rafts have a distinct behavior in lateral motion, if compared to the 
surrounding lipids. Considering the differences in the packing parameters, lipid rafts are in 
the lamellar gel phase while the surrounding lipids are in the liquid disordered phase. These 
membrane subdomains are of biological relevance since they play a role in different 
endocytic pathways 92 and in the recruitment of several proteins for example. 93 
 Membrane deformation against the intrinsic shape of a lipid membrane is an energy 
consuming process and must exceed resistance to bending 94. By using the classical 
Canhman 95 and Helfrich 96 theory, Stachowiak J. C. et al. estimated the energy cost for 
creating a curved sphere from a plain membrane as follows:  
 
Gbending = (8πκ)/ (4πr
2) 
 
Where κ is the bending rigidity of the membrane and r is the vesicle radius. Usual 
values for κ are κ ~ 10 kBT for a fluid membrane and κ ~ 50 kBT for a typical mammalian 
plasma membrane containing 50% cholesterol 97.  
Several mechanisms have been identified regarding how local membrane 
deformation is generated in cells. One mechanism is the generation of lipid asymmetry 
between the opposing membrane leaflets (Figure 6A). Here, the geometries of the different 
lipid species are the driving force for membrane curvature and the headgroups as well as the 
structure of the fatty acid chain contribute to deformation processes 98. To avoid lipid packing 
defects that result exposure of the hydrophobic acyl moieties to the aqueous solution, the 
membrane compensates by adopting to the intrinsic shape of the lipid geometry 99, 100. One 
example for the influence of lipid modification on membrane asymmetry is the conversion of 
lysophosphatidic acid (LPA) to PA mediated by LPA acyl transferase or the reverse 
conversion of PA to LPA by phospholipase A2 
101, 102. PA induces negative membrane 
curvature due to the small headgroup in respect to the fatty acid chains. The loss of an acyl 
moiety inverses the conical structure resulting in an induction of positive curvature by LPA 
101. Another example is the asymmetry of the plasma membrane itself. The exterior leaflet is 
enriched in sphingolipids and PtdCho. Both lipid species are cylindrically shaped but 
sphingolipids neighboring cylindrical lipids pack more tightly and increase the mechanical 
stability of this leaflet 103. The interior leaflet is enriched in PtdEtn that creates negative 
curvature due to its strong conical shape 104. This asymmetry is assumed to be involved in 
membrane curvature generation at the membrane 94.  
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Integral membrane proteins can have an impact on membrane deformation as well 
(Figure 6B). If the intrinsic shape of these proteins is conical, the membrane adapts to the 
shape to avoid packing defects and local membrane curvature is generated 105, 98. Integral 
membrane proteins often cluster and enhance the deformation induction by their self-
assembly. Barbot M. et al. demonstrated that Mic10, a protein of the mitochondrial contact 
site and cristae organizing system (MICOS), is able to induce membrane hairpin formation 
via its self-assembly 106. Mic10 consists of 2 transmembrane helices, one expands vertical 
through the hydrophobic area of the membrane, the other is assumed to expand in a slightly 
tilted way due to its length. Membrane deformation induced by this protein, is due to its 
ability to homo-oligomerize, since mutants without this ability did not induce curvature. 
The cytoskeleton can induce membrane curvature in several ways (Figure 6C). 
Bursts of actin polymerization can induce stress on the membrane by pushing force, for 
instance in the generation of filopodia 107, 108. Microtubules together with motor proteins can 
also exert pulling force on the membrane. This was demonstrated for membrane remodeling 
in the mammalian ER 109 as well as in Saccharomyces cerevisiae 110. 
The scaffolding mechanism was extensively studied in BAR (Bin/Amphiphysin/Rvs) 
domain proteins (Figure 6D). These soluble proteins dimerize 111 resulting in an intrinsic 
concave shape 112. The concave region is enriched in positively charged amino acids that 
interact with negatively charged phospholipids 113. They preferentially bind to membrane 
curvatures corresponding to their own intrinsic shape 49. A subgroup of this protein family, 
like amphiphysin and endophilin, contain the N-BAR domains that have amphipathic helices 
in addition to the protein scaffold 114, 48, 113.The insertion of the amphipathic helices 
destabilizes the membrane tension and then it can be forced into the intrinsic BAR domain 
shape with lower energy costs.  
The insertion of an amphipathic helix into one leaflet of the membrane is another 
mechanism to deform membranes (Figure 6E), called the hydrophobic insertion mechanism 
115, 105. Proteins that use this mechanism have domains that act as a molecular wedge by the 
insertion into one leaflet of the membrane. This asymmetrically increases the surface of the 
membrane leading to packing defects and generation of positive curvature 115. This 
mechanism was demonstrated for N-BAR proteins 48, as mentioned before, but especially 
proteins of the Epsin family are known to induce membrane curvature by hydrophobic 
insertion 115, 116.  
Finally, a more recent mechanism to induce membrane curvature was introduced by 
Stachowiak J. C. et al., designated the protein crowding mechanism 117 (Figure 6F). In this 
mechanism, peripheral membrane proteins bind with high density at the membrane. The 
resulting protein collisions induce membrane stress by lateral pressure 118. The membrane 
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then compensates by curvature generation. This principle was demonstrated by attaching 
globular domains to membranes 119. 
 
 
Figure 6: Schematic illustration of the different mechanisms of bending membranes. A Lipid asymmetry of 
conical shaped, or inverse conical shaped lipids induce membrane curvature. B The membrane adapts to the 
intrinsic shape of integral membrane proteins. C Cytoskeleton proteins can induce membrane curvature by 
pushing (or pulling). D The scaffolding mechanism is predominately used by BAR-domain proteins. E Insertion of 
an amphipathic molecule into one leaflet of the membrane induces lipid packing defects. F Protein crowding 
induces lateral pressure on the membrane, resulting in membrane deformation (adapted from McMahon et al. 
2005 
98
 and Stachowiak et al. 2013 
94
). 
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1.4 Epsin 
Epsins are a family of membrane binding adaptor proteins, which are highly 
conserved across eukaryotic evolution and are expressed in all vertebrates. Epsin1, the 
eponym of this protein family, was originally identified as a binding partner of Eps15, one of 
the clathrin mediated endocytosis initiation proteins 120. In the same study, it was revealed 
that the perturbation of Epsin1 function in CHO cells inhibited cellular uptake of clathrin 
mediated endocytosis cargoes.  
  
1.4.1 Functional and strucral relationship of Epsin 
The different Epsins have a similar architecture to Epsin1. This protein contains a 
characteristic 150 amino acid long ENTH (Epsin N-Terminal Homology) domain, which is in 
contrast to the rest of the protein tightly folded, and the main lipid binding module of the 
whole protein. The ENTH domains of Epsin1, 2 and 3 bind specifically 
phosphatidylinositol(4,5)bisphosphate (PtdIns(4,5)P2) (Figure 7), a lipid highly enriched at 
the plasma membrane at endocytic sites.  
It is generally believed that Epsins play a role in cargo sorting for endocytic 
internalization. C-terminal to the ENTH domain Epsin1 possesses two to three ubiquitin 
interacting motifs (UIMs), depending on the spliced isoform 121. In vitro, the UIMs interact 
tandemly to recruit purified tetraubiquitin and higher ubiquitinated proteins from cell extracts 
122. The same study showed that the α subunit of the interleukin receptor is internalized into 
HeLa cells by endocytosis if it carries a tetraubiquitin. In contrast, the monoubiquitinated 
receptor was not internalized. The unstructured C terminus of Epsin1 also contains several 
repeats of DPW (aspartic acid - proline - tryptophan) motifs, which are demonstrated to 
interact with the α-appendage of the endocytic AP-2. The position and number of DPW 
motifs within the different Epsins is not conserved. This region is flanked by two clathrin 
binding motifs, LMDLADV (leucine - methionine - aspartic acid - leucine - alanine - aspartic 
acid - valine) and LVDLD (leucine - valine - aspartic acid - leucine - aspartic acid), that 
cooperatively bind one clathrin triskelion 123. The clathrin interaction region together with the 
AP-2 binding motifs is often referred to as CLAP (clathrin and AP-2). 
Several copies of NPF (asparagine - proline - phenylalanine) motifs are located at the 
C-terminal end of Epsin1, which mediate binding to EH (Eps15 homology) domain containing 
proteins like the CME initiation protein Eps15 120, POB1 ( BTZ/POZ domain-containing 
protein POB1) and intersectin. POB1 is involved in the regulation of DNA duplication during 
mitosis 124 and intersectin is involved in the coordination of CME with the actin assembly 
machinery 125. 
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1.4.2 Epsin proteins in different species 
Epsins are crucial for cell homeostasis and yeast cells are not viable if their Epsin-
like proteins are knocked down 126. Mammals have in general three Epsins (Figure 7). 
Epsin1 and Epsin2 are enriched in the brain and have crucial function in CME as they 
interact with AP-2 and clathrin 127. Epsin3 is upregulated in wounded epithelia 128. In addition, 
EpsinR (Epsin related protein) was identified as another ENTH domain containing protein 129, 
130. This protein is involved in membrane trafficking from the Trans-Golgi to endosomes. 
EpsinR rather binds to phosphatidylinositol(4)phosphate (InsPtd(4)P) than PtdIns(4,5)P2 and 
has a high affinity to AP-1 (Adaptor protein complex1). Other names for this protein are 
CLINT 129 and Enthoprotin 131. Embryonic fibroblasts from conditional Epsin triple KO (knock 
out) mice were used to demonstrate that endocytosis is impaired if all Epsin genes are 
knocked out 132. 
 
 
Figure 7: The linear architecture of Epsins across different species. The structures of human Epsins were 
taken and modified from Horvath et al., 2006 
133
 and the modified structures of yeast, D. melanogaster and T. 
brucei Epsins derived from De Camilli et al., 2002 
134
. 
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Proteins containing the ENTH domain have in common the fact that they bind to 
PtdIns(4,5)P2 membranes. Saccharomyces cerevisiae possesses 4 proteins containing this 
characteristic motif (Figure 7). Ent1p and Ent2p (Equilibrative Nucleotide Transporter 2) are 
paralogues which can compensate each other in single KO mutants 126. They are involved in 
endocytosis by clathrin recruitment to the cell membrane and are involved in actin patch 
assembly. Ent3p (Equilibrative Nucleotide Transporter 3) has the highest similarity to EpsinR 
135. It is involved in the traffic between the Golgi and endosomes. Ent4p (Equilibrative 
Nucleotide Transporter 4) is not completely described so far and it is thought to be involved 
in Arn1p trafficking in absence of ferrichrome 136. 
Drosophila melanogaster (D. melanogaster) possesses one Epsin protein (Figure 7), 
which is called Lqf (liquid facets) 137. This protein plays a critical role in the Notch signaling 
pathway 138 but it is not required for synaptic vesicle recycling, which is classically regulated 
by clathrin mediated endocytosis 139. Electrophysiological examination on third instar larval 
body walls did not show any defects in synaptic vesicle endocytosis when lqf mutants were 
analyzed in comparison to the wild type. In contrast, it was shown that the Notch pathway 
strongly depends on three motifs of Lqf: its ENTH domain, the ubiquitin interaction motifs 
and the C-terminal binding motifs 140. The Notch pathway enables cells to communicate with 
each other by integral membrane proteins. The ligand cell carries the delta ligands that bind 
to the Notch receptor of the signal receiving cell. The Notch receptor then undergoes a 
series of proteolysis steps and a part of it, NICD (Notch intracellular domain), is transported 
to the nucleus where it activates Notch target genes. The extracellular part of the Notch 
receptor remains at the delta ligand and is internalized by endocytosis. Meloty-Kapella L. et 
al. demonstrated that in D. melanogaster Epsin and actin are responsible for the initiation of 
the signal cascade, once they pull the Notch receptor, making it available for the first 
proteolysis 141. Lqf binds the ubiquitinated delta ligand Notch extracellular domain complex 
and induces pulling force. The complex is then internalized by transendocytosis into the 
ligand cell. The pulling force of Epsin was demonstrated by using the Notch1 (Notch 
homolog 1) soluble part of the receptor attached to laser trapped beads. The displacement 
of the Notch1 beads, as a measure for pulling force, was then detected in presence of ligand 
cells. The pulling force decreased if the cells used were silenced by Epsin siRNAs (small 
interfering RNA). 
Evolutionary studies about Epsins were also carried out in Trypanosoma brucei (T. 
brucei), which is a protozoan parasite. Remarkably, this organisms possess a reduced 
clathrin adaptor gene cohort, consisting of one Epsin protein (TbEpsinR) (Figure 7), a CALM 
(Clathrin assembly lymphoid myeloid leukemia protein) protein and the clathrin heavy and 
light chain, but not AP-2 142. The Epsin protein is most related to the mammalian EpsinR. 
TbEpsinR has a double function: it is localized at endosomal membranes and surprisingly it 
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also accumulates, unlike mammalian EpsinR, at the flagellar pocket, where clathrin 
mediated endocytosis in T.brucei takes place 143. 
 
1.4.3 Epsin and endocytosis 
Epsin1 plays a crucial role in endocytosis of synaptic vesicles 144. It was shown that 
Epsin1 concentrates at nerve terminals in primary cultures of hippocampal cells. Endocytosis 
was impaired and arrested at the cell surface if Epsin1 was silenced by shRNAs (short 
hairpin RNA). It is remarkable that synaptic vesicle internalization could be rescued by 
introducing an Epsin1 construct that at least possessed the ENTH domain, the CLAP region 
and the NPF motifs. The interaction between clathrin and Epsin1 was elucidated in a model 
membrane system with different degrees of curvature 145. Clathrin alone was not able to bind 
to the membrane system, but Epsin1 was sufficient to recruit clathrin to highly curved 
membranes. In 2012 Boucrot E. et al. demonstrated the significance of Epsins during 
endocytosis in different cell types 115. In triple silenced cells (Epsin1, 2 ,3 siRNAs) endocytic 
cargo uptake was impaired and clathrin remained as flat lattices on the plasma membrane. 
In addition, they showed that Epsins are sufficient to mediate clathrin coated vesicle fission 
from the plasma membrane if dynamin expression in such cells was reduced. 
Although AP-2 is the main adaptor protein for cargo recognition in CME, there are a 
few cargo proteins, which are Epsin specific. One example is the epithelial sodium channel 
(ENaC) which is predominantly localized in polarized epithelial cells in kidneys, lung and 
colon 146. These channels are involved in maintaining the Na+ and K+ concentration in blood, 
epithelial and extra epithelial fluids. In 2009 it was shown that ENaC is a cargo for CME 147. 
They demonstrated by immunoprecipitation and in a Xenopus oocytes expression system 
that the UIMs of Epsin specifically bind to ubiquitinated ENaC. Another CME cargo that is 
internalized upon the interaction with Epsin is the EGFR. Its activation leads to receptor 
dimerization, autophosphorylation and cascadial phosphorylation of cytosolic signaling 
proteins. The cell can respond in different ways to the signaling, for instance with 
proliferation or migration. The activated receptor is internalized by CME into the cytosol 148 
after ubiquitination, where it is degraded or recycled back to the cell membrane. EGFR 
uptake is dependent on its ubiquitination and the interaction with Epsin. Internalization was 
significantly decreased if Epsin in HeLa cells was silenced by siRNA 149. 
 
1.4.4 Clinical Relevance of Epsin 
Besides its classical role as an endocytic adaptor, several research works suggest 
that these proteins have a role in the regulation of the activation of GTPases 150, 151. Epsins 
were reported to interact and inhibit several GTPase activating proteins (GAPs) which are 
recruited or localized at the plasma membrane, promoting the accumulation of GTP-loaded 
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GTPases and the development of polarized edges. These studies suggest that Epsins may 
be able to regulate cell polarity and migration through an unknown alternative mechanism. 
Since Epsins are involved in cell proliferation, a growing interest has arisen on the 
potential of migration and differentiation to regulate carcinogenesis. In fact, several 
transcriptomic and proteomic studies reported elevated expression of Epsins in tumor 
tissues and tumor cell lines 128, 152, 153. By using mouse models, in which Epsin1 and 2 were 
indelibly deleted, it was shown that adult mice lacking these proteins presented highly 
disorganized vascular structures and markedly increased vascular permeability in tumors, 
which resulted in increased nonproductive tumor angiogenesis and retarded tumor growth. 
The Epsins interact with the activated vascular epithelial growth factor receptor 2 (VEGFR2) 
and the authors propose a model, in which Epsin attenuates the VEGF (vascular epithelial 
growth factor) signal for a controlled angiogenesis 154. Another study showed that expression 
of Epsins is upregulated in both human and mouse prostate cancer cells, as well as in 
prostate cancer tissues 155. Taken together, these data highlight Epsins as potential targets 
for antitumoral strategies. 
Another pathological condition to which Epsins seem to be related to is 
schizophrenia. This disease is a highly heritable psychosis that affects 1% of the world’s 
population, but the genes that contribute to its development remain elusive 156. An 
association study performed by Pimm J. et al, in which blood samples from 450 volunteers 
with schizophrenia and 450 controls from London and Southern England were used, marked 
the Epsin 4 gene (which encodes Enthoprotin, a protein involved in vesicular transport) on 
chromosome 5q as a robust candidate for schizophrenia susceptibility 157. Two other studies, 
conducted in the Han Chinese population, provided contradictory evidence for this 
population 158, 159.  
Epsins might also play a role in pathogenic bacteria entry into the cell. For example, 
the extracellular pathogens EPEC (enteropathogenic Escherichia coli) adhere to intestinal 
cells causing the formation of pedestals (actin-rich structures). This process is dependent on 
Epsin1, which co-localizes with pedestals in infected HeLa cells 160. 
Finally, Epsins seem also to be involved in the clathrin mediated endocytosis of the 
influenza virus independent of the AP-2 adaptor 161. The contemporaneous recruitment of 
Epsin1 to the binding sites of influenza viruses with the assembly of clathrin coated pits was 
observed in BS-C-1 cells 162. The knockdown of Epsin1 significantly inhibited clathrin 
mediated endocytosis of the influenza virus and the majority of the virus particles entered 
through a CIEs. Overexpression of the dominant-negative Epsin1 mutant, which lacks the 
UIMs, almost completely blocked the clathrin mediated entry of the influenza virus.  
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1.5 The ENTH domain 
The organization and composition of the binding motifs vary within the different Epsin 
proteins, except for the ENTH domain which is always located at the very N-terminus. This 
150-amino acid stretch is the membrane binding module of this protein family. The ENTH 
domain of Epsin1 has the highest affinity to PtdIns(4,5)P2, but is also recruited to 
PtdIns(3,4,5)P3 containing membranes 
163. In the same study, it was demonstrated that the 
overexpression of a mutant form of Epsin1 (with an ENTH domain defect in phosphoinositide 
binding) promotes an impairment in the internalization of EGFR in COS-7 cells. It was 
concluded that the interaction between the membrane and Epsin1 is critical for its role in 
endocytosis. 
 
1.5.1 Structural properties of the ENTH domain 
The crystal structure of the ENTH domain was first resolved by Hyman J. et al. 
(Figure 8A), revealing that it has a globular fold that is composed of seven -helices, and a 
misaligned eighth one 164. The seven helices are stacked consecutively with a right-handed 
twist. Moreover, an additional helix was detected at the very N-terminus of the ENTH domain 
(Figure 8C) through the incubation with inositol-1,4,5-triphosphate (the headgroup of 
PtdIns(4,5)P2). This additional helix was designated helix zero (H0) 
116. H0 is amphipathic and 
was demonstrated to insert into one leaflet of a lipid bilayer. This was determined by 
measuring the change of surface pressure of a monolayer in presence and absence of the 
ENTH domain via a computer-controlled tensiometer 165. The hydrophilic, positively charged 
amino acids, of H0 contribute to PtdIns(4,5)P2 headgroup binding. In contrast, the 
hydrophobic amino acids of this helix are facing the fatty acid region of the membrane 
(Figure 8D and 8E). This way of binding membranes is termed the hydrophobic insertion 
mechanism 116. 
The binding of the ENTH domain to soluble inositides depends on the different 
positions of the phosphate groups within the cyclic alcohol ring. Isothermal titration calometry 
(ITC) analysis, revealed that the ENTH domain has a high affinity and a one to one 
stoichiometry for Ins(1,4,5)P3 and an even higher affinity for the short fatty acid chained 
diC8PtdIns(4,5)P2, which is still soluble in aqueous suspension. In the same study, it was 
shown that ENTH had a moderate affinity to inositol(1,3,4,5)P4, while the dissociation 
constant for other inositides tested was high, reflecting low affinity. The phosphates at 
position one, four and five are critical for ENTH domain binding and coordinate within a 
binding pocket formed by H0, H1, the loop H1-H2, H3 and H4. 
Structurally, the ENTH domain is highly related to the ANTH (AP180 N-terminal 
homology) domain (Figure 8B), which is the lipid binding module of AP180 (adaptor protein 
180) and CALM 116. These proteins also play a role in clathrin mediated endocytosis 37, 166. 
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The ANTH domain also has a high binding affinity to PtdIns(4,5)P2, but it binds to 
membranes upon surface charge interactions and not by the hydrophobic insertion 
mechanism 165. 
 
Figure 8: Structural properties of the ENTH domain and related domains. A: The ENTH domain of Epsin1 
without structured H0 (Hyman, 2000) in comparison to the ANTH domain of CALM (B, Ford, 2001). C: The ENTH 
domain of Epsin1 with structured N-terminal H0 (Ford, 2002). D: A close-up of the PtdIns(4,5)P2 binding pocket 
with Ins(1,4,5)P3. E: Radial projection of the amino acids that compose the amphipathic helix. 
 
1.5.2 Function of the ENTH domain 
The ENTH domain deforms membranes in vitro 116. The protein was incubated with 
large unilamellar vesicles (LUVs) composed by a lipid extract (FOLCH lipids), derived from 
brain, containing 10% PtdIns(4,5)P2. Electron microscopic analysis revealed that the 
presence of the ENTH domain and full length Epsin1 induced the generation of membrane 
tubules. This tubulation activity was not observed without PtdIns(4,5)P2, in absence of the 
protein or in replacement of the ANTH domain. To find out how the amphipathic helix 
contributes to membrane deformation, ENTH domain mutants were generated of the lysine 
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at the sixth position in the amino acid sequence (L6). Lysine was mutated to glutamic acid 
(E), glutamine (Q), histidine (H) or tryptophan (W). The ability of these mutants to bind to 
membranes was determined by liposome co-sedimentation assays. L6E completely failed in 
binding to membranes and did not show membrane deformation activity. With increasing 
hydrophobicity of the substituted amino acid, the membrane binding and deformation ability 
was increasingly restored. L6W showed, in contrast to the wild type, a strong vesiculation 
activity. Finally, they also showed, in morphological studies of lipid monolayers, that Epsin1 
alone is able to recruit clathrin to the membrane as invaginated clathrin lattices 116.  
In order to demonstrate how H0 penetrates the membrane, two groups performed 
electron paramagnetic resonance (EPR) examination using site-directed spin-labeled ENTH 
domains bound to LUVs 167, 168. Kweon D. et al. demonstrated that the amphipathic helix was 
only stably formed in presence of LUVs containing PtdIns(4,5)P2. The immersion depth and 
the tilt angel of the inserted helix remain controversial. This study determined that the bulk of 
the helix orients in the depth of the lipid headgroups and the amino acids on position nine 
and thirteen (glutamine and isoleucine) immerse until 5 Å. The amphipathic helix inserts into 
the membrane with a tilt angle of 11°. Yoon Y. et al. determined a tilt angel of the inserted 
amphipathic helix with 23° in respect to the membrane normal 168. The immersion depth was 
12 Å. Both groups used similar lipid compositions for their membranes. Using EPR analysis 
and by fluorescence microscopy with labeled ENTH domain incubated on GUVs, they 
detected that the ENTH domain seemed to form clusters. Membrane binding, but not 
clustering, was still present if they mutated K23E and E42K of the ENTH domain. The data 
indicates that the amphipathic helix of the ENTH inserts into one leaflet of bilayer in a 
horizontal, slightly tilted manner. It orientates in the height of the glycerol backbone, the 
energetic most favorable insertion depth to induce membrane deformation 115. 
As it was mentioned before, BAR domain proteins are endocytic proteins that are able 
to sense membrane curvature and bind to a preferential degree of curvature 50. Capraro B. 
R. et al. investigated if the ENTH domain was also able to sense membrane curvature 169. 
Therefore, they used a model membrane system with two degrees of curvature by pulling 
out membrane tethers from a GUV by optical tweezers. The ENTH domain bound 
preferentially to the tether and less binding was observed on the GUV. 
It remains controversial if the ENTH domain is able to form higher ordered clusters on 
membranes. EPR spectroscopic experiments demonstrated that ENTH domains dimerize on 
preformed membrane tubules 170. Coarse grained molecular dynamics simulation showed 
that the ENTH domain dimerized in an antiparallel manner and formed a lattice on 
membrane tubules. ENTH domain bound to vesicles did not order in this way. 
In contrast to an older study of the same group, Boucrot E. et al. showed that the 
presence of ENTH domain induces the generation of 20 nm vesicles from LUVs in vitro by 
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electron microscopy 115. This effect was enhanced with the L6W mutant and decreased with 
the L6E mutant. The generation of very small vesicles as the main membrane deformation 
effect of the ENTH domain was confirmed by using burst analysis spectroscopy (BAS) 171.  
Gleisner M. et al. gave insights into the underlying physics upon membrane insertion 
of the amphipathic helix 172. On pore spanning membranes they were able to control 
membrane curvature by using buffers on both sites of the membrane that were unequal in 
osmolarity. Addition of the ENTH domain to PtdIns(4,5)P2 containing membranes induced 
membrane curvature in buffers with constant osmolarities. They conclude that ENTH domain 
binding decreased the lateral membrane tension. 
Finally, Gleisner M. et al. demonstrated in another study that the ENTH domain 
membrane deformation activity depends on the tension of the membrane 173. They were able 
to control the membrane tension of GUVs by the concentration of Mg2+. The addition of the 
ENTH domain to GUVs with high tension resulted in collapsing GUVs. In contrast, if they 
used GUVs with low membrane tension, they observed the formation of membrane tubles. 
Single ENTH domain molecules have a complex diffusive behavior even on simple 
membrane compositions 174. The trajectories of single ENTH domains bound to membranes 
composed of phosphatidylcholine and PtdIns(4,5)P2 were recorded by TIRFM and used to 
determine their diffusion behavior. The results revealed that the ETNH domain trajectories 
are a result of three different diffusion processes that are all distinct from Brownian 
movement. The authors concluded in this way that the ENTH domain has three different 
membrane binding states.  
Taken together, these results lead to a molecular model of membrane deformation by 
the ENTH domain. Its amphipathic helix inserts into one leaflet of the membrane with a tilted 
angle. It inserts until the glycerol backbone, leading to an increase in surface area of one 
bilayer leaflet and to the generation of positive curvature (Figure 9).  
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Figure 9: ENTH domain interactions with the membrane: The ENTH does not bind to membranes without 
PtdIns(4,5)P2. In presence of PtdIns(4,5)P2 H0 structures and penetrates the membrane, resulting in membrane 
curvature. 
 
1.5.3 The protein crowding model 
In contrast to the amphipathic insertion mechanism, Stachowiak J. C. et al. introduced 
a distinct molecular model: membrane deformation by protein crowding. They generated 
regions of high local PtdIns(4,5)P2 concentration on GUVs and observed only in these 
regions membrane tubulation by either using ENTH domain or the ANTH domain. They 
repeated this experiment with an ENTH domain mutant without H0, but containing a hexa-
histidine, and GUVs with Ni2+ NTA (Nitrilotriacetic acid) lipids. Without the insertion of an 
amphipathic helix they still observed tubulation. They concluded that tubules are generated 
by lateral pressure of colliding proteins attached to the membrane 118. It was shown that 
Epsin1 and AP180 are able to induce membrane deformation at lower concentrations if 
compared to their single N-terminal domains 175, concluding that the unstructured C-termini 
apply even more local lateral pressure.  
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1.5.4 ENTH domain protein interactions 
 Surprisingly, the yeast ENTH domain and the yeast ANTH domain form hetero-
oligomers. This was observed in addition to membrane tubulation on PtdIns(4,5)P2 
containing membranes forming a regular coat in vitro 176. The oligomerization region was 
determined distinct from the lipid interaction sites of both proteins 
ENTH domains seem to play a role in SNARE mediated membrane fusion in yeast. 
The analyzes of the crystal structure revealed that the ENTH domain of Ent3p has an 
additional binding pocket for the vesicle transport v-SNARE protein Vti1 which is conserved 
across all ENTH domains 177. The physiological impact of inhibiting the complex formation 
was the mis- localization of Vti1 in yeast. 
In another study it was demonstrated that the ENTH domain also has regulatory 
effects on cell polarity during mitosis in yeast 178. The ENTH domain of the yeast Ent1 and 
Ent2 proteins have an additional binding pocket for a GTPase-activating protein specific for 
Cdc42 (Cell division control protein 42).  
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2. Scope of the thesis 
 
During clathrin mediated endocytosis cargo molecules are transported across the 
plasma membrane from the outer cell surface into the cytosol. The plasma membrane 
undergoes massive local remodeling events. This pathway is mediated and regulated by a 
complex protein machinery, each component is recruited to the plasma membrane at 
specific timepoints.  
One of these proteins is Epsin1, which is fundamental for CME and highly conserved 
across eukaryotic evolution. Its N-terminal ENTH domain is the lipid binding motif and 
specifically binds to phosphatidylinositol-4,5bisphosphate (PtdIns(4,5)P2). Upon membrane 
binding, the ENTH domain structures an additional amphipathic helix that inserts into the 
membrane. The ENTH domain interaction with membranes is associated with the induction 
of membrane deformation and the predominant generation of small vesicles. Although the 
ENTH domain induced membrane deformation was extensively studied, little is known about 
the mechanisms how it generates high degrees of membrane curvature. 
So far, membrane deformation analysis were performed with model membranes 
composed of unspecific lipid extracts, while membranes composed of simple lipid 
compositions resisted ENTH domain mediated deformation induction. Thus, it is necessary 
to identify lipid species, beside PtdIns(4,5)P2, that govern ENTH domain induced membrane 
deformation to determine if these lipid species directly interact with the ENTH domain or if 
they influence the physical properties of the membrane. 
Therefore, a combined strategy of membrane binding and deformation assays will be 
used with liposomes of defined lipid compositions to determine the effect of different lipid 
species. Promising lipid compositions will be then further examined for dynamics of 
membrane binding and deformation by the GUV assay. Furthermore, regions of interest 
within the ENTH domain will be mutated and tested for their function. Therefore, lipid binding 
and formation of homo-oligomers will be examined by FRET assays and identified by mass 
spectrometry. 
Finally, the fucnction of Epsin1 within endocytosis is not completely elucidated. 
Hence, it potential role in cargo sorting into clathrin coated vesicles will be investigated by 
co-migration assays and by GUV assays. 
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3. Materials and methods 
 
3.1 Materials 
 
3.1.1 Reagents  
Reagent Company 
(NH4)2SO4 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
100x MeM vitamin solution Thermo Fisher Scientific Inc., Waltham, 
USA 
10X FastDigest Green Buffer Thermo Fisher Scientific Inc., Waltham, 
USA 
Acetic acid, ROTIPURAN® 100% Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Acetone, ROTIPURAN® 99.8% Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Acetonitril, ROTIPURAN® 99.5% Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Agar-Agar, Kobe Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Agarose NEEO ultra quality Thermo Fisher Scientific Inc., Waltham, 
USA 
Ammonium persulfate Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Ammonium-15N2 sulfate Sigma-Aldrich Corp., St. Louis, USA 
Ampicillin Sigma-Aldrich Corp., St. Louis, USA 
Anza™ 10 DpnI Buffer Invitrogen AG, Carlsbad, USA 
Bromophenol blue Sigma-Aldrich Corp., St. Louis, USA 
CaCl2 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
CHCl3, ROTIPURAN
® 99% Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Coomassie Briliant Blue R-250 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
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CuSO4 Sigma-Aldrich Corp., St. Louis, USA 
D(+)-sucrose Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
D-glucose-1-13C Sigma-Aldrich Corp., St. Louis, USA 
Dimethylformamide (DMF) Sigma-Aldrich Corp., St. Louis, USA 
Dimethylsulfoxid (DMSO) Thermo Fisher Scientific Inc., Waltham, 
USA Germany 
Dithiotreitol (DTT) Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Ethidium bromide, 0.025% Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Ethylenediaminetetraacetic acid (EDTA) Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
EtOH, ROTIPURAN® 99.8% Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
FeSO4  7H2O Sigma-Aldrich Corp., St. Louis, USA 
Glycerol Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Glycine Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
HCl, 6N Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Hepes Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Histodenz™  Sigma-Aldrich Corp., St. Louis, USA 
Homobifunctional 
bis(sulfosuccinimidyl)suberate 
Sigma-Aldrich Corp., St. Louis, USA 
Imidazol Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Iodoacetamide Sigma-Aldrich Corp., St. Louis, USA 
Isopropyl-β-D-thiogalactopyranosid (IPTG) Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
K(CH3COO) Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
K2HPO4 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Kanamycin sulfate Sigma-Aldrich Corp., St. Louis, USA 
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KC2H3O2 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
KCl Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
KH2PO4 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Lipid-free bovine serum albumin Sigma-Aldrich Crop., St. Louis, USA 
MeOH, ROTIPURAN® 99.8% Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Mg(CH3COO)2 · 4 H2O Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
MgCl2 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
MgSO4 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
MnCl2 · 4 H2O Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
MnSO4  H2O Sigma-Aldrich Corp., St. Louis, USA 
MOPS Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Na2HPO4 ∙ 2 H2O Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
NaCl Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
NaHCO3 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
NaOH Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
NaOH 50% (v/v) Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
NH4HCO3 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
NH4MoO4 Sigma-Aldrich Chemie GmbH, Darmstadt, 
Germany 
Perchloric acid, ROTIPURAN® 70% Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
RbCl Sigma-Aldrich Corp., St. Louis, USA 
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Reduced Glutathion Sigma-Aldrich Corp., St. Louis, USA 
Rotiphorese Gel 30, Acrylamide/ 
Bisacrylamide (37.5:1) 
Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Sodium dodecyl sulfate (SDS) Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
T4 DNA Ligase Thermo Fisher Scientific Inc., Waltham, 
USA 
T4 DNA ligase Buffer Thermo Fisher Scientific Inc., Waltham, 
USA 
Tetramethylethylenediamine (TEMED) Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Trichloroacetic acid Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Trifluoroacetic acid Sigma-Aldrich Corp., St. Louis, USA 
Tris Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Tryptone Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Uranyl acetate  2 H2O SERVA Electrophoresis GmbH, 
Heidelberg, Germany 
Yeast extract Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
ZnSO4  7H2O Sigma-Aldrich Corp., St. Louis, USA 
β-mercaptoethanol Sigma-Aldrich Corp., St. Louis, USA 
 
 
3.1.2 Consumables 
Consumable Company 
Whatman® Nuclepore™ Track-Etched 
Membrane Filters 
Whatman plc, Maidstone, England 
Indium tin oxide-coated glass slides Nanion Technologies GmbH, Munich, 
Germany 
Nunc® Lab-Tek® II chambered coverglass Thermo Fisher Scientific Inc., Waltham, 
USA 
Spectra/Por Standard RC Tubing 3.5 kD Spectrum Labs Inc., Broadwick St, USA 
Amicon® Ultra 4 10,000 NMWL Merck KGaA, Darmstadt, Germany 
Materials and methods: materials 
 
32 
 
Amicon® Ultra 15 10,000 NMWL Merck KGaA, Darmstadt, Germany 
 
 
3.1.3 Devices 
Equipment Company 
Pneumatic cell disintegrator EmulsiFlex-C3 Avestin Inc., Ottawa, Canada 
Isobiotec Cell Homogenizer Isobiotec, Heidelberg, Germany 
GUV generation chamber Nanion Vesicle 
Prep Pro 
Nanion Technologies GmbH, Munich, 
Germany 
NanoDrop 2000 Thermo Fisher Scientific Inc., Waltham, 
USA 
Horizontal electrophoresis system Sub-
Cell® GT cell 
Bio-Rad Laboratories Inc., Hercules, USA 
Mini-PROTEAN® Tetra Vertical 
Electrophoresis Cell 
Bio-Rad Laboratories Inc., Hercules, USA 
PowerPac™ HC High-Current Power 
Supply 
Bio-Rad Laboratories Inc., Hercules, USA 
Biometra power pack model 250 power 
supply 
Biometra GmbH, Göttingen, Germany 
Intas gel documentation system INTAS Science Imaging Instruments 
GmbH, Göttingen, Germany 
UV light source Biometra TI 1 Biometra GmbH, Göttingen, Germany 
MICCRA D-9 homogenizer Miccra GmbH, Müllheim, Germany 
JASCO V-650 Spectrophotometer JASCO Germany GmbH, Gross-Umstadt, 
Germany 
Biometra Tpersonal thermocycler Biometra GmbH, Göttingen, Germany 
Savant SPD-131DDA SpeedVac 
Concentrator 
Thermo Fisher Scientific Inc., Waltham, 
USA 
Thermomixer comfort Eppendorf AG, Hamburg, Germany 
Incubator B-6120 Heraeus GmbH, Hanau, Germany 
Innova 4200 New Brunswick Scientific, Edison, USA 
Innova 44 New Brunswick Scientific, Edison, USA 
Eppendorf BioPhotometer Eppendorf AG, Hamburg, Germany 
Isobiotec Cell Homogenizer Isobiotec, Heidelberg, Germany 
SONOPLUS HD2200 BANDELIN electronic GmbH & Co. KG, 
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Berlin, Germany 
SONOPLUS UW2070 BANDELIN electronic GmbH & Co. KG, 
Berlin, Germany 
Mini-extruder Avanti Polar Lipids Inc., Alabaster, USA 
Tpersonal thermocycler Biometra GmbH, Göttingen, Germany 
ÄKTAPrime Plus system GE Healthcare Life Science, Chalfont St 
Giles, UK 
ÄKTAPurifier 10 GE Healthcare Life Science, Chalfont St 
Giles, UK 
Nikon Eclipse Ti Nikon Instruments K.K., Tokyo, Japan 
Electron Multiplying CCD Camera C9100 Hamamatsu Photonics K.K., Hamamatsu, 
Japan 
JEOL JEM 1011 JEOL Ltd., Akishima, Japan 
Gatan Orius 1000 CCS detector Gatan Inc., Pleasanton, USA 
Sony DSC-HX60 Sony Corp., Tokyo, Japan 
F-7000 Fluorescence Spectrophotometer Hitachi K. K., Tokio, Japan 
PerkinElmer UltraVIEW VoX system Perkin Elmer, Waltham, USA 
Spinning disk confocal scan head CSU-X1 Yokogawa Denki K. K., Tokyo, Japan 
Chirascan CD Spectrometer Applied Photophysics Ltd., London, UK 
Orbitrap Fusion Tribrid mass spectrometer Thermo Fisher Scientific Corp, Waltham, 
USA 
Biometra WR12 tumbling shaker Bioemtra GmbH, Göttingen, Germany 
PEQLAB semi-dry blotting chamber PEQLAB Biotechnologie GmbH, Erlangen, 
Germany 
CAWOMAT 2000 IR developing machine  CAWO Solutions, Schrobenhausen, 
Germany 
 
 
3.1.4 Rotors 
Rotor Company 
H-12000 BioProcessing Thermo Scientific, Dreieich, Germany 
Swing-bucket A-4-62 Eppendorf AG, Hamburg, Germany 
Type 70 Ti Beckman Coulter Inc., Fullerton, California 
Eppendorf F45-24-11 Eppendorf AG, Hamburg, Germany 
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TLA 100.3 Beckman Coulter Inc., Fullerton, California 
 
 
3.1.5 Buffers, mediums and solutions 
Buffer Composition 
LB medium NaCl 10 g/L  
Yeast extract 5 g/L 
Tryptone 10 g/L 
 
LB agar NaCl 10 g/L 
Yeast extract 5 g/L 
Tryptone 10 g/L 
Agar 15 g/L 
 
Hepes-Buffer (pH 7.4) NaCl 200 mM 
Hepes/NaOH 10 mM 
 
Lysis Buffer (pH 7.4) NaCl 150 mM 
Tris/HCl 50 mM 
DTT 2 mM 
EDTA 2 mM 
 
HKM Buffer (pH 7.4) Hepes 25 mM 
C2H3KO2 125 mM 
Mg(CH3COO)2 5 mM 
 
Clathrin disassembly Buffer Tris 1 M 
DTT 1 mM 
 
GUV salt buffer (pH 7.4) NaCl 192 mM 
Hepes/NaOH 10 mM 
 
GUV sucrose buffer (pH 7.4) D(+)-sucrose 300 mM 
Hepes/NaOH 10 mM 
 
M9 basal medium (pH7.4) Na2HPO4 42.5 mM 
KH2PO4 22 mM 
NaCl 17.1 mM 
(NH4)2SO4 7.6 mM 
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Trace elements ZnSO4  7 H2O 0.35 mM 
MnSO4  H2O 4.7 mM 
FeSO4  7 H2O 1.8 mM 
CuSO4  0.63 mM 
CaCl2 9.1 mM 
 
Competent cell buffer 1 (pH 5.6) K(CH3COO) 30 mM 
RbCl 100 mM 
CaCl2 10 mM 
MnCl2 50 mM 
Glycerol 15% (v/v) 
 
Competent cell buffer 2 (pH 6.8) MOPS/HCl 10 mM 
RbCl 10 mM 
CaCl2 75 mM 
Glycerol 15% (v/v) 
 
TAE buffer Tris (pH 7.6) 40 mM 
Acetic acid 20 mM 
EDTA 1 mM 
 
4x Loading buffer  Tris/HCl pH 6.8 62.5 mM 
SDS 70 mM 
Glycerol 50% (v/v) 
Bromophenol blue 0.1% (w/v) 
β-mercaptoethanol 5% (v/v) 
 
SDS-PAGE running buffer Tris/HCl 25 mM 
Glycerol 192 mM 
SDS 0.1% (w/v) 
 
Staining solution EtOH 96% 10% (v/v) 
Acetic acid 5% (v/v) 
Coomassie Briliant 
Blue R-250 
0.1% (w/v) 
 
Destaining solution 
 
 
EtOH 96% 10% (v/v) 
Acetic acid 5% (v/v) 
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12.5% Separation gel (pH 8.8) Acrylamide/ 
Bisacrylamide 
12.5% /0.33% 
(v/v) 
Tris/HCl  375 mM 
SDS 0.1% (w/v) 
Ammonium 
persulfate 
0.1% (w/v) 
TEMED 0.08% (v/v) 
 
5% Stacking gel (pH 6.8) Acrylamide/ 
Bisacrylamide 
5% /0.16% 
(v/v) 
Tris/HCl  125 mM 
SDS 0.1% (w/v) 
Ammonium 
persulfate 
0.1% (w/v) 
TEMED 0.08% (v/v) 
 
PBS buffer (pH 7.4) NaCl 136 mM 
KCl 2.7 mM 
Na2HPO4 ∙ 2 H2O 8 mM 
K2HPO4 1.8 mM 
 
GST binding buffer (pH 7.4) NaCl 150 mM 
Hepes/NaOH 50 mM 
DTT 2 mM 
EDTA 2 mM 
 
GST elution buffer (pH 8) NaCl 100 mM 
Tris/HCl 50 mM 
Reduced 
Glutathion 
10 mM 
 
His binding buffer (pH 7.4) 
 
 
 
 
 
NaCl 150 mM 
Hepes/NaOH 50 mM 
DTT 2 mM 
Imidazol 20 mM 
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His elution buffer (pH 7.4) NaCl 150 mM 
Hepes/NaOH 50 mM 
Imidazol 1 M 
 
Anion exchange binding buffer (pH 8) NaCl 50 mM 
Hepes/NaOH 50 mM 
 
Anion exchange elution buffer (pH 8) NaCl 1 M 
Hepes/NaOH 50 mM 
 
TBS-T buffer (pH 7.5) Tris 20 mM 
NaCl 125 mM 
Tween 20 0.1% 
 
Blotting buffer  Tris 20 mM 
NaCl 150 mM 
SDS 0.02% 
Methanol 20% 
 
 
 
3.1.6 Chromatography columns 
Column name Company 
GSTrap™ FF, 5 ml GE Healthcare Life Science, Chalfont St 
Giles, UK 
HiLoad™ 16/600 Superdex™ 75 pg GE Healthcare Life Science, Chalfont St 
Giles, UK 
HiTrap™ Q HP, 5 ml GE Healthcare Life Science, Chalfont St 
Giles, UK 
HiTrap™ Desalting, 5 ml GE Healthcare Life Science, Chalfont St 
Giles, UK 
HisTrap™ FF, 5 ml GE Healthcare Life Science, Chalfont St 
Giles, UK 
HiLoad™ 16/600 Superdex™ 200 pg GE Healthcare Life Science, Chalfont St 
Giles, UK 
Superose™ 6, 10/300 GL GE Healthcare Life Science, Chalfont St 
Giles, UK 
PD MiniTrap G-25 GE Healthcare Life Science, Chalfont St 
Giles, UK 
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3.1.7 Fluorophores 
Fluorophore Company 
Atto 390 NHS ester ATTO-TEC GmbH (Siegen, Germany) 
Atto 488 maleimide ATTO-TEC GmbH (Siegen, Germany) 
Atto 532 maleimide ATTO-TEC GmbH (Siegen, Germany) 
Atto 542 NHS ester ATTO-TEC GmbH (Siegen, Germany) 
 
 
3.1.8 Kits 
Kit name Company 
Wizard® Plus SV Minipreps DNA 
Purification Systems 
Promega GmbH, Mannheim, Germany 
Wizard® SV Gel and PCR Clean-Up 
System 
Promega GmbH, Mannheim, Germany 
 
 
3.1.9 DNA and Protein standards 
Standard Company 
Gene Ruler DNA Ladder Mix Thermo Fisher Scientific Inc., Waltham, 
USA 
PageRuler™ Plus Prestained Protein 
Ladder 
Thermo Fisher Scientific Inc., Waltham, 
USA 
Mark12™ Unstained Standard Thermo Fisher Scientific Inc., Waltham, 
USA 
 
 
3.1.10 Designed DNA Oligos  
Primer Sequence 5’ – 3’ Tm  Purpose 
MM74F AACGTATTGAAGCTATCCC 53°C Cloning BAR domain 
into vector pGEX-6P-2 
MM75R TCAAGAATTATACACTCCG 51°C 
MM80F CCAAGGAGAAACTGTGCCAGACTGCCA
CGGCTTCC 
 
80°C 
 
Mutagenisis of ENTH 
domain A155C 
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MM81R GGAAGCCGTGGCAGTCTGGCACAGTTT 
CTCCTTGG 
80°C 
MMP215F CTCGGATCCATGTCGGGCCAAAC 68°C ANTH domain from 
AP180 into vector 
pGEX-6P-2 
MM218R GCGCGGCCGCCTATTTCTTTCCTTCTAA
G 
71°C 
MMP224F GCGTGTATCACAACAGGCCAAAGAGAA
CATGTATGC 
75°C Mutagenisis of Epsin1 
and ENTH domain 
C96A  
MMP224R GCATACATGTTCTCTTTGGCCTGTTGTG
ATACACGC 
75°C 
MMP245F CACCTGCTGTCCCTCCAGCTGCTGATC 74°C Sequencing Epsin1 
MMP248F CATACCATGGGGATGCAGATTTTCGTGA
AAAC 
74°C Clone ubiquitin from 
pET28a (+) into 
pPROex-HTc 
MMP248R CAACTCGAGCTAACCACGAAGTCTCAAC
ACAAG 
74°C 
MMP263F CAATATGTGGACGCTGATGGCAAGGAC
CAG 
73°C Mutagenisis of ENTH 
domain R114A 
MMP263R CTGGTCCTTGCCATCAgcGTCCACATAT
TG 
73°C 
MMP264F CACCTACAATGCTGCGGCCTTCTCCG 73°C Mutagenisis of ENTH 
domain V50,51A 
MMP264R CGGAGAAGGCCGCAGCATTGTAGGTG 73°C 
 
 
3.1.11 Commercial DNA Oligos 
Primer Sequence 5’ – 3’ Target vector Company 
pGEX5-FP AACGTATTGAAGCTATCCC Sequencing 
pGEX 
GATC Biotech 
pGEX3-RP TCAAGAATTATACACTCCG Sequencing 
pGEX 
GATC Biotech 
pQE-FP CGGATAACAATTTCACACAG Sequencing 
pProEX HTc 
GATC Biotech 
pTrcHis-RP CTGATTTAATCTGTATCAGG Sequencing 
pProEX HTc 
GATC Biotech 
T7 TAATACGACTCACTATAGGG Sequencing pET 
vectors 
GATC Biotech 
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3.1.12 Antibodies 
Antibody Catalog number Company 
Epsin 1 ab75879 Abcam AG, Cambridge, UK 
Clathrin Heavy Chain 610500 Becton Dickinson Corp., 
Franklin Lakes, USA 
 
 
3.1.13 Vectors 
Vector Company 
pGEX-6P-2 GE Healthcare Life Science, Chalfont St 
Giles, UK 
pPROEX-HTc Thermo Fisher Scientific, Carlsbad, USA 
pET28+ EMD Biosciences Inc., San Diego, USA 
 
 
3.1.14 Constructs 
Construct Insert Vector 
MM_155 Rat EndophilinA1 N247 (BAR) pGEX-6P-2 
MM_178 Rat Epsin1 WT ENTH 1-164 pGEX-6P-2 
MM_202 Rat Epsin1 WT (full length) - 6His pPROEX-HTc 
MM_274 Rat Epsin1 ENTH C96A A155C pGEX-6P-2 
MM_276 Rat Epsin1 (full length) C96A pPROEX-HTc 
MM_285 Rat Epsin1 ENTH R114A pGEX-6P-2 
MM_286 Rat Epsin1 ENTH C96A R114A 
A155C 
pGEX-6P-2 
MM_B01 Rat Epsin1 ENTH V50,51A pGEX-6P-2 
 
 
3.1.15 Enzymes 
Enzymes Company 
BamHI Thermo Fisher Scientific Inc., Waltham, USA 
EcoRI Thermo Fisher Scientific Inc., Waltham, USA 
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SalI Thermo Fisher Scientific Inc., Waltham, USA 
NotI  Thermo Fisher Scientific Inc., Waltham, USA 
XhoI Thermo Fisher Scientific Inc., Waltham, USA 
Phusion High-Fidelity DNA 
Polymerase 
Thermo Fisher Scientific Inc., Waltham, USA 
T4 DNA Ligase Thermo Fisher Scientific Inc., Waltham, USA 
PreScission protease  GE Healthcare Life Science, Chalfont St Giles, 
UK 
TEV protease Sigma-Aldrich Chemie GmbH, Darmstadt, 
Germany 
Anza™ 10 DpnI Thermo Fisher Scientific Inc., Waltham, USA 
 
 
3.1.16 Lipids 
Abbreviation Full name Company 
L-PtdCho L-α-phosphatidylcholine (Egg, Chicken) Avanti Polar Lipids Inc., 
Alabaster, USA  
L-PtdEtn L-α-phosphatidylethanolamine (Egg, 
Chicken) 
Avanti Polar Lipids Inc., 
Alabaster, USA 
L-PtdSer L-α-phosphatidylserine (Brain, Porcine) 
(sodium salt) 
Avanti Polar Lipids Inc., 
Alabaster, USA 
Brain Extract Polar Brain Polar Lipid Extract (Porcine) Avanti Polar Lipids Inc., 
Alabaster, USA 
Lα-PtdIsn L-α-phosphatidylinositol (Liver, Bovine) 
(sodium salt) 
Avanti Polar Lipids Inc., 
Alabaster, USA 
Lα-PtdIns(4,5)P2 L-α-phosphatidylinositol-4,5-
bisphosphate (Brain, Porcine) 
(ammonium salt) 
Avanti Polar Lipids Inc., 
Alabaster, USA 
Chol Cholesterol (ovine wool, >98%) Avanti Polar Lipids Inc., 
Alabaster, USA 
Atto647N PtdEtn ATTO 647N labeled 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine 
ATTO-TEC GmbH (Siegen, 
Germany) 
Atto 532 PtdEtn ATTO 532 labeled 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine 
ATTO-TEC GmbH (Siegen, 
Germany) 
Atto 532 PtdSer ATTO 532 labeled 1,2-dioleoyl-sn-
glycero-3-phospho-L-serine 
ATTO-TEC GmbH (Siegen, 
Germany) 
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3.1.17 Bacteria strains 
E. coli strains Genotype Company 
BL21(DE3) F- dcm ompT hsdS(rB-mB-)gal Stratagene, California, USA 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZM15 Tn10 (Tetr)] 
Stratagene, California, USA 
 
 
3.1.18 Rat strains 
Rat strain Company 
Lewis rats Charles River Laboratories International Inc 
(Wilmington, USA) 
 
 
3.1.19 Software 
Software Company 
Double digest calculator Thermo Fischer Scientific™, Dreieich, 
Germany 
ExPASy ProtParam web tool ExPASy, Swiss Institute of Bioinformatics, 
Lausanne, Switzerland 
Volocity® 6.3 PerkinElmer Corp., Waltham, USA 
Proteome Discover 2.1 Software Thermo Fisher Scientific Corp, Waltham, 
USA 
xiNET Rappsilber Lab, Edinburgh, UK 
Digital Micrograph™ 1.84.1177 Gatan Inc., Pleasanton, USA 
Fiji (ImageJ) Schindelin, J.; Arganda-Carreras, I. & 
Frise, E. et al. 
GNU Image Manipulation Program (GIMP)  
Origin 8.5.1 OriginLab Corp, Northampton, USA 
PyMOL 1.8.6.0 DeLano Scientific LLC, Palo Alto, USA 
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3.2 Methods 
 
3.2.1 Molecular biological methods 
 
3.2.1.1 Determination of DNA concentration 
The concentration of the purified plasmid DNA was determined photometrically using 
NanoDrop 2000 (Thermo Fisher Scientific Inc., Waltham, USA). The DNA concentration (c) 
was determined according to the Lambert-Beer equation by measuring the absorbance at 
260 nm, with a path length of d = 1 cm and an extinction coefficient of ε = 20 (ml/ng * cm-1).  
 
A260 = c  ε  d 
 
3.2.1.2 DNA isolation 
The isolation of plasmid DNA was performed with the Wizard® Plus SV Minipreps 
DNA Purification Systems according to the manufacturer’s manual (Promega GmbH, 
Mannheim, Germany). For this purpose, E. coli XL-1 Blue competent cells were transformed 
with the desired plasmid and plated on LB agar as described before. A single colony was 
transferred into 5 ml LB medium which contained the corresponding antibiotic for selection. 
The culture was incubated for 8 h at 37°C and 250 rpm until reaching an OD600 of 2.5 to 4 
and subsequently centrifuged for 10 minutes at 20°C and 3220 xg (H-12000 BioProcessing 
Rotor, Thermo Fisher Scientific Inc., Waltham, USA).  
 
3.2.1.3 Restriction digest 
 The key enzyme of this procedure is the restriction endonuclease. It is only found in 
the domain bacteria and archaea as part of their defensive mechanism against phages to 
fragmentize foreign DNA. Restriction endonucleases cleave at specific, palindromic 
recognition sites by hydrolyzing the phosphodiester bond between two nucleotides. The 
restriction endonucleases, used in this work, were only able to generate overhangs of 
unpaired nucleotides in the end of the DNA molecule (cohesive ends). This ensures the 
correct hybridization of DNA molecules (inserts) into target vectors. The DNA constructs in 
this work were always designed with two different restriction recognition sites at the 5’- end 
and the 3’-end. BamHI, EcoRI, SalI, NotI and XhoI (10 U/µl, Thermo Fisher Scientific Inc., 
Waltham, USA) were pairwise used as restriction endonucleases. The double digest 
calculator web tool (Thermo Fisher Scientific Inc., Waltham, USA) was used to determine the 
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correct temperature, the appropriate molar ratios of the enzymes and the buffers. The 
restriction digests were performed at 37°C during 1.5 h during.  
 
Table 1: Restriction digest mix 
Component Quantities 
Template vector / DNA fragment 1 µg 
Rstriction enzyme buffer 1x 
Restriction endonuclease for 5’ recognition site 10 U 
Restriction endonuclease for 3’ recognition site 10 U 
ddH2O Add to 20 µl 
 
3.2.1.4 Ligation of DNA 
 The DNA ligase plays an important role in the general DNA replication. It catalyzes 
the formation of a phosphodiester bond between two DNA chains by linking the free hydroxy 
group at the 3’-end of a nucleotide to the 5’-phosphate group of a second nucleotide.  
These enzymes are used to target DNA with the appropriate position of the multiple 
cloning site of modified vectors in molecular biological procedures. For the ligation to occur, 
it is necessary that the vector and insert are digested with the same restriction 
endonucleases, in order to generate matching cohesive ends. The ligase of the T4 phage is 
the most commonly used ligase in molecular biological methods because of its versatility. It 
is able to link blunt ends (no single strand overhang) as well as cohesive ends and even 
RNA to DNA molecules. In this work, the T4 DNA Ligase 5 U/µl (Thermo Fisher Scientific 
Inc., Waltham, USA) was used together with the 10x T4 DNA ligase Buffer (Thermo Fisher 
Scientific Inc., Waltham, USA). Two different molar ratios (1:1 and 3:1) of the insert DNA to 
the vector DNA were prepared in the reaction mixtures in general. The ligations were 
performed at 16°C during 18 h. 
 
Table 2: Ligation reaction mix 
Component Quantities 
Vector 25 ng 
Insert DNA Molar ration of 1 or 3 
T4 DNA ligase 7.5 U 
10x T4 DNA ligase buffer 1x 
ddH2O Add to 20 µl 
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3.2.1.5 Agarose gel electrophoresis 
The agarose gel electrophoresis is a method used to separate and further analyze 
DNA molecules. The phosphate backbone confers the nucleic acids a negative charge that 
is proportional to their size. Thus, the DNA molecules migrate into the direction of the anode 
in an electric field. The agarose gel acts as a shive, restraining DNA molecules according to 
their size. Larger DNA fragments migrate slower than smaller ones.  
In order to prepare1% agarose gels, 1% (w/v) Agarose NEEO ultra quality (Carl Roth 
GmbH & Co KG, Karlsruhe, Germany) was added into TAE buffer and the mixture was 
heated up until the agarose was solved. To visualize the separated DNA after 
electrophoresis, 0.1% (v/v) ethidium bromide solution 250 µg/ml (Carl Roth GmbH & Co KG, 
Karlsruhe, Germany) was added to the solved agarose. The gels were solidified and the 
electrophoresis was performed in the horizontal electrophoresis system Sub-Cell® GT cell 
(Bio-Rad Laboratories GmbH, Munich, Germany). The DNA samples were mixed with 10x 
FastDigest Green Buffer (Thermo Fisher Scientific Inc., Waltham, USA) with a volume ration 
of 1:9 before loading them into the agarose gel. Gene Ruler DNA Ladder Mix 0.5 µg/µl 
(Thermo Fisher Scientific Inc., Waltham, USA) was also loaded in the gel, in order to 
determine the size of the DNA fragments. After preparing the gel as well as the samples, the 
electrophoresis was performed at 90 V during 30 min with the Biometra power pack model 
250 power supply (Biometra GmbH, Göttingen, Germany). The separated DNA was 
visualized with the Intas gel documentation system (INTAS Science Imaging Instruments 
GmbH, Göttingen, Germany) 
 
3.2.1.6 DNA extraction from agarose gels 
After the separation of DNA molecules by agarose gel electrophoresis, it is possible 
to extract the identified target DNA fragments from the gel. The isolation was performed with 
the Wizard® SV Gel and PCR Clean-Up System according to the manufacturer’s manual 
(Promega GmbH, Mannheim, Germany). For this purpose, the DNA fragments were made 
visible with the UV light source Biometra TI 1 (Biometra GmbH, Göttingen, Germany) and 
cut out of the gel. The agarose slices were melted at 50°C to isolate the DNA with the 
purification kit.  
 
3.2.1.7 Polymerase chain reaction 
 The polymerase chain reaction (PCR) is a versatile method to amplify DNA. The key 
enzyme in the PCR is a thermostable DNA polymerase that retains its enzymatic activity 
even at the high temperatures used for this method. The DNA polymerase catalyzes the 
linking of phosphodiester bonds between single nucleotides in dependence of a 
complementary single stranded DNA template. The enzyme used in this work, was the 
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Phusion High-Fidelity DNA Polymerase 2 U/µl (Thermo Fisher Scientific Inc., Waltham, 
USA). The PCR mix needs in addition short DNA oligonucleotides (self-designed Primers 
were manufactured at Metabion GmbH, Steinkirchen, Germany) that flank the DNA 
sequence of interest and deoxyribonucleotide triphosphates to elongate the new synthesized 
DNA strand. 
One PCR cycle consist of three steps: 
1. Denaturing: the separation of the DNA molecule into two single strands at 95°C. 
2. Hybridization: the attachment of the DNA primers to the complementary sequence on 
the template DNA at lower temperature, e.g. 55°C. 
3. Elongation: Synthesis of a new DNA strand mediated by the DNA-polymerase at the 
catalytic temperature optimum, e.g. 68°C) 
The three steps were repeated 20 to 40 times. The excess of DNA primers ensured that 
the new synthesized DNA strands could also be used as templates for the following PCR 
cycle. Thus, the number of new DNA molecules increased exponentially.  
 
Table 3: PCR reaction mix 
Component Quantities 
DNA template 100 ng 
5’-primer 10 pmol 
3’-primer 10 pmol 
dNTPs (dATP, dGTP, dCTP, dTTP) 10 nmol 
5x HF buffer (Thermo Fisher Scientific Inc., Waltham, USA) 1x 
DMSO (Sigma-Aldrich Chemie GmbH, Darmstadt, Germany) 3% (v/v) 
ddH2O Add to 50 µl 
 
 
Table 4: PCR program 
Step Temperature Time  Cycles 
1. Initial denaturation 98 °C 30 sec   
2. Denaturation 98 °C 50 sec  
x20 3. Hybridization X°C 30 sec 
4. Elongation 68°C 2 min 
5. Final elongation 68°C 2 min   
6. Storage 8°C ∞   
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The hybridization temperature was adjusted 5°C lower than the melting temperature 
of the used DNA primers. The PCRs were performed in the Biometra Tpersonal 
thermocycler (Biometra GmbH, Göttingen, Germany). Subsequently to the PCR, a DpnI 
digest was performed after with every mix to fragmentize the methylated template DNA. 
Therefore, 10 U of Anza™ 10 DpnI Buffer (Invitrogen AG, Carlsbad, USA) were added 
directly into the PCR mixes and incubated at 37°C for 1 h. The digested PCR mixes were 
purified with the Wizard® SV Gel and PCR Clean-Up System according to the 
manufacturer’s manual (Promega GmbH, Mannheim, Germany) afterwards. Finally, the DNA 
concentration was determined and the DNA was stored at -20°C. 
 
3.2.1.8 Mutagenisis 
 In order to mutate a single amino acid in the protein sequence, a mutagenisis PCR 
was performed. The primers needed for this special kind of PCR were designed with 20 to 
30 bp with an alteration in the nucleotide sequence, in respect to the template DNA, in the 
middle of the primers. Finally, the nucleotide exchange leads to the expression of a mutated 
protein. The elongation step of the PCR was also increased to 10 min to ensure that the 
whole plasmid was amplified.  
 
Table 5: Mutagenisis PCR program  
Step Temperature Time  Cycles 
1. Initial denaturation 98 °C 30 sec   
2. Denaturation 98 °C 50 sec  
x20 3. Hybridization X°C 30 sec 
4. Elongation 68°C 10 min 
5. Final elongation 68°C 10 min   
6. Storage 8°C ∞   
 
 
3.2.1.9 General cloning strategy 
 In order to insert a target DNA fragment into a vector of choice, suitable restriction 
sites on the vector sequence were chosen. The DNA fragment and the vector were both 
cleaved with the same restriction endonucleases. After performing a separation by gel 
electrophoresis and the extraction of the target DNAs out of the agarose gel, a T4 DNA 
ligation was performed. Finally, the ligated DNA was used for transformation of E. coli XL1-
Blue cells for vector amplification and plated out on LB agar plates. 
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3.2.1.10 Sequencing of DNA 
 All generated plasmid constructs were sequenced by GATC Biotech AG (Konstanz, 
Germany). 
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3.2.2 Cell biological methods 
 
3.2.2.1 Transformation of chemically competent cells 
In the process of transformation, modified vectors which carry the target genes, are 
introduced into competent bacterial cells for recombinant expression and vector 
amplification. For this purpose, 100 to 200 ng of a vector are added to 50 µl of a competent 
bacterial suspension and gently mixed. After incubating the suspension on ice during 5 min, 
a heat shock is performed within 45 sec at 42°C for the uptake of the vector (Thermomixer 
comfort, Eppendorf AG, Hamburg, Germany). After cooling the suspension on ice for 2 more 
minutes, 300 µl of lysogeny broth (LB) medium is added to the bacteria suspension and 
incubated for 1 h at 37°C and 450 rpm (Thermomixer comfort, Eppendorf AG, Hamburg, 
Germany). Depending on transformation efficiency, 50 µl up to the whole transformation 
preparation is transferred onto an LB agar plate, containing the corresponding antibiotics for 
selection, and streaked out. The prepared agar plates are then incubated for at least 14 h at 
37°C in order to obtain visible single colonies (Incubator B-6120, Heraeus GmbH, Hanau, 
Germany). 
In this work, the E. coli strain BL21(DE3) was used as bacterial expression host for 
all proteins and the E. coli strain XL1-Blue was used for amplification of all vectors. 
 
3.2.2.2 Expression of recombinant proteins by IPTG induction 
The modified vectors that were used to transform E. coli expression and amplification 
hosts have a similar architecture. They contain their own origin of replication and a gene 
encoding the β-lactamase, which introduces ampicillin resistance to the bacterial host and 
acts as a selective marker for bacteria carrying the target vector. The expression is regulated 
by the lac system. The lac operon upstream of the target gene is under control of the lac 
repressor. The repressor loses the affinity to the operator in presence of lactose or a lactose 
analogue (Isopropyl-β-D-thiogalactopyranosid) and the target gene is accessible for the 
RNA-polymerase. 
In this work the vectors pGEX-6P-2 (GE Healthcare Europe, Freiburg, Germany) and 
pProEx HTc (Thermo Fisher Scientific, Carlsbad, USA) were used. The transcription of 
pGEX-6P-2 is regulated by a hybrid promotor (tac promotor) composed by the trp and lac 
UV5 promotors. The expressed fusion protein contains a N-terminal glutathione S-
transferase and a cleavage site for a modified human rhinovirus 3C protease (PreScission 
protease). The pProEx HTc vector also contains a hybrid promotor (trc promotor) composed 
by the trp and lac UV5 promotors. The expressed fusion protein contains a N-terminal hexa-
histidine, that can be cleaved by a modified tobacco etch virus protease (TEV protease). 
Materials and methods: methods 
 
50 
 
For the recombinant expression E. coli BL21 (DE3) cells were transformed as 
described before. A single colony was transferred from the LB-agar plate into 50 to 100 ml 
liquid LB medium containing 100 µg/ml ampicillin (pre-culture) and incubated during 12 to 16 
h at 37°C and 250 rpm agitation (Innova 4200, New Brunswick Scientific, Edison, USA). 
After incubation, the optical density (OD) of the pre-culture was determined (Eppendorf 
BioPhotometer, Eppendorf AG, Hamburg, Germany) at 600 nm and used to inoculate 2 to 4 l 
of LB medium, which contained also 100 µg/ml ampicillin (expression culture). Therefore, the 
appropriate inoculation volume to reach an OD600 of 0.05 in the expression culture was 
calculated. The expression culture was incubated afterwards during 2 to 2.5 h at 37°C and 
140 rpm agitation until it reached an OD600 of 0.6 to 0.8. The cell density indicated that the 
bacterial culture was still in the exponential growth phase. Isopropyl-β-D-
thiogalactopyranosid (IPTG) was added to the expression culture with a final concentration 
of 1 mM and it was incubated during 3 more hours at 30°C and 140 rpm agitation (Innova 
44, New Brunswick Scientific, Edison, USA). The expression culture was finally centrifuged 
for 10 min at 4°C and 5316 xg (Thermo Scientific H-12000 BioProcessing Rotor). The cell 
pellet was separated from the supernatant and resuspended with 40 ml Hepes-Buffer per 2 l 
culture on ice. The cell suspension was subsequently centrifuged for 30 min at 4°C and 
3250 xg (Eppendorf Swing-bucket rotor A-4-62). The supernatant was discarded and the cell 
pellet was stored at -20°C. 
In order to express isotope labeled proteins for NMR studies, transformed E. coli 
BL21 (DE3) cells were cultured and the expression was performed in M9 minimal medium 
179. The used minimal medium contained D-glucose-1-13C (Sigma-Aldrich Corp., St. Louis, 
USA) as defined carbon source and ammonium-15N2 sulfate (Sigma-Aldrich Corp., St. Louis, 
USA) as defined nitrogen source to ensure that the expressed proteins would be isotope 
labeled. The cultivation and expression was performed in the same way as the expression in 
LB medium. The M9 minimal medium was freshly mixed together before inoculation and 
consisted of: 1 l M9 basal medium (containing ammonium-15N2 sulfate), 2 g D-glucose-1-
13C, 
2 mM MgSO4, 20 ml trace elements, 10 ml 100x MeM vitamin solution (Thermo Fisher 
Scientific Inc., Waltham, USA).  
 
3.2.2.3 Cell lysis 
 E. coli cells were always lysed physically by using the pneumatic cell disintegrator 
EmulsiFlex-C3 (Avestin Inc., Ottawa, Canada). For this purpose, the E. coli cell pellet was 5-
fold diluted (w/v) and resuspended with lysis buffer. The lysis was performed at a pressure of 
1000 bar and 3 cycles at 4°C. The whole cell lysate was centrifuged at 208000 xg and 4°C 
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during 1 h (Type 70 Ti Rotor, Beckman Coulter Inc., Fullerton, California) to separate the cell 
debris from soluble lysate which was used for purification by chromatographic methods. 
 
3.2.2.4 Competent cells 
The generation of chemically competent E. coli cells was performed according to the 
procedure described by Hanahan D. et al. 180. Therefore, untransformed E. coli cells were 
grown in 1 l LB medium at 37°C and 140 rpm until reaching an OD600 of 0.6 to 0.7. The 
culture was subsequently centrifuged for 10 min at 4°C and 2700 xg (Thermo Scientific H-
12000 BioProcessing Rotor) and the supernatant was discarded. The cell pellet was then 
resuspended with 200 ml of competent cell buffer 1 on ice and centrifuged again for 10 min 
at 4°C and 2700 xg (Thermo Scientific H-12000 BioProcessing Rotor). Finally, the resulting 
cell pellet was separated from the supernatant and resuspended in 30 ml of competent cell 
buffer 2. The cell suspension was then aliquoted, frozen in liquid nitrogen and stored at -
80°C. 
 
3.2.2.5 Synaptosomal CCV isolation from rat brains 
Brains were extracted from Lewis rats, deep frozen, and homogenized using a 
MICCRA D-9 homogenizer (Miccra GmbH, Müllheim, Germany) in HKM buffer, in a ratio of 
1:1 (w/v). The homogenized rat brains were 6-fold (v/v) diluted with HKM buffer and 
centrifuged at 1000 xg and 4°C for 10 min (H-12000 BioProcessing Rotor, Thermo Fisher 
Scientific Inc., Waltham, USA). After collecting the supernatant, it was centrifuged at 10200 
xg and 4°C for 15 minutes (Type 70 Ti Rotor, Beckman Coulter Inc., Fullerton, California). 
After separation, the supernatant was collected and homogenized with twenty cycles to 12 
µm clearance by the Isobiotec Cell Homogenizer (Isobiotec, Heidelberg, Germany) and 
subsequently centrifuged at 25000 xg and 4°C for 20 minutes (Type 70 Ti Rotor, Beckman 
Coulter Inc., Fullerton, California) to separate CCVs from the plasma membrane. The 
supernatant was collected and centrifuged at 100000 xg at 4°C for 1 h to pellet CCVs. 
Finally, the supernatant was discarded. The pellet was resuspended in 5 ml of clathrin 
disassembly buffer and incubated at 250 rpm agitation and 4°C during 1 h and then further 
subjected for purification by chromatographic methods. 
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3.2.3 Lipid related methods 
 
3.2.3.1 Lipid stocks 
 The lipids used in this work were obtained lyophilized from Avanti Polar Lipids Inc. 
(Alabaster, USA). Lipids were resuspended in a 1:1 (v/v) mixture of CHCl3 ROTIPURAN
® 
(Carl Roth GmbH & Co. KG, Karlsruhe, Germany) and MeOH ROTIPURAN® (Carl Roth 
GmbH & Co. KG, Karlsruhe, Germany). The stock concentrations of the membrane matrix 
lipids Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns, cholesterol and the Brain Polar Lipid 
Extract (Folch) were adjusted to 25 mg/ml. The lipid Lα-PtdEtn-Rhod (PtdEnt coupled to the 
fluorescent molecule lissamine rhodamine B sulfonyl) (Avanti Polar Lipids Inc., Alabaster, 
USA) was obtained already dissolved in CHCl3 and MeOH in the ratio 1:1 (v/v) with the 
concentration of 1 mg/ml. Lα-PtdIns(4,5)P2 (Avanti Polar Lipids Inc., Alabaster, USA) was 
also obtained already dissolved, but in a mixture of CHCl3, MeOH and H2O with the ratio 
20:9:1 (v/v/v) and a concentration of 5 mg/ml. 
The fluorescent lipids Atto 647N PtdEnt (Atto 647N coupled to 1,2-Dioleoyl-sn-
glycero-3-phosphoethanolamin), Atto 532 PtdEnt (Atto 532 coupled to 1,2-Dioleoyl-sn-
glycero-3-phosphoethanolamin) and Atto 532 PtdSer (Atto 532 coupled to 1,2-dioleoyl-sn-
glycero-3-phospho-L-serine) were obtained from ATTO-TEC GmbH (Siegen, Germany) and 
were already dissolved in a 1:1 (v/v) mix of CHCl3 and MeOH with a concentration of 1 
mg/ml). All lipid stocks were stored at -80°C. 
 
3.2.3.2 Preparation of small and large unilamellar vesicles 
 Artificial vesicles, of different sizes, are a well-established membranes model and 
commonly used in a variety of membrane related methods, because of their versatility. LUVs 
and SUVs are distinguished by their sizes: If the vesicles are larger than 100 nm, they are 
called LUVs, while vesicles smaller than 50 nm are called SUVs. 
The desired lipid mixtures were prepared directly from the stock solutions. Therefore, 
the molar ratios of the lipids were calculated and the in solvent solved lipids were transferred 
into glass tubes. In order to produce a lipid film, the solvents were evaporated initially by 
flushing with N2 and finally by desiccation with applied vacuum for 2 h. After drying the lipid 
film, Hepes buffer was added. The final lipid concentrations were between 4 mg/ml and 10 
mg/ml.  
The method to produce unilamellar vesicles by coupling freeze-thaw cycles with 
extrusion through polycarbonate filters was described by Hope M. J. et al. 181. The lipid 
suspensions were frozen in liquid nitrogen, thawed and finally vortexed during 30 sec. The 
cycle was repeated ten times. The lipid suspensions were forced into the right vesicle sizes 
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by 41 times extrusion with a mini-extruder (Avanti Polar Lipids Inc., Alabaster, USA) through 
Whatman® Nuclepore™ Track-Etched Membranes (Whatman plc, Maidstone, UK) filters 
with 200 nm (for LUVs) or 30 nm (for SUVs). An additional step was included to obtain SUVs 
after the freeze-thaw cycles. The lipid suspension was treated by sonification with one 1 sec 
pulse at 20 kHz and 30% amplitude (SONOPLUS HD2200 & UW2070, BANDELIN 
electronic GmbH & Co. KG, Berlin, Germany), followed by 15 secs incubation on ice. The 
cycle was repeated 30 times 
 
3.2.3.3 Preparation of giant unilamellar vesicles 
  GUVs are an important model membrane system since it is possible to observe them 
by light microscopy methods. Due to their large size (> 1 µm) they are accepted as a model 
membrane system with low curvature. These vesicles are often used to perform protein 
binding and deformation studies by fluorescence microscopy 53, 182, or to analyze the 
physical properties of membranes 173. GUVs were prepared according to Angelova M. I. et 
al. 183 in an external alternating (AC) electrical field 184. 8 µl of the desired lipid mix (0.2 
mg/ml) in 1:1 (v/v) CHl3 and MeOH (Carl Roth GmbH & Co. KG, Karlsruhe, Germany) was 
spread onto two indium tin oxide-coated glass slides (ITOs, Nanion Technologies GmbH, 
Munich, Germany) and dried at 50°C, then by nitrogen flushing and finally by desiccation 
with applied vacuum for 2 h. After drying, the ITOs were assembled into the GUV generation 
chamber Nanion Vesicle Prep Pro (Nanion Technologies GmbH, Munich, Germany), 
separated by 600 µl of GUV sucrose buffer in a rubber spacer ring. The GUVs were 
electroformed by applying an electric field for 3 h starting at 20 mV and increasing 
continuously to 1.1 V at 12 Hz. To detach the GUVs from the ITO slides a final step was 
included changing the conditions to 2 V, 4 Hz during 30 min.  
 
3.2.3.4 Determination of lipid content 
 The lipid content of a liposome sample was determined by measuring the phosphate 
content described by Rouser G. et al. 185. Therefore, 200 µl of perchloric acid (70%) was 
added to 30 µl of the liposome sample. The mixture was heated up to 220°C for 60 min in 
order to extract the inorganic phosphate out of the lipids. Subsequently, the sample was 
cooled down to room temperature and 700 µl of molybdenum solution (0.45% (w/v) 
NH4MoO4 and 12.6% (w/v) HClO4) and 700 µl of a 1.7% (w/v) ascorbic acid solution were 
added. The sample was incubated at 80°C for 10 minutes and finally, the absorption at 820 
nm was measured for the samples by a JASCO V-650 Spectrophotometer (JASCO 
Germany GmbH, Gross-Umstadt, Germany). The phosphate content was determined by 
using a standard ranging from 0 µg to 2 µg phosphate produced from a NaH2PO2 solution.  
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3.2.4 Protein biochemistry 
 
3.2.4.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
  
 The SDS-PAGE is a method to separate proteins according to their molecular size. 
The negatively charged detergent SDS assembles into complex with proteins in a constant 
mass to charge proportion. The proteins denature due to the formation of the detergent-
protein complexes, thus the intrinsic structure and charge of the proteins are irrelevant. The 
polyacrylamide matrix acts as a molecular shive, decelerating the migration of larger 
proteins.  
SDS-gels for this work were prepared according to Lämmli U. K.186. The gels were casted 
with two SDS matrices, a separation gel overlaid by a stacking gel. The coarse-pored 
stacking gel had a pH of 6.8 and the fine-pored separation gel had a pH of 8.8. Due to the 
pH differences within the gel, glycine ions show two different migration behaviors in 
comparison to the chloride ions. In the stacking gel glycine migrates slow because of the 
zwitterionic character, while it migrates faster in the separation gel. This effect is used to 
focus the protein samples within the interlayer between the two gel matrices.  
The electrophoretic separation was performed in a Mini-PROTEAN® Tetra Vertical 
Electrophoresis Cell (Bio-Rad Laboratories Inc., Hercules, USA) with the PowerPac™ HC 
High-Current Power Supply (Bio-Rad Laboratories Inc., Hercules, USA). 4x loading buffer 
was added to the samples and loaded into the wells of the SDS gel. PageRuler™ Plus 
Prestained Protein Ladder (Thermo Fisher Scientific Inc., Waltham, USA) was loaded into 
one well in addition, in order to determine the sizes of the proteins. The chamber was filled 
with SDS-PAGE running buffer and the run was performed at initially 70 V until the samples 
were focused and then at 180 V until the running front reached the end of the gel. The gels 
were then used for Coomassie staining, or for Western blotting.  
 
3.2.4.2 Visualization of proteins by Coomassie Brilliant Blue 
 In order to visualize the separated proteins after gel electrophoresis the SDS gels 
were stained with a solution containing Coomassie Brilliant Blue R-250. The staining solution 
contains in addition acetic acid to fix the proteins on the gel. 
The gels were placed into the staining solution, shortly heated up and incubated 
under gentle agitation for 30 min. After that, the staining solution was discarded and the gels 
were washed with water. Finally, the gels were put into destaining solution to remove the 
unspecific residuals of the Coomassie Brilliant Blue R-250.  
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In order to visualize also lipids, in addition to proteins on a gel, a staining solution without 
EtOH was used and the destaining procedure was performed just with ddH2O. 
 
3.2.4.3 Protease digest 
 Proteases are enzymes, that catalyze the hydrolyses of a peptide bond between two 
amino acids. The protease digests in this work were performed to cleave the expressed 
fusion proteins into affinity tag and target protein. The PreScission-Protease was used for 
fusion proteins expressed from pGEX-6P vectors. It is a modified cysteine protease from the 
human rhinovirus 3C and recognizes the sequence Leu - Glu - Val - Leu - Phe - Gln - Gly - 
Pro. The TEV (tabacho etch virus) protease was used if proteins were expressed from the 
pProEx HTc. The TEV protease is also a cysteine protease and recognizes the sequence 
Glu - Asn - Leu - Tyr - Phe - Gln – Gly. 
The proteases were added to the fusion protein with a molar ratio of 1:100. The 
digest reaction was performed at 4°C with gentle agitation during 16 h. 
 
3.2.4.4 Concentration of proteins  
 Proteins in aqueous solution were concentrated by centrifugation. Therefore, 
concentrators that possess a membrane with defined pore sizes (Amicon® Ultra 4 and 15 
mL Centrifugal Filters 10,000 NMWL, Merck KGaA, Darmstadt, Germany) were used. The 
proteins are concentrated in the solution above the membrane, while the flow through is 
collected into vile. The size of the target proteins correlates with the pore size thus the 
proteins can be retained above the membrane. The centrifugation was performed at 5316 xg 
(H-12000 BioProcessing Rotor, Thermo Fisher Scientific Inc., Waltham, USA) and 4°C 
during 5 min. The procedure was repeated several times and the proteins suspension was 
mixed by pipetting after each centrifugation.  
 
3.2.4.5 Protein determination  
 Protein concentrations were determined spectrophotometrically either by 
NanoDrop™ 2000 (Thermo Fisher Scientific Inc., Waltham, USA), or by the JASCO V-650 
Spectrophotometer (JASCO Germany GmbH, Gross-Umstadt, Grmany). The protein 
concentrations (c) were calculated according to the Lambert-Beer equation by measuring the 
absorbance at 280 nm, with a path length of d = 1 cm. The individual extinction coefficients 
(ε) and the exact molar masses of the proteins were determined by the EXPASY ProtParam 
web tool 187. 
A280 = c  ε  d 
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3.2.4.6 Fluorescent label of proteins  
 In order to perform fluorescence microscopy with GUVs and also FRET experiments, 
several proteins were fluorescently labeled during this work. Two different reactive groups, 
coupled to the fluorophore, are commonly used to label proteins:  
1. N-Hydroxysuccinimide (NHS-ester) reacts with primary amines of the amino acid 
chains. Thus, the first amino acid of the sequence as well as accessible lysines are 
labeled. The substitution reaction takes preferentially place in a pH of 8.0 to 9.0. 
Fluorophores attached to NHS-ester were dissolved in dimethyl sulfoxide (DMSO) 
with a concentration of 8 mg/ml. 
2. Maleimides react with accessible cysteines of the protein and the preferred pH for the 
reaction is between 7.0 and 7.5. Fluorophores attached to maleimides were 
dissolved in dimethylformamide (DMF) with a concentration of 8 mg/ml. 
The ENTH WT (C96A A155C) domain, the ENTH R114A (C96A A155C) and Epsin1 WT 
(C96A) were labeled with Atto488 maleimide (ATTO-TEC GmbH, Siegen, Germany), and for 
FRET experiments with Atto532 maleimide in addition, by cysteine modification. The 
substitution reaction took place in PBS buffer (pH 7.4) with a molar access of the fluorophore 
of 1.4 in respect to the protein. The substitution was performed at 4°C with gentle agitation 
on a tumbling shaker (Biometra WR12 Taumelschüttler, Bioemtra GmbH, Göttingen, 
Germany) during 16 h.  
Clathrin was labeled with Atto542 NHS-ester and Ubiquitin chains were labeled with 
Atto390 NHS-ester (ATTO-TEC GmbH, Siegen, Germany) by primary amine modification. 
The substitution was performed in PBS buffer, in which the pH was increased by the addition 
of 200 mM NaHCO3 (pH 9) with a ratio of 20:1 (v/v). The molar access of both fluorophores 
was 3 in respect to the proteins. The substitution was performed at 4°C with gentle agitation 
on a tumbling shaker (Biometra WR12 Taumelschüttler, Bioemtra GmbH, Göttingen, 
Germany) during 16 h. 
When the reaction was finished, the proteins were separated from the free 
fluorophores by size exclusion chromatography with PD MiniTrap G-25 prepacked columns 
(GE Healthcare Life Science, Chalfont St Giles, UK). Finally, the degree of labeling (DoL) of 
the proteins was determined spectrophotometrically by measuring the UV-Vis (NanoDrop 
2000, Thermo Fisher Scientific Inc., Waltham, USA). For this purpose, the following equation 
was used: 
 
DoL = Amax  εprot  (A280 - (Amax  CF280)
-1  εmax
-1 
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Amax is the absorption at the characteristic wavelength of the fluorophore, εmax is the molar 
extinction coefficient of the fluorophore, A280 is the absorption of the protein at 280 nm, εprot is 
the molar extinction coefficient of the labeled protein and CF280 is the correction factor of the 
fluorophore. 
 
3.2.4.7 TCA precipitation 
 Protein precipitation by trichloroacetic acid (TCA) (Carl Roth GmbH & Co. KG, 
Karlsruhe, Germany) is a commonly used method to denature proteins and to reduce the 
volume of a protein sample for SDS-PAGE. TCA denatures proteins by promoting 
hydrophobic aggregation in two assumed ways: it dehydrates the hydration shell around 
proteins and it presumably disrupts electrostatic interactions within the proteins, due to its 
strong anionic character. Therefore, 10% (w/v) of ice-cold TCA was added to the protein 
samples and incubated on ice during 30 min. The samples were then centrifuged at 16000 
xg at 4 °C for 30 min (Eppendorf rotor F45-24-11, Eppendorf AG, Hamburg, Germany). The 
supernatant was discarded after centrifugation and the pellet was resuspended with 500 µl 
ice-cold acetone. The samples were centrifuged a second time with the same conditions and 
the pellets were dried for 2 h with a Savant SPD-131DDA SpeedVac Concentrator (Thermo 
Fisher Scientific Inc., Waltham, USA), after separating them from the supernatants. Finally, 
the dried samples were resuspended with 30 µl 2x SDS-loading buffer and analyzed by 
SDS-PAGE. 
 
3.2.4.8 Western Blot and immuno staining 
In order to detect specific proteins after SDS-PAGE, proteins were transferred from 
SDS Gels by western blotting and visualized by immuno staining. Therefore, the SDS gels 
was placed on a methanol-activated PVDF membrane, soaked with blotting buffer and 
transferred into a semi-dry blotting chamber (PEQLAB Biotechnologie GmbH, Erlangen, 
Germany). The western blot was performed for 1 h at125 mA and 13 V. 
After blotting, the membrane was blocked in TBS-T buffer containing 5% skim milk 
and the appropriate concentration of antibodies for 1 h at room temerpature. Subsequently 
to this, the membrane was washed 3 times for 15 min in TBS-T buffer and incubated with the 
appropritate concentration of secondary antibody in TBS-T buffer for 1 h at room 
temperature. Finally, the membrane was washed again 3 times for 15 min in TBS-T buffer. 
The ECL or Luminata solutions were added to the membrane and signals were detected on 
x-ray films by developing in the CAWOMAT 2000 IR developing machine (CAWO Solutions, 
Schrobenhausen, Germany). 
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3.2.5 Chromatographic methods 
 
3.2.5.1 Affinity chromatography of GST fusion proteins 
 The purification by Glutathion S-transferase (GST) affinity chromatography is a highly 
specific and selective isolation method of target proteins. Target proteins are expressed from 
pGEX vectors as GST fusion proteins. The 26 kDa GST protein has a high affinity to the 
tripeptide glutathione (GSH), which is embedded into the sepharose matrix of GST affinity 
chromatography columns (GSTrapFF™ 5 ml, GE Healthcare Life Science, Chalfont St Giles, 
UK). The elution of the GST fusion proteins is achieved by the addition of reduced GSH in 
the liquid phase which binds to GST with a higher affinity than the GSH sepahrose and GST 
proteins are mobilized again. 
GSTrapFF™ 5 ml columns were used together with the ÄKTAPrime Plus system (GE 
Healthcare Life Science, Chalfont St Giles, UK) in this work. The column was equilibrated 
with GST binding buffer in the initial step with a flow of 5 ml/min for 5 column volumes (25 
ml), followed by the injection of the soluble cell lysate or the protein sample with a flow of 0.4 
ml/min. The column was then washed with GST binding buffer until the absorbance at 280 
nm decreased to 0 with a flow of 5 ml/min. In the final step, the elution of GST or GST fusion 
proteins was promoted by GST elution buffer with a flow of 1 ml/min. All purifications were 
performed at 4°C. 
 
3.2.5.2 Affinity chromatography of polyhistidine fusion proteins 
 Fusion proteins that were expressed with a polyhistidine (polyhis) affinity sequence 
from pProEx vectors, were purified by HisTrapFF™ 5 ml (GE Healthcare Life Science, 
Chalfont St Giles, UK). The principle of this method is that metal chelate complexes 
embedded into the column matrix by sepharose. HisTrapFF™ 5 ml columns possess Ni2+ as 
metal ions which are immobilized by nitrilotriacetic acid (Ni-NTA). The elution of the fusion 
proteins is promoted by high concentrations of imidazole that binds with higher affinity to the 
column material.  
The method is less specific and selective than the GST affinity chromatography since 
proteins with histidines in relative proximity on the molecular surface of the proteins also bind 
the column material. Thus, the elution was always promoted by an imidazole gradient with 
increasing concentration.  
HisTrapFF™ 5 ml columns were always used with the ÄKTAPrime Plus system (GE 
Healthcare Life Science, Chalfont St Giles, UK) in this work. In the initial step, the column 
was equilibrated with five times the column volume (25 ml) and a flow of 5 ml/min of His 
binding buffer. After equilibration, the sample was injected onto the column with a flow of 0.5 
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ml/min, followed by a wash step with a flow of 5 ml/min until the absorbance at 280nm 
decreased to 0. The elution was promoted with a gradient of 20 mM imidazole to 1 M 
imidazole (His binding buffer to His elution buffer) for 75 ml and a flow of 2 ml/min. Finally, 
the column was washed with 30 ml with His elution buffer and a flow of 5 ml/min. All 
purifications were performed at 4°C. 
 
3.2.5.3 Buffer exchange of protein solutions with the ÄKTAPrime Plus 
 Small scale buffer exchanges of protein solutions were performed with HiTrap™ 
Desalting 5 ml columns (GE Healthcare Life Science, Chalfont St Giles, UK) coupled with 
ÄKTAPrime Plus system (GE Healthcare Life Science, Chalfont St Giles, UK). The column 
matrix of the desalting columns consists of Sephadex G-25 Superfine, a porous material 
which decelerates the migration speed of molecules anti-proportional to their size.  
The buffer exchanges were initiated by washing with five times the column volume, 
using the buffer of choice and a flow of 5 ml/min. The protein sample was injected with 1 
ml/min and a maximum volume of 2 ml of sample. Finally, the sample was eluted with 2 
ml/min. All purifications were performed at 4°C. 
 
3.2.5.4 Anion exchange chromatography 
 The principle of ion exchange chromatographies is based on the net surface charge 
of the proteins. The matrix of anion exchange column consists of sepharose coupled to a 
quaternary ammonium that is positively charged. The net charge of a protein depends on the 
pH of the buffer. Proteins with a negative net charge interact with the column material and 
are separated from positively charged or non-charged proteins. The elution is promoted by 
using high salt buffers.  
Anion exchange chromatography was predominantly used to separate the ENTH 
domain (and mutants) from cleaved GST. The computed theoretical isoelectric point (pI) of 
the ENTH domain was 9.14, and pI of the GST tag was 5.20 (computation of the pI was 
performed with the EXPASY ProtParam web tool). Thus, the pH of the buffers was adjusted 
to 8.0 in which the ENTH domain is positively charged and the GST tag is negatively 
charged. So, the ENTH domain was expected to pass through column and the GST was 
expected to be retained.  
In this work, HiTrap™ Q HP, 5 ml (GE Healthcare Life Science, Chalfont St Giles, 
UK) coupled with ÄKTAPrime Plus system (GE Healthcare Life Science, Chalfont St Giles, 
UK) were used for anion exchange chromatography. All steps were performed at 4°C. In the 
initial step, the column was equilibrated with 5 column volumes of the anion exchange 
binding buffer with a flow of 5 ml/min, followed by the injection of the protein sample with a 
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flow of 1 ml/min and a washing step with a flow of 3 ml/min until the absorption at 280 nm 
decreased to zero. The ENTH domain was expected to elute in these steps. Finally, the 
elution of GST was promoted by running a short gradient from the anion exchange binding 
buffer to the anion exchange elution buffer for 50 ml and a flow of 3 ml/min, followed by 30 
ml of 100% anion exchange elution buffer with a flow of 3 ml/min. 
  
3.2.5.5 PD 25 buffer exchange chromatography  
 The principle of separation by PD MiniTrap G-25 (GE Healthcare Life Science, 
Chalfont St Giles, UK) is the size exclusion chromatography. In this work, it was 
predominately used to separate free fluorophores from labeled proteins after the fluorophore 
conjugation reaction by gravity flow. The columns were equilibrated with 5 times the bed 
volume of the buffer of choice. 0.5 ml of the protein sample was transferred onto the bed and 
finally eluted by adding the buffer of choice. Two visible bands were observed during the 
chromatography: the band with the faster migration speed representing the conjugated 
proteins, the slower band corresponded to the free fluorophores. All steps were performed at 
4°C. 
 
3.2.5.6 Size exclusion chromatography 
 Molecules are separated due to their hydrodynamic voluminal by size exclusion 
chromatography (gel filtration). The molecules do not bind to the column material like in the 
affinity chromatographic methods. The matrix of the columns consists of a composite cross-
linked agarose and dextran in the case of superdex columns, or of cross linked agarose in 
the case of superpose columns. The column materials form a matrix with defined pore sizes 
that decrease the migration speed of passing molecules due to their molecular mass and 
shape.  
For the purification of smaller proteins (< 30 kDa) the HiLoad™ 16/600 Superdex™ 75 pg 
(GE Healthcare Life Science, Chalfont St Giles, UK) was used and bigger proteins like 
Epsin1 and AP180 were purified with the HiLoad™ 16/600 Superdex™ 200 pg pg (GE 
Healthcare Life Science, Chalfont St Giles, UK). Clathrin triskelia were separated with 
Superose™ 6, 10/300 GL pg (GE Healthcare Life Science, Chalfont St Giles, UK). 
The columns were equilibrated with the buffer of choice, 1.5 times of the column 
volume and a flow rate of 1 ml/min. The protein sample was injected with a flow of 1 ml/min 
and a sample size that did not exceed 2 ml for superdex columns and 0.5 ml for the 
superpose column. The elution was performed with 1 ml/min until 1 column volume of the 
buffer of choice passed through the column. All chromatographies were performed at 4°C 
using the ÄKTAPrime Plus system, or the ÄKTAPurifier 10 system. 
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3.2.5.7 Dialysis 
 The principle of dialysis is based on the endeavor of particles for entropy and 
osmosis. The dialysis was used to perform buffer exchanges, in this work. A dialysis bag 
with a defined pore size of 3.5 kD (Spectra/Por Standard RC Tubing, Spectrum Labs Inc., 
Broadwick St, USA) was filled with a protein sample (5 to 30 ml) and closed. The bag was 
then transferred into 3 to 5 l of a buffer of choice and incubated for 12 h at 4°C with gentle 
magnetic stirring. Smaller particles are able to defund through the pores of the dialysis bag, 
whereas molecules of a bigger size, like proteins, are retained. The buffer molecules defund 
until reaching equilibrium. Thus, the concentration of the components of the previous buffer 
is strongly diluted and the proteins are transferred into the dialysis buffer. The dialysis was 
coupled with the protease digest for the cleavage of the BAR domain and the ANTH domain 
fusion proteins.  
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3.2.6 Analytical methods 
 
3.2.6.1 DLS 
 Dynamic light scattering (DLS) is a method to determine the hydrodynamic radius of 
spherical particles in solution. Coherent and monochromatic laser beams are scattered if 
they encounter particles in solution that cause interferences. The particles in solution are 
under constant motion, due to the Brownian movement and the scatter intensities fluctuate. 
The fluctuations give information about the motion speed of the particles which is used to 
determine the hydrodynamic radii of these particles. DLS determinations were used for two 
purposes in this work, they gave information about the quality of a whole liposome 
population after extrusion, and they were used to determine if liposomes were deformed. 
The motion of spherical liposomes differs from the motion of membrane tubules causing 
great error bars in the measurement.  
The liposome suspension was diluted to 0.2 mg/ml and set into the measurement 
chamber of a Zetasizer Nano-S (Malvern Instruments Ltd., Worcestershire, UK). The data 
was acquired by three independent measurements, each one consisting of 21 repetitions at 
25°C, and using the Zetasizer Software 7.01 (Malvern Instruments Ltd., Worcestershire, 
UK). 
 
3.2.6.2 Co-sedimentation assay 
 The co-sedimentation assay (spin assay) was used for two detections. Liposomes in 
aqueous samples sediment if they are ultracentrifuged, while soluble proteins remain in the 
supernatant. Thus, the detection of protein binding to liposomes was determined via the spin 
assay. This assay was also used to detect if small vesicles were generated due to 
membrane deformation. The sedimentation of spherical particles in aqueous solution is 
described by Stokes’s law: 
 
Fg = (ρp – ρf)  g  4/3  π  R
3 
 
The excess force Fg is dependent on the difference of the densities of the spherical 
object and the surrounding fluid (ρp – ρf), the gravity (g) and the cubed radius of the spherical 
object (R3). The sedimentation behavior of a liposome is more dependent on the size than 
on the density and it is possible to separate SUVs from LUVs by centrifugation. 
The liposomes were prepared as described before, diluted to 2 to 3 mg/ml and mixed with 
7.5 to 20 µM purified proteins. After incubating the sample for 3 h at 30°C, 150 µl of the 
sample was ultracentrifuged at 22°C and 205000 xg for 19 min (TLA 100.3, Beckman 
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Coulter Inc., Fullerton, California). Finally, the supernatant was separated from the pellet and 
analyzed by SDS-PAGE. 
 
3.2.6.3 Co-migration 
 The co-migration assay (flotation assay) was used in order to detect protein binding 
to liposomes and the potential membrane deformation ability of these proteins. Liposomes 
migrate through a density gradient until reaching a layer that corresponds to their own 
density. Deformed liposomes have another migration behavior through the gradient, thus 
their migration stops at a different layer. If proteins bind to liposomes, they migrate through 
the layers together. 
Liposome (4 mg/ml), or liposome protein (20 µM) samples were incubated at 30°C for 3 h 
and overlaid with a discontinuous Histodenz™ (Sigma-Aldrich Corp., St. Louis, USA) 
gradient of 40%, 20%, 10%, 5% and 0%. Histodenz™ was previously dissolved in Hepes 
buffer. Each density layer of the discontinuous gradient had a volume of 800 µl. The density 
gradient was centrifuged at 150000 xg and 20°C for 1 h (SW 60 Ti, Beckman Coulter Inc., 
Fullerton, California). After centrifugation, pictures were taken from the floated liposomes in 
the gradient (Sony DSC-HX60, Sony Corp., Tokyo, Japan). Finally, the layers were 
separated into 500 µl fractions, precipitated with TCA and analyzed by SDS-PAGE. 
 
3.2.6.4 Electron microscopy 
 LUVs were used for electron microscopy to visualize membrane deformation. 
Therefore, liposomes (0.2 mg/ml) were incubated with proteins (15 µM) at 30°C during 3 h. 
The samples were subsequently diluted to 0.2 mg/ml of liposomes with Hepes buffer and 5 
µl of the suspension was then transferred onto a formvar carbon coated copper grid (Agar 
Scientific Ltd., Essex, UK) and incubated for 1 min at room temperature. The suspension 
was removed and the grid was set onto a droplet (50 µl) of 3% uranyl acetate for negative 
staining. The residual solution was directly removed. 
Electron microscopic visualization was performed with a JEOL JEM 1011 
transmission electron microscope (JEOL Ltd., Akishima, Japan) and a Gatan Orius 1000 
CCS detector (Gatan Inc., Pleasanton, USA). 
 
3.2.6.5 Binding and membrane deformation dynamics on GUVs 
 GUVs were used for fluorescence microscopy in order to examine the dynamics of 
protein membrane binding and membrane deformation. Therefore, GUVs were prepared as 
previously described in addition with 0.5 % of the fluorescently labeled lipid Atto647N PtdEnt 
(ATTO-TEC GmbH, Siegen, Germany). 50 µl of the GUV suspension was carefully 
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transferred into the microscopy chamber Nunc® Lab-Tek® II chambered coverglass 
(Thermo Fisher Scientific Inc., Waltham, USA), that was coated with lipid-free bovine serum 
albumin (Sigma-Aldrich Crop., St. Louis, USA) and filled with 250 µl of GUV salt buffer.  
The fluorescence spinning disc confocal microscopy was performed at 25°C with a 
Nikon Eclipse Ti microscope (Nikon Instruments K.K., Tokyo, Japan), a PerkinElmer 
UltraVIEW VoX system (Perkin Elmer, Waltham, USA) with a spinning disk confocal scan 
head CSU-X1 (Yokogawa Denki K. K., Tokyo, Japan) and an Electron Multiplying CCD 
Camera C9100 (Hamamatsu Photonics K.K., Hamamatsu, Japan). The data was acquired 
with the software Volocity® 6.3 (PerkinElmer Corp., Waltham, USA). Proteins that were 
labeled with Atto488 maleimide, Atto390 NHS ester, or Atto542 NHS (ATTO-TEC GmbH, 
Siegen, Germany) were titrated into the GUV suspension in 10 µM steps and mixed by 
gentle stirring. The fluorophores were excited at the optimal wavelength and detected at the 
optimal emission wavelength according to the manufacturer (ATTO-TEC GmbH, Siegen, 
Germany). All fluorophores were excited at low laser powers (5% to 8%) and at fast 
exposure times (50 msec to 120 msec). The pictures were taken with speed 30 frames per 
minute for 30 min. 
 
3.2.6.6 FRET assays 
 Förster resonance energy transfer (FRET) measurments are used to detect 
interaction between molecules. The principle this effect is based upon the radiation-free 
energy transfer between two fluorophores. These fluorophores are called a FRET pair, if the 
emission of the donor fluorophore overlaps with the excitation of the acceptor fluorophore. 
The FRET effect appears, if the distance between the donor and acceptor fluorophores does 
not exceed is between 0.5 to 10 nm. 
In this work, FRET measurements were performed to detect the oligomerization of 
ENTH domains and the interaction between these proteins and specific lipids. Atto 488 
coupled to the ENTH domain was used as donor and Atto 532 coupled to DOPS, DOPE, or 
ENTH domain was used as acceptor. The donor was excited at 493 nm and the acceptor 
emission maximum is at 552 nm. For the measurments, a total concentration of 5 and 15 µM 
labeled ENTH domain added into a 2 mg/ml lipid suspension. The FRET experiments were 
performed in a F-7000 Fluorescence Spectrophotometer (Hitachi K. K., Tokio, Japan) and 
the emission spectra were recorded between 500 nm and 700 nm. All FRET analysis were 
carried out by Niels Denkert of the Michael Meinecke group (Biochemistry 2, Humboldallee 
23, Göttingen, Germany). 
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3.2.6.7 Secondary structure analysis by CD spectroscopy 
 Circular dichroism (CD) spectroscopy is a powerful method to analyze secondary 
structures within biological macromolecules. Linear polarized is converted by a quarter-wave 
plate to left-handed and right-handed circular polarized light that are absorbed by chiral 
molecules, like proteins, to different extends. The CD spectrum results upon of the 
percentages of β-sheets and α-helices within the protein. 
CD spectroscopy was used to compare the folding of the wildtype ENTH domain and 
the ENTH domain mutant R114A by using a Chirascan CD Spectrometer (Applied 
Photophysics Ltd., London, UK). Proteins were transferred into a 10 mM sodium potassium 
phosphate buffer pH 7.4 with a concentration of 0.1 mg/ml. The measurements were carried 
out at 25°C between 180 nm and 260 nm with 1 nm step sizes and an accumulation time of 
5 sec. The mean residue weight ellipticity was calculated according to Kelly S. M. et al. 188 
with the following formula: 
 
[Θ]MRW = (Θ  MRW) / (10  c  d) 
 
The molar ellipticity (Θ) and the mean residue weight (MRW) are dependent on the 
optical path length (d) and the protein concentration (c). 
 
3.2.6.8 Chemical cross-linking and In-Gel digest 
      Protein-liposome samples were chemically cross linked, in order to visualize the 
oligomerization of the ENTH. Therefore, protein samples were prepared with, or without 
liposomes in Hepes buffer, as described before. The proteins were chemically cross-linked 
by the addition of the amine-reactive, water-soluble and homobifunctional 
bis(sulfosuccinimidyl)suberate (BS3, Thermo Fisher Scientific Inc., Waltham, USA) with a 
molar excess of 50 to 300. After addition of BS3, the samples were mixed and incubated at 
RT for 40 min. The reaction was finally quenched by the addition of 4x sample buffer (final 
concentration: 100mM DTT, 50 mM Tris-HCl, 2 % SDS) and incubated during 10 min at 
70°C. The cross-linked protein was visualized by SDS-PAGE and Coomassie staining.  
The cross-linked samples were further subjected for an In-Gel digest. Therefore, the 
bands that corresponded to cross-linked proteins were extracted from the gel and incubated 
with 150 µl acetonitrile (ACN) for 15 min at 26°C and 1050 rpm agitation (Thermomixer 
comfort, Eppendorf AG, Hamburg, Germany). To reduce disulfide bonds, the pieces were 
incubated in 100 µl 10 mM dithiothreitol (DTT) for 50 min at 56°C and washed again with 
ACN afterwards. In order to alkylate reduced cysteine residues, 100 µl of 55 mM 
iodoacetamide was added to samples, incubated for 20 min at 26°C and 1050 rpm and 
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washed again with ACN afterwards. The gel pieces were additionally treated with 150 µl of 
100 mM NH4HCO3 and incubate for 15 min at 26°C and 1050 rpm, washed again with ACN 
and finally dried by SpeedVac (Savant SPD-131DDA SpeedVac Concentrator, Thermo 
Fisher Scientific Inc., Waltham, USA). The digest was performed by rehydrating the gel 
pieces with In-Gel digest buffer 1 (0.0125 µg/µl Trypsin, 4 mM CaCl2, 40 mM ABC) for 30 to 
45 min at 4°C. 10 to 20 µl In-Gel digest buffer 2 was added to the gel pieces and the digest 
was performed at 37°C overnight. 
The digested peptides were extracted from the SDS gel by the addition of 5% (v/v) 
formic acid and incubation for 15 min at 37°C and 1050 rpm agitation. The chemical cross-
linking, as well as the In-Gel digest was performed by Iwan Parfentev of the Henning Urlaub 
group (MPIBPC, research group: Mass Spectrometry, Am Fassberg 11, Göttingen, 
Germany). 
 
3.2.6.9 MS/MS analysis 
      Mass spectrometry (MS) was employed to analyze the cross-linked ENTH domain 
monomers and oligomers. Therefore, the digested and extracted peptides were separated 
by reverse-phase high performance liquid chromatography (RP-HPLC) on a Dionex Ultimate 
3000 chromatography system (Thermo Fisher Scientific Corp., Waltham, USA): The injection 
was performed with 5% (v/v) ACN as the liquid phase and 0.1% (v/v) trifluoroacetic acid 
(TFA) as the proton donor onto a 0.3 x 5 mm µ-Precolumn (C18 PepMap100, 5 µm, 100Å, 
Thermo Fisher Scientific Corp., Waltham, USA). The separation was performed with a linear 
gradient of 10% to 46% (v/v) ACN for 36 min with 300 nl/min flow rate on a 30 cm C18 
analytical column (packed in-house with Reprosil-Pur 120 C18-AQ, 1.9 µm, Dr. Maisch, 
Ammerbuch-Entringen, Germany). 
The analysis of the ionized peptides was performed by Orbitrap Fusion Tribrid mass 
spectrometer (Thermo Fisher Scientific Corp, Waltham, USA). The tandem MS analysis was 
performed in three technical replicates with the method called “Top Speed”. Briefly, after a 
survey scan (MS1), the most intense precursors with the charge states of 3 to 8 (380 - 1500 
(m/z) scan range) were isolated in the quadrupole mass filter (MS2) and fragmented by 
higher-energy collisional dissociation (HCD) (the 3 technical replicates were analysed with 
28%, 30% and 33% normalized collision energy, respectively). A dynamic exclusion time of 
2 sec was set. MS1 was performed with an Orbitrap resolution of 120,000, automatic gain 
control (AGC) target of 4  105 and a maximum injection time of 50 msec. MS2 was 
performed with an Orbitrap resolution of 30000. The AGC targets were set to 5  104 and a 
maximum injection time of 120 msec. 
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Finally, the raw files were converted into the mgf format by the Proteome Discover 2.1 
Software (Thermo Fisher Scientific Corp, Waltham, USA). The converted files were used for 
a database search, containing the sequence of rat Epsin1, by pLink 1.23. The search 
parameters included a maximum of three trypsin miss-cleavages, a mass filter of ± 10 ppm, 
carbamidomethylation of cysteines as a fixed modification and oxidation of methionines as 
variable modification. The results were obtained with a false discovery rate of 1% and the 
cross-links were visualized by xiNET (Rappsilber Lab, Edinburgh, UK). The tandem MS, as 
well as the data analysis was performed by Iwan Parfentev of the Henning Urlaub group 
(MPIBPC, research group: Mass Spectrometry, Am Fassberg 11, Göttingen, Germany). 
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4. Results 
4.1 Protein purifications 
4.1.1 Purification of ENTH domain proteins 
The ENTH domain consists of the first 164 amino acids of Epsin1. In order to express 
and purify the protein the first 492 bp of Rattus norvegicus Epsin1 were cloned into the 
vector pGEX-6p-2. This construct was further used to generate the mutants used in this 
work: ENTH C96A A155C, ENTH R114A, ENTH C96A R114A A155C and ENTH V50,51A. 
 
 
Figure 10: Schematic illustration of the purification strategy of ENTH domain constructs. 
 
The ENTH domain was expressed as the fusion protein GSTENTH in E. coli BL21 
(DE3) as described before (3.2.2.2 Expression of recombinant proteins by IPTG induction). 
After pelleting the cells and cell lysis, the soluble lysate was separated from cell debris and 
used for GST affinity chromatography. The GSTENTH fusion protein was successfully 
separated from the soluble lysate and eluted after changing the buffer to GST elution buffer. 
150 mg of fusion protein was purified in the first chromatography step. In order to cleave the 
GST affinity tag from the ENTH domain, a PreScission-Protease digest was performed. To 
ensure a clear separation of the ENTH domain from cleaved GST, anion exchange 
chromatography was employed as the subsequent purification step. Therefore, the 
isoelectric points of the ENTH domain (9.14) and the GST affinity tag (5.73) were 
computationally determined by the EXPASY ProtParam web tool. The pH of the purification 
buffers was adjusted to 8. In these conditions, the GST tag is negatively charged, while the 
ENTH domain has a cationic character. The separation was successfully performed and 
ENTH domain didn’t bind to column in anion exchange washing buffer, while the GST tag 
bound to the column material. Size exclusion chromatography with a HiLoad™ 16/600 
Superdex™ 75 pg (GE Healthcare Life Science, Chalfont St Giles, UK) was performed as 
the last purification step to set the target protein into Hepes buffer and to receive single band 
purity (Figure 10). In this way, 46 mg of the highly pure and soluble monomeric ENTH 
domain was purified out of 1 l expression culture (Figure 10). 
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Figure 11: Recombinant expression and purification of rat ENTH domain. BL21 cells were induced by 
addition of 1 mM IPTG at 30 °C for 3 h (uninduced, induced). The soluble cell lysate was separated from the 
insoluble cell debris by ultracentrifugation (Uc P, Uc Sn). The GSTENTH fusion protein was isolated by GST 
affinity chromatography (GST FT, GST Elu), the tag was cleaved (PP digest) and the ENTH domain was isolated 
from the tag by anion exchange chromatography (Anion FT, Anion Elu). The ENTH domain was finally purified by 
size exclusion chromatography (GeFi). PageRuler™ Plus Prestained Protein Ladder (Thermo Fisher Scientific 
Inc., Waltham, USA) was used as protein standard. 
 
 The mutant proteins that were generated from the ENTH domain WT construct were 
expressed and purified in the same way (Figure 11). The purification of ENTH R114A was 
similar successful as the WT protein. A small amount of fusion protein did not remain in the 
supernatant und pellet with the cell debris and a small amount of fusion protein was not 
retained during GST affinity chromatography. In the end, 52 mg of the highly pure and 
soluble monomeric ENTH R114A was purified out of 1 l expression culture.  
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Figure 12: Recombinant expression and purification of ENTH R114A. ENTH R114A was purified in the same 
as the ENTH domain (Fig. 8). The protein was expressed in BL21 cells by 1 mM IPTG induction (uninduced, 
induced). The soluble cell lysate was separated from the insoluble cell debris by ultracentrifugation (Uc P, Uc 
Sn). The fusion protein was isolated by GST affinity chromatography (GST FT, GST Elu), the tag was cleaved 
(PP digest) and ENTH R114A was isolated from the tag by anion exchange chromatography (Anion FT, Anion 
Elu). Size exclusion chromatography was used as last purification step (GeFi). PageRuler™ Plus Prestained 
Protein Ladder (Thermo Fisher Scientific Inc., Waltham, USA) was used as protein standard 
 
 The purification of ENTH V50,51A was less efficient (Figure 13). Less fusion protein 
was expressed and thus, purified during GST affinity chromatography and just 98 mg of 
fusion protein was determined. It was also not possible to purify ENTH V50,51A to single 
band purity by this strategy and several higher order kDa bands were observed beside a 
prominent target protein band after size exclusion chromatography. 31 mg of the soluble 
protein was purified.  
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Figure 13: Recombinant expression and purification of ENTH V50,51A. ENTH V50,51A was purified in the 
same as the ENTH domain (Fig. 8). The protein expression was performed in BL21 cells (uninduced, induced) 
and the lysate was separated by ultrcentrifugation (Uc P, Uc Sn). The fusion protein was isolated by GST affinity 
chromatography (GST FT, GST Elu), the tag was cleaved (PP digest) and ENTH V50,51A was isolated from the 
tag by anion exchange chromatography (Anion FT, Anion Elu). Size exclusion chromatography was used as last 
purification step (GeFi). PageRuler™ Plus Prestained Protein Ladder (Thermo Fisher Scientific Inc., Waltham, 
USA) was used as protein standard. 
 
4.1.2 Purification of the BAR domain and ANTH domain 
 The BAR domain and the ANTH domain are well described endocytic proteins and 
used in this work as controls. The BAR domain encoding gene was designed from the first 
741 bp of endophilinA1 of Rattus norvegicus. The ANTH domain encoding gene was 
obtained from the 795 bp of Rattus norvegicus AP180. Both genes were cloned into the 
vector pGEX-6P-2. Both proteins were expressed and purified in the same way. 
 
 
Figure 14: Schematic illustration of the purification strategy of BAR domain and ANTH domain 
constructs. 
 
 The BAR domain and ANTH domain were expressed as GST fusion proteins in E. 
coli BL21 (DE3) as described before. The soluble cell lysate was used for GST affinity 
chromatography to isolate the GST fusion proteins, after cell lysis and separation by 
ultracentrifugation. Because anion exchange chromatography was not suitable to separate 
the cleaved GST tag from the target proteins, a second GST affinity chromatography was 
included into the purification strategy. Therefore, the PreScission-Protease digest was 
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coupled to rebuffering by dialysis. 1% (mol/mol) PreScission-Protease was added to the 
fusion proteins and the protein suspension was dialysed against GST binding buffer at 4°C 
with gentle agitation over night. The suspension was used for the second GST affinity 
chromatography subsequently and the target proteins eluted into the flow through, while the 
GST tag was retained. The ANTH and the BAR domain were both finally purified by size 
exclusion chromatography (Figure 14). 
 
 
Figure 15: Recombinant expression and purification of the BAR domain. The BAR domain was expressed 
in BL21 cells by 1 mM IPTG induction (uninduced, induced). The soluble cell lysate was separated from the 
insoluble cell debris by ultracentrifugation (Uc P, Uc Sn). The fusion protein was isolated by GST affinity 
chromatography (1. GST FT, 1. GST Elu), the tag was cleaved (PP digest) and the BAR domain was isolated 
from the tag by a second GST affinity chromatography (2. GST FT, 2. GST Elu). Size exclusion chromatography 
was used as last purification step (GeFi). PageRuler™ Plus Prestained Protein Ladder (Thermo Fisher Scientific 
Inc., Waltham, USA) was used as protein standard. 
 
 The purification of the BAR domain led to 31 mg soluble protein from 1 l expression 
culture (Figure 15). The purified protein was not highly pure because a second prominent 
protein signal appeared on the SDS gel (approx. 23 kDa) beneath the expected BAR domain 
signal (29 kDa). In addition, higher order bands were observed that might have been 
uncleaved protein, impurity or homo-oligomers after size exclusion chromatography. 
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Figure 16: Recombinant expression and purification of the ANTH domain. The ANTH domain was purified in 
the same way as the BAR domain starting with the expression in BL21 cells by 1 mM IPTG induction (uninduced, 
induced), the separation of the soluble cell lysate from the insoluble cell debris by ultracentrifugation (Uc P, Uc 
Sn) and the isolation of the fusion by GST affinity chromatography (1. GST FT, 1. GST Elu). After tag cleavage 
(PP digest), the ANTH domain was isolated from the tag by a second GST affinity chromatography (2. GST FT, 
2. GST Elu). Size exclusion chromatography was used as last purification step (GeFi). PageRuler™ Plus 
Prestained Protein Ladder (Thermo Fisher Scientific Inc., Waltham, USA) was used as protein standard. 
 
 The purification of the ANTH domain was more successful and 29 mg of the soluble 
protein were purified from a 1 l expression culture (Figure 16). The ANTH domain protein 
band appeared very pronounced on the SDS gel, although it migrated to approx. 27 kDa 
instead to 23 kDa, as expected. The purified protein was also not completely pure, since a 
faint protein signal appeared beneath and above the ANTH domain band after size exclusion 
chromatography.  
 
4.1.3 Purification of Epsin1 
In order to recombinantly express and purify the full-length protein Epsin1, the coding 
sequence of Rattus norvegicus Epsin1 was cloned into the vector pProEx HTc. The resulting 
construct was further used to generate the mutant for this work: Epsin1 C96A. 
 
 
Figure 17: Schematic illustration of the purification strategy of Epsin1 constructs. 
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Epsin1 was recombinantly expressed with an N-terminal hexaHis-tag in in E. coli 
BL21 (DE3) as described before. The soluble cell lysate was used for polyHis affinity 
chromatography after cell lysis and isolation by ultracentrifugation and Epsin1 was 
successfully separated from the rest of the lysate. In order to cleave the hexaHis tag from 
the target protein, the fusion protein was incubated with 1:100 (mol:mol) TEV protease and 
incubated at 4°C with gentle agitation over night. Finally, Epsin1 was separated from 
residual impurity by size exclusion chromatography. 
 
 
Figure 18: Recombinant expression and purification of the rat Epsin1. Epsin1 was recombinantly expressed 
in BL21 cells by 1 mM IPTG induction (uninduced, induced). The soluble cell lysate was separated from the 
insoluble cell debris by ultracentrifugation (Uc P, Uc Sn) and the isolation the hexaHis-tagged Epsin1 was by size 
exclusion chromatography (GeFi). PageRuler™ Plus Prestained Protein Ladder (Thermo Fisher Scientif ic Inc., 
Waltham, USA) was used as protein standard. A. SDS-PAGE of all purification steps. B. Visualization of Epsin1 
by western blot and immuno staining of the His trap elution, the tag cleavage and the size exclusion 
chromatography. 
The soluble, highly pure Epsin1 was successfully purified and 27 mg of the target 
protein were isolated from 1 l expression culture (Figure 18). The SDS gel shows a 
pronounced protein signal at approx. 80 kDa with faint degradation bands beneath. It is 
obvious that the target protein underwent a slight size shift after it was digested with TEV 
protease. To ensure that Epsin1 was really purified, samples before the TEV protease 
digest, after the TEV protease digest and after size exclusion chromatography were used for 
western blot and immune detection with the Epsin1 antibody. 
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4.1.4 Purification of clathrin triskelia from native tissue 
 
 
Figure 19: Schematic illustration of the purification strategy of clathrin triskelia from rat brains.. 
 
Clathrin triskelia were isolated from brains of Lewis rats, since it is not possible to 
recombinantly express them. Therefore, the brains were homogenized, clathrin coated 
vesicles were isolated by serial centrifugation and clathrin disassembly was induced by 
incubation in clathrin disassembly buffer, as described before (3.2.2.5 Synaptosomal CCV 
isolation from rat brains) and incubated. Clathrin triskelia were finally isolated by size 
exclusion chromatography with a Superose™ 6, 10/300 GL (GE Healthcare Life Science, 
Chalfont St Giles, UK) (Figure 19). 
 
 
Figure 20: Purification of clathrin triskelia from rat brains. CCVs were purified and disassembled into clathrin 
triskelia. Finally, clathrin triskelia were purified by size exclusion chromatography (Superose 6). Right side: SDS-
PAGE and Coomassie staining, left side: Western blot and immuno staining. 
 
Clathrin was successfully purified in this way (Figure 20). The SDS gel shows a 
pronounced protein band at approx. 180 kDa which is the size of the clathrin heavy chain. In 
addition, several protein bands were observed above the heavy chain, but none beneath, 
indicating that native adaptor proteins were successfully separated. To ensure that clathrin 
was purified, the sample was used for western blot and immune detection with the Clathrin 
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Heavy Chain antibody (Becton Dickinson Corp., Franklin Lakes, USA). Just one pronounced 
protein signal was detected at the same height as in the SDS gel. 6 mg of soluble clathrin 
triskelia were purified from 20 brains. The soluble protein was stored in the clathrin 
disassembly buffer and rebuffered by dialysis shortly before usage. 
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4.2 PtdSer promotes ENTH domain dependent membrane deformation 
The ENTH domain of Epsin1 was shown in many different studies to bind to 
PtdIns(4,5)P2 containing liposomes, as well as to deform those liposomes 
116, 171, 115. But so 
far, liposomes used in these experiments to demonstrate the membrane deformation activity 
of the ENTH domain were prepared with an not complete defined brain lipid extract (Folch) 
in addition with PtdIns(4,5)P2.  
In the beginning, we wanted to find out, if we can observe ENTH domain induced 
membrane deformation on liposomes with a defined lipid composition. By this we addressed 
the question, if other lipid species are involved in the ENTH domain induced membrane 
deformation processes. 
As a starting point, we analyzed the binding and membrane deformation of the ENTH 
domain on liposomes with different lipid compositions. Therefore we prepared liposomes of 
100% Folch lipids, 95% Folch and 5% Lα-PtdIns(4,5)P2 and 65% L-PtdCho, 30% L-
PtdEtn and 5% L-PtdIns(4,5)P2. These liposomes were incubated with 12 µM purified 
ENTH domain for 3 h at 30°C. Membrane binding was analyzed by a co-sedimentation 
assay and the morphological changes as the result of membrane deformation were analyzed 
by electron microscopy and by DLS.  
As expected ENTH domain binding was only dependent on the presence of 
PtdIns(4,5)P2 and it co-sedimented with liposomes composed of Folch Lα-PtdIns(4,5)P2 and 
65% L-PtdCho, 30% L-PtdEtn and 5% L-PtdIns(4,5)P2 (Figure 21A). The assay was 
adjusted to detect possible vesiculation as a consequence of ENTH domain induced 
membrane deformation and if vesiculation would appear, the lipid signal would have shifted 
from the pellet into the supernatant as published before 115. Intrestingly, no vesiculation 
appeared in all tested conditions. Noteworthy, the ENTH domain incubated with liposomes 
composed of Folch Lα-PtdIns(4,5)P2 led to a prominent protein signal at about 35 kDa. 
 The ENTH domain was only able to induce membrane deformation on liposomes 
composed of Folch Lα-PtdIns(4,5)P2 whereas all the other liposome compositions remained 
unaffected (Figure 21B). The analyzes by EM showed, that ENTH domain induced 
membrane deformation resulted in the generation of membrane tubles. The scatter profile of 
DLS analysis showed a similar results (Figure 21C): liposomes composed of Folch and Lα-
PtdIns(4,5)P2 and 65% L-PtdCho, 30% L-PtdEtn and 5% L-PtdIns(4,5)P2 had a similar 
profile like the control liposomes, indicating that no deformation was induced. The scatter 
profile of Folch Lα-PtdIns(4,5)P2 was more diverse with long error bars, indicating that the 
liposomes did not behave like spherical particles anymore.  
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Figure 21: The ENTH domain deforms LUVs composed of brain lipid extract in PtdIns(4,5)P2 dependency. 
LUVs were composed of brain lipid extract (Folch), brain lipid extract + PtdIns(4,5)P2 (Folch PIP2) and PtdCho, 
PtdEtn and PtdIns(4,5)P2 (PC PE PIP2). A. Co-sedimentation of the ENTH domain with LUVs (P = pellet, Sn = 
supernatant), B. Membrane deformation analysis of LUVs by electron microscopy. LUVs composed of Folch + 
PtdIns(4,5)P2 incubated without ENTH domain were used as control. Scale bars correspond to  200 nm. C. 
Membrane deformation analysis of LUV populations by DLS.  
 
The first results confirmed that ENTH domain binding to liposomes is only dependent 
on the presence of PtdIns(4,5)P2. The protein was not able to deform liposomes prepared 
from a simple lipid composition while it deformed efficiently liposomes composed of a brain 
lipid extract (FOLCH). Together, these results indicate that membrane deformation 
additionally depends on the lipid composition.  
 As control experiment, we performed co-sedimentation assays and detection of 
protein dependent liposome deformation with the ENTH domain in comparison to the BAR 
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domain of rat endophiliA1 and the ANTH domain of rat AP180 (Figure 22A). These protein 
domains are well studied and derive from endocytic proteins. The ANTH domain was shown 
to bind to PtdIns(4,5)P2 containing liposomes but does not deform them. The BAR domain in 
contrast would be a positive control since it binds liposomes and induces tubulation. 
Liposomes composed of 2 mg/ml 95% Folch and 5% Lα-PtdIns(4,5)P2 were incubated with 
12 µM protein for 3 h at 30°C. All three protein domains co-sedimented with the liposomes 
and the proteins alone remained in the supernatant. We observed again the appearance of a 
band at about 35 kDa of lipid bound ENTH domain, while the unbound ENTH domain 
remained monomeric. 
 The ENTH domain and the BAR domain both deformed liposomes (Figure 22B). The 
tubules that were generated by the BAR domain appeared more straight and rigid, while 
ENTH domain induced tubles showed kinks. The ANTH domain did not deform liposomes as 
expected. The results were confirmed by the corresponding DLS scattering profiles (Figure 
22C). The scattering profile indicated membrane deformation only if liposomes were 
incubated with the ENTH domain or the BAR domain, while incubation with the ANTH 
domain showed a similar profile to the control. 
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Figure 22: Comparison of endocytic, membrane interacting domains. LUVs, composed of brain lipid extract 
+ PtdIns(4,5)P2 (Folch PIP2), were incubated either with the ENTH domain of Epsin1 (ENTH), the BAR domain of 
endophilinA1 (BAR) and the ANTH domain of AP180 (ANTH). A. Co-sedimentation of the ENTH domain, BAR 
domain and ANTH domain with LUVs (P = pellet, Sn = supernatant). Proteins without LUVs and LUVs without 
proteins were used as control. B. Membrane deformation analysis of LUVs by electron microscopy. LUVs 
composed of Folch + PtdIns(4,5)P2 incubated without proteins were used as control. Scale bars correspond to 
200 nm. C. Membrane deformation analysis of LUV populations by DLS.  
 
Next, we started to screen for phospholipids to include in our liposome compositions 
that would promote membrane deformation. Although information about the total lipid 
content of the Floch lipids is not available, Avanti Polar Lipid homepage provides information 
about the most abundant lipid species inside their extract (Table 6).  
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Table 6: Phospholipid profile of the Avanti polar brain lipid extract. From the Avanit Polar Lipids webpage. 
Component % (wt/wt) 
PtdCho 12.6 
PtdEtn 33.1 
PtdIns 4.1 
PtdSer 18.5 
PA 0.8 
Unkonwn 30.9 
 
The table shows first of all the diversity within this lipid extract. Beside PtdCho and 
PtdEtn, PtdSer is the most abundant phospholipid. The mammalian plasma membrane 
contains high amounts of PtdSer 4. The distribution of PtdSer in the plasma membrane is 
asymmetrical and only present in the inner leaflet 189, where endocytic proteins are located. 
To test if the addition of PtdSer to our liposome composition is able to promote ENTH 
domain induced membrane deformation we used three compositions with decreasing molar 
percentages of PtdSer: Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 5), 
(60 : 30 : 5 : 5) and (65 : 30 : 0 : 5). To distinguish if occurrent effects are related to the 
additional negative charge, introduced by PtdSer or by headgroup specificity, we additionally 
used the lipid composition Lα-PtdCho, Lα-PtdEtn, Lα-PtdIns, Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 
5). PtdIns introduces equal negative charges to liposomes, but has a different packing 
parameter due to its bulky headgroup. As additional controls we used a liposome 
composition without PtdIns(4,5)P2 in which we did not expect recruitment of the ENTH 
domain to the membrane, liposomes with ENTH domain (Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, 
Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 5)) and ENTH domain without liposomes. We incubated 12 
µM of ENTH domain together with the differently composed liposomes at 30°C for 3 h and 
analyzed the membrane binding and membrane deformation. 
The co-sedimentation assay showed that the ENTH domain was only recruited to 
liposomes in presence of PtdIns(4,5)P2 (Figure 23A). Without PtdIns(4,5)P2 the ENTH 
domain remained in the supernatant similar to protein incubated without liposomes 
Surprisingly, the presence of 20% PtdSer induced the formation of ENTH homo-oligomers 
and protein bands appeared at approx. 35 kDa, 60 kDa and above 70 kDa that remained still 
stable during SDS-PAGE. In the liposome composition with 5% PtdSer these bands became 
fainter but were still visible. In all the other conditions used the ENTH domain behaved 
monomeric, independent from liposome binding. 
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When the same samples were analyzed for membrane curvature induction we found 
the ENTH domain induced membrane deformation only in the presence of PtdSer (Figure 
23B, 22C). With 20% PtdSer nearly all liposomes showed tubles and DLS analysis 
confirmed that the liposome population did not behave like spherical particles anymore. 
Liposomes with 5% PtdSer showed still moderate membrane deformation but many 
liposomes did not have tubles. The DLS confirmed that membrane deformation occurred, but 
to a lesser extent than with 20% PtdSer. The ENTH domain was not able to deform 
liposomes in lipid compositions without PtdSer and with 20% PtdIns. The controls, ENTH 
domain incubated with liposomes without PtdIns(4,5)P2, liposomes alone and ENTH domain 
alone behaved like expected in the co-sedimentation assay and in the analysis of membrane 
deformation. Based on electron microscopy pictures, a quantitative evaluation of deformed 
membrane structures and tubule length was performed. For this purpose, we counted at 
least 150 membranous structures at every condition. In the liposome samples containing 
20% PtdSer more than 80% of the counted structures were tubulated (Figure 24A). With 5% 
PtdSer the percentage of tubulated structures decreased to approx. 45%. Without PtdSer, 
with 20% PtdIns and in liposomes without PtdIns(4,5)P2 nearly no deformation occurred 
similar to the control liposomes. Most of the tubules had a length between 125 nm and 250 
nm (Figure 24B). 
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Figure 23: PtdSer promotes ENTH domain induced membrane deformation and the formation of ENTH 
domain homo-oligomers. LUVs were composed of PtdCho, PtdEtn, PtdSer, PtdIns(4,5)P2 (20% PS - 45 : 30 : 
20 : 5). (5% PS - 60 : 30 : 5 : 5), (0% PS - 65 : 30 : 5) and were incubated with the ENTH domain. In addition, 
LUVs composed of PtdCho, PtdEtn, PtdIns, PtdIns(4,5)P2 (20% PI - 45 : 30 : 20 :5) and PtdCho, PtdEtn, PtdSer 
(- PIP2 - 50 : 30 : 20) were also incubated with the ENTH domain. A. Co-sedimentation of the ENTH domain with 
LUVs (P = pellet, Sn = supernatant). ENTH domain without LUVs and LUVs without ENTH domain were used as 
control. B. Membrane deformation analysis of LUVs by electron microscopy. LUVs incubated without proteins 
were used as control. Scale bars correspond to 200 nm. C. Membrane deformation analysis of LUV populations 
by DLS.  
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Figure 24: Quantitative evaluation of PtdSer dependent membrane deformation by the ENTH domain. At 
least 150 membranous structures were evaluated per condition. LUVs were composed as in figure 23. A. 
Percentage of spherical and tubulated membranous structures per condition. B. Percentage of tubule length 
generated by the ENTH domain on LUVs composed of PtdCho, PtdEtn, PtdSer, PtdIns(4,5)P2 (45 : 30 : 20 : 5). 
 
Together, these results show that ENTH domain dependent membrane deformation 
and formation of homo-oligomers is dependent on the presence of PtdSer. This effect is not 
only dependent on the negative charges introduced by PtdSer since it was not possible to 
get similar results by replacing PtdSer with PtdIns. 
Next, we asked if ENTH domain induced membrane deformation is dependent on the 
lipid species PtdSer itself, or if PtdSer changes the physical properties of the membrane so it 
becomes easier to deform? PtdSer has an inverse conical shape with a small headgroup in 
comparison to the rest of the lipid similar to PtdEtn which is not charged. We replaced the 
additional molar percentage of PtdSer with PtdEtn to get the lipid composition: Lα-PtdCho, 
Lα-PtdEtn, Lα-PtdIns(4,5)P2 (45 : 50 : 5). 2 mg/ml liposomes of this composition were 
incubated with and without 12 µM ENTH domain and tested again for membrane binding 
and membrane deformation.  
The ENTH domain was still recruited to these liposomes but the formation of homo-
oligomers did not occur (Figure 25A). We also did not see any tubulation and the liposomes 
behaved like spherical particles in DLS analysis (Figure 25B, 25C). The intrinsic controls of 
this experiment behaved like expected: liposomes without ENTH pelleted and ENTH domain 
without the liposomes remained in the supernatant. The control liposomes were not 
deformed as well. 
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Figure 25: PtdEtn is not able to promote ENTH domain induced membrane deformation and the formation 
of ENTH domain homo-oligomers. LUVs were composed of PtdCho, PtdEtn PtdIns(4,5)P2 (50% PE - 45 : 50 : 
5) and were incubated with the ENTH domain. A. Co-sedimentation of the ENTH domain with LUVs (P = pellet, 
Sn = supernatant). ENTH domain without LUVs (ENTH) and LUVs without ENTH domain (Lipos) were used as 
control. B. Membrane deformation analysis of LUVs by electron microscopy. LUVs incubated without protein 
were used as control. Scale bars correspond to 200 nm. C. Membrane deformation analysis of LUV populations 
by DLS.  
 
So far, the results indicated that the ENTH domain is able to induce membrane 
deformation on liposomes containing PtdSer. To observe membrane binding and 
deformation in real time we employed fluorescence microscopy together with GUVs. We 
chose Atto 488 maleimide to label the ENTH domain and Atto 647N DO-PtdEtn for the 
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GUVs to avoid the FRET effect. The emission of Atto 488 does not overlap with the 
absorption of Atto 647N (Figure 26A). The ENTH domain possesses one cysteine at position 
96 within helix 5 that might have been a target for maleimide modification. To avoid helix 
breaks and disrupt the structural integrity of the protein we mutated this cysteine to an 
alanine and mutated the alanine on position 155 in the end of the ENTH domain to a 
cysteine (Figure 26B). The mutant ENTH C96A A155C was efficiently labeled and still bound 
to membranes. We subsequently tested the stability of Atto 647N over 157 min (Figure 26C). 
Therefore, we generated GUVs by using a lipid composition with Lα-PtdCho, Lα- PtdEtn, 
Atto 647N DO-PtdEtn (69.5 : 30 : 0.5). The GUVs were recorded with 5% laser intensity, an 
exposure time of 100 msec and a recording frequency of 30 pictures per min. The 
fluorophore remained stable over this time and no cross-talk into the emission wavelength of 
Atto 488 occurred. 
 
 
Figure 26: The GUV assay. A. Spectra of Atto 488 and Atto 647N. B. ENTH domain C96A A155C used as 
labeling mutant. Mutated residues are indicated in blue. C. Atto 647N did not show cross-talk into emission of 
Atto 488 and was photo stabile Scale bars correspond to 8 µm. 
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 2 µM of the labeled ENTH domain was incubated with GUVs composed of Lα-
PtdCho, Lα- PtdEtn, Lα- PtdSer, Lα- PtdIns(4,5)P2 and Atto 647N DO-PtdEtn (44.5 : 30 : 20 : 
5 : 0.5) at 25°C. Since it is not possible to mix the GUV suspension without disturbing the 
integrity of the vesicles, we waited until the ENTH domain diffused to the target GUV. After 
reaching the membrane, the ENTH domain started to bind (Figure 27A). Shortly, after 
saturation of the ENTH signal at the membrane, we observed the generation of long 
membrane tubles originating from the GUV accompanied with the shrinking of the GUV and 
final collapse of the GUV (Figure 27B). 
 
 
Figure 27: The ENTH domain binds to and deforms PtdSer containing GUVs. Atto 488 ENTH (520 nm) and 
the GUV membrane Atto647N PE (664 nm) were recorded. A. Full membrane coverage of the ENTH domain 
was observed after 47 min. B. The membrane tubulation started after 62 min. Scale bars correspond to 5 µm. 
 
 In comparison, we incubated labeled ENTH domain with GUVs composed of Lα-
PtdCho, Lα- PtdEtn, Lα- PtdIns(4,5)P2 and Atto 647N DO-PtdEtn (64.5 : 30 : 5 : 0.5) under 
the same conditions. The recruitment of the protein to the GUVs was still observed but no 
signs of the generation of membrane tubules occured and the GUVs remained stable during 
the recording time (Figure 28). 
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Figure 28: The ENTH domain does not deform GUVs without PtdSer. Atto 488 ENTH (520 nm) and the GUV 
membrane Atto647N PE (664 nm) were recorded. Full membrane coverage of the ENTH domain was observed 
after 40 min. But no membrane deformation occurred until the end of recording (134 min). Scale bars correspond 
to 8 µm. 
 
 The whole tubulation event was very fast and took just 22 sec until the GUV 
collapsed (Figure 29). In the beginning, nucleation spots were observed on the GUV in 
which the intensity of the membrane signal and the protein signal increased. Membrane 
tubules originated from these spots on which the protein still co-localized. The GUV shrunk 
and more membrane material was put into the growing tubules until the GUV was not in 
focus anymore. 
 
Figure 29: The ENTH domain does not deform GUVs without PtdSer. Atto 488 ENTH (520 nm) and the GUV 
membrane Atto647N PE (664 nm) were recorded. Full membrane coverage of the ENTH domain was observed 
after 40 min. But no membrane deformation occurred until the end of recording (134 min). Scale bars correspond 
to 8 µm. 
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 Finally, we examined, if the soluble PtdSer headgroup is sufficient to induce similar 
effects as the lipid embedded inside the membranes. Therefore, we prepared LUVs 
composed of Lα-PtdCho, Lα- PtdEtn and Lα- PtdIns(4,5)P2 (65 : 30 : 5) and incubated them 
with and without 12 µM ENTH domain, 48 µM O-phosphoserine, or both together for 3 h at 
30°C. The ENTH domain was also incubated with O-phosphoserine alone as control. The 
analysis of the co-sedimentation assay showed, that the ENTH domain was recruited to the 
membranes in presence and absence of O-phosphoserine, while it remains in the 
supernatant without LUVs (Figure 30A). But only in presence of the PtdSer headgroup and 
the membrane the ENTH domain formed homo-oligomers again and protein signal was 
visible at 35 kDa, above 55 kDa and above 70 kDa. 
 The analysis by electron microscopy reveled that membrane deformation occurred, if 
LUVs were incubated with ENTH domain and O-Phosphoserine together, although it was not 
as drastic as if the PtdSer was part of the membrane in electron microscopy confirmed by 
DLS (Figure 30B, 30C). Liposomes alone or with O-phosphoserine or with ENTH domain did 
not show tubulation in the electron microscopy, as well as no deformation measured by DLS.  
 We counted again over 150 membrane structures per condition, taken from 
electron microscopy pictures, for the statistical analysis (Figure 30D). Here, the results 
indicate, that the membrane deformation activity of the ENTH domain was partially 
recovered by the presence of PtdSer headgroup in comparison to the other conditions. In the 
presence of the headgroup, about 50% of the counted structures were tubulated, while 
nearly no deformation occurred only with O-phosphoserine, or only with ENTH domain.  
All results together strongly indicate that PtdSer affects the ENTH domain induced 
membrane deformation. PtdSer does not seem to change the physical properties of the used 
model membranes, since protein induced membrane deformation was not observed in the 
control conditions containing the negatively charged PtdIns, or the inverse conical shaped 
PtdEtn. In addition, the presence of PtdSer induced the formation of ENTH domain homo-
oligomers, if the ENTH domain was recruited to model membranes indicating that ENTH 
domain induced membrane deformation and homo-oligomerization are associated. 
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Figure 30: O-phosphoserine is partially able to rescue ENTH domain induced membrane deformation and 
homo-oligomer formation. LUVs were composed of PtdCho, PtdEtn, PtdIns(4,5)P2 (Lipos - 65 : 30 : 5) and 
were incubated with the ENTH domain with or without O-phosphoserine (PS hg). A. Co-sedimentation of the 
ENTH domain with LUVs (P = pellet, Sn = supernatant). ENTH domain without LUVs (ENTH) and LUVs without 
ENTH domain and with, or without O-phosphoserine (Lipos) were used as control. B. Membrane deformation 
analysis of LUVs by electron microscopy. LUVs incubated without protein were used as control. Scale bars 
correspond to 200 nm. C. Membrane deformation analysis of LUV populations by DLS. D. Quantitative evaluation 
of electron micrographs. 
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All results together strongly indicate that PtdSer interacts with the ENTH domain. 
PtdSer does not seem to change the physical properties of the model membranes so that 
ENTH domain induced membrane deformation becomes more favorable, since tubulation 
was not observed with the negatively charged PtdIns or the inverse conical shaped PtdEtn. 
In addition, the presence of PtdSer induced the formation of ENTH domain homo-oligomers, 
if the ENTH domain was recruited to the used model membranes. This indicates, that ENTH 
domain induced membrane deformation and homo-oligomerization are associated. 
  
We started to cooperate with the Zweckstetter group (Markus Zweckstetter, Max 
Planck Institute for Biochemistry, Göttingen, Germany) to perform solid state NMR studies of 
13C and 15N labeled ENTH domain bound to LUVs composed of PtdCho, PtdEtn, 
PtdIns(4,5)P2 (65 : 30 : 5) and PtdCho, PtdEtn, PtdSer, PtdIns(4,5)P2 (45 : 30 : 20 : 5). The 
data indicates that the ENTH domain bound to PtdSer underwent structural changes and 
appeared to be more “rigid” in comparison to ENTH domain bound to LUVs without PtdSer 
(data not shown). 
Finally, we started to examine the effect of cholesterol on ENTH domain dependent 
membrane deformation (Figure 31). For preliminary studies, we used LUVs composed of 
PtdCho, PtdSer, chol, PtdIns(4,5)P2 (45 : 30 : 20 : 5). Those LUVs (2 mg/ml lipid content) 
were incubated with 12 µM ENTH domain the same way as described before. The analysis 
of membrane deformation revealed a new phenotype for membrane deformation. The ENTH 
domain still induced the generation of tubles, but these membrane tubles were segmented. 
We designated this phenotype beads-on-a-sting. The single segments were approx. 25 nm 
in diameter.  
All these results taken together indicate that the ability of the ENTH domain strongly 
depended on the lipid composition as well as the phenotype of resulting membrane 
deformation. 
 
 
Results: PtdSer promotes ENTH domain dependent membrane deformation 
 
93 
 
 
Figure 31: The presence of cholesterol within LUVs promotes the ENTH domain dependent generation of 
segmented membrane tubules. LUVs were composed of PtdCho, PtdSer, chol, PtdIns(4,5)P2 (45 : 30 : 20 : 5) 
and were incubated with and without the ENTH domain. Membrane deformation analysis of LUVs were 
performed by electron microscopy. Scale bars correspond to 200 nm. 
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4.3 ENTH domain oligomerization is dependent on PtdSer and the arginine 114 
 
PtdSer had two effects on the ENTH domain: we observed that the ENTH domain 
induced the generation of membrane tubules in dependency of PtdSer. In addition, we 
observed at least dimerization of membrane bound ENTH domains, also only in the 
presence of PtdSer. The effects we observed on the ENTH domain were lipid headgroup 
specific since it was not possible to obtain similar effects if we exchanged PtdSer with lipids 
that had similar physical characteristics. But so far, we were not able to identify the 
molecular background of this effect. 
In 2012 Lai C. et al performed coarse-grained molecular dynamics (CG MD) 
simulation of the ENTH domain bound to liposomes and to membrane tubules. Beside the 
PtdIns(4,5)P2 binding pocket, they identified two regions of interest: The ENTH domain 
possesses two valines (V50,51) in the N-terminal end of helix 3 (Figure 32). The CG MD 
simulations showed that these two residues are surface exposed and the authors proposed 
that these residues might have a role as protein-protein interaction sites to form ENTH 
domain homo-dimers in an antiparallel orientation 170. The second region of interest was 
identified within the loop between helix 6 and helix 7. Based upon EPR studies and structural 
analysis the authors claimed that this loop touches the surface of the membrane 170. 
Especially, an arginine (R114) within this region had a significant role in their considerations 
(Figure 32) and they proposed that this basic amino acid might interact with acidic lipid 
headgroups and determines the orientation of the ENTH domain on the membrane. The 
ENTH domain would form at least dimers to stabilize membrane tubules and act as a 
scaffold. Since these ideas are lacking experimental evidence we adopted them to test if our 
observations about PtdSer dependent membrane tubulation and homo-oligomerization are in 
context with these two regions. 
 
 
Figure 32: Positions of amino acids V50,51 and R114 within the crystal structure of the ENTH domain. 
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First, we generated an ENTH domain construct in which we mutated the two valines 
on the positions 50 and 51 of the amino acid sequence to alanines (ENTH V50,51A). By 
doing this we intended to make this region less hydrophobic and inhibit the oligomerization 
of the protein. We tested ENTH V50,51A for membrane binding by co-sedimentation assays 
and analyzed the ability to deform membrane by electron microscopy. In order to do so we 
used three different lipid compositions to generate LUVs which we used already to 
characterize membrane binding and membrane deformation by the ENTH domain WT: 
1. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 5) 
2. Lα-PtdCho, Lα-PtdEtn, Lα-PtdIns(4,5)P2 (65 : 30 : 5) 
3. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer (50 : 30 : 20) 
We incubated 12 µM of ENTH V50,51A with LUVs (2 mg/ml lipid content) of each 
liposome composition and used liposomes (Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-
PtdIns(4,5)P2) and ENTH V50,51A alone as control. The samples were incubated for 3 h at 
30°C.  
Analysis of the co-sedimentation revealed an unexpected behavior of ENTH V50,51A 
(Figure 33A). Unlike the ENTH domain WT which co-sedimented only in dependency of 
PtdIns(4,5)P2 containing LUVs ENTH V50,51A pelleted along with any used LUV population. 
Interestingly, ENTH V50,51A still behaved like a soluble protein in the control that did not 
contain liposomes. The mutant formed homo-oligomers (or agglomerates) independently 
from the membrane and protein bands were observed at about 35 kDa and 70 kDa. 
The analysis of the electron micrographs revealed that ENTH V50,51A was unable to 
deform membranes, also if we used a lipid composition containing PtdSer and PtdIns(4,5)P2 
together (Figure 33B). The results together indicate that ENTH V50,51A is a loss of function 
mutant, which we did not investigate further. 
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Figure 33: ENTH V50,51A is a loss of function mutant. LUVs were composed of PtdCho, PtdEtn, PtdSer 
PtdIns(4,5)P2 (PS PIP2 - 45 : 30 : 20 : 5), PtdCho, PtdEtn, PtdIns(4,5)P2 (PIP2 - 65 : 30 : 5) and PtdCho, PtdEtn, 
PtdSer (PS - 50 : 30 : 20). Those LUVs were incubated with ENTH V50,51A. A. Co-sedimentation of ENTH 
V50,51A with LUVs (P = pellet, Sn = supernatant). ENTH V50,51A without LUVs and LUVs without protein 
(Lipos) were used as control. B. Membrane deformation analysis of LUVs by electron microscopy. LUVs 
incubated without protein were used as control. Scale bars correspond to 200 nm.  
 
Next, we mutated the positively charged arginine at the amino acid sequence 
position 114 of the ENTH domain WT to a non-charged alanine (ENTH R114A). This region 
might play a central role in interaction with negatively charged lipids within the membrane. 
To test the ability of ENTH R114A to bind and deform membranes we used again the co-
sedimentation assay and electron microscopy and compared the results directly with the 
ENTH domain WT. Therefore, we used our established lipid compositions to generate LUVs 
in which we expect binding and deformation, only binding and no binding: 
1. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 5) 
2. Lα-PtdCho, Lα-PtdEtn, Lα-PtdIns(4,5)P2 (65 : 30 : 5) 
3. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer (50 : 30 : 20) 
ENTH R114A and ENTH domain WT (12 µM) were incubated with LUVs of each lipid 
composition (2 mg/ml lipid content) for 3 h at 30°C. The membrane recruitment of ENTH 
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R114A was similar to the ENTH domain WT (Figure 34A and 34B). It co-sedimented with 
LUVs that contained PtdIns(4,5)P2, did not bind to LUVs that were only composed of 
PtdCho, PtdEtn and PtdSer and behaved like a soluble protein without membranes. But it 
was remarkable that ENTH R114A did not show any signs of higher molecular weight band 
pattern on the SDS gel, showing that the mutant lost the ability to form homo-oligomers. 
 
 
Figure 34: Co-sedimentation of ENTH R114A in comparison to the ENTH domain WT. LUVs were 
composed of PtdCho, PtdEtn, PtdSer PtdIns(4,5)P2 (PS PIP2 - 45 : 30 : 20 : 5), PtdCho, PtdEtn, PtdIns(4,5)P2 
(PIP2 - 65 : 30 : 5) and PtdCho, PtdEtn, PtdSer (PS - 50 : 30 : 20). Those LUVs were incubated with ENTH 
R114A and the ENTH domain WT. A. Co-sedimentation of ENTH R114A with LUVs (P = pellet, Sn = 
supernatant). ENTH R114A without LUVs and LUVs without protein (Lipos) were used as control. B Co-
sedimentation of the ENTH domain WT with LUVs (P = pellet, Sn = supernatant). ENTH domain WT without 
LUVs and LUVs without protein (Lipos) were used as control. 
 
Analysis of the ability to deform membranes revealed that R144A was not able to 
induce the formation of membrane tubules in any lipid composition (Figure 35A, 33C) while 
the ENTH domain WT tubulated LUVs containing both PtdSer and PtdIns(4,5)P2 as shown 
before (Figure 23B). This was confirmed by DLS analysis where all liposome populations 
incubated with ENTH R114A behaved like spherical particles. In comparison, LUVs 
containing PtdSer and PtdIns(4,5)P2 showed a characteristic profile for deformed 
membranes in the DLS experiments if incubated with the ENTH domain WT (Figure 35B and 
35D).  
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Figure 35: Analysis of membrane deformation by ENTH R114A in comparison to the ENTH domain WT. 
LUVs were composed of PtdCho, PtdEtn, PtdSer PtdIns(4,5)P2 (PS PIP2 - 45 : 30 : 20 : 5), PtdCho, PtdEtn, 
PtdIns(4,5)P2 (PIP2 - 65 : 30 : 5) and PtdCho, PtdEtn, PtdSer (PS - 50 : 30 : 20). Those LUVs were incubated 
with ENTH R114A and the ENTH domain WT. A. Electron micrographs of ENTH R114A and the ENTH domain 
WT incubated with PS PIP2 and PIP2 LUVs. Scale bars correspond to 200 nm. B. Corresponding DLS analysis 
profiles to A. C. Electron micrographs of control experiments with ENTH R114A and the ENTH domain WT 
incubated with PS LUVs and liposomes without protein. Scale bars correspond to 200 nm. D. Corresponding DLS 
analysis profiles to C. 
 
We evaluated the electron microscopy pictures and counted tubulated membrane 
structures and spherical membrane structures (Figure 36). At least 200 membrane 
structures were counted for each used condition. The resulting statistics revealed only the 
ENTH domain WT deformed membranes if the LUVs contained PtdSer and PtdIns(4,5)P2 
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and approx. 90% of the counted membranous structures were tubulated. In comparison, 
LUVs without PtdSer, or without PtdIns(4,5)P2 did not show a significant increase in 
tubulation. ENTH R114A failed in deforming the membranes. We just detected approx. 15% 
of tubulated membranous structures if it was incubated with LUVs containing PtdSer and 
PtdIns(4,5)P2 and even less in the other LUV compositions.  
 
Figure 36: Statistical analysis of membrane deformation by ENTH R114A in comparison to the ENTH 
domain WT. Electron micrographs of figure 32 were used for evaluation. 
 
In order to resolve membrane deformation and binding of the wildtype and mutant at 
the same time we employed the flotation assay (co-migration assay). 18 µM of ENTH 
R114A, or ENTH domain WT was incubated with LUVs of the same lipid compositions as 
before (3 mg/ml) for 3 h at 30°C and finally used for the flotation assay (Figure 37 and 38). 
The ENTH domain WT did not affected the flotation pattern of LUVs composed either of 
PtdCho, PtdEtn and PtdIns(4,5)P2, or PtdCho, PtdEtn and PtdSer and the liposomes 
migrated between the 0% (w/v) histodenz layer and the 5% (w/v) layer as the undeformed 
control LUVs without protein. If the LUVs were composed of PtdCho, PtdEtn, PtdSer and 
PtdIns(4,5)P2 membrane signals were visible between all layers indicating that the ENTH 
domain WT induced membrane deformation. In comparison, LUVs of any lipid composition 
incubated ENTH R114A were not deformed and migrated only between the 0% layer and the 
5% layer. The layers of each flotation sample were separated and used for SDS-PAGE to 
analyze if the proteins co-migrated with the LUVs. The ENTH domain WT co-migrated with 
LUVs containing PtdIns(4,5)P2, while it did not migrate along LUVs composed of PtdCho, 
PtdEtn and PtdSer or without any LUVs. The protein was found between the 0% layer and 
the 5% layer if incubated with LUVs composed of PtdCho, PtdEtn and PtdIns(4,5)P2 and in 
all interlayers if incubated with LUVs composed of PtdCho, PtdEtn, PtdSer and 
PtdIns(4,5)P2. In addition, we saw the formation of at least homo-dimers. In comparison 
ENTH R114A migrated only between the interlayer between 0% and 5% histodenz if 
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incubated with LUVs containing PtdIns(4,5)P2 or did not migrate without LUVs, or with LUVs 
composed of PtdCho, PtdEtn and PtdSer. We did not observe any formation of homo-dimers 
with ENTH R114A. 
 
 
Figure 37: Co-migration assay of ENTHR114A in comparison to the ENTH domain WT. LUVs were 
composed of PtdCho, PtdEtn, PtdSer PtdIns(4,5)P2 (PC PE PS PIP2 - 45 : 30 : 20 : 5), PtdCho, PtdEtn, 
PtdIns(4,5)P2 (PC PE PIP2 - 65 : 30 : 5) A. Flotation pattern and co-migration of the ENTH domain WT with PC 
PE PS PIP2 and PC PE PIP2 LUVs. B. Flotation pattern and co-migration of ENTH R114A with PC PE PS PIP2 
and PC PE PIP2 LUVs. 
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Figure 38: Controls of the co-migration assay of ENTHR114A in comparison to the ENTH domain WT. 
LUVs were composed of PtdCho, PtdEtn, PtdSer (PC PE PS – 50 : 30 : 20) A. Flotation pattern and co-
migration of ENTH domain WT and ENTH R114A incubated with LUVs. B. Flotation pattern of liposomes without 
protein (Lipos). C. Migration of the ENTH domain WT and ENTH R114A without liposomes. 
 
In sum, the results show that the characterized mutant ENTH R114A, which still 
binds to membranes containing PtdIns(4,5)P2, fails completely to generate membrane 
tubules and to form homo-oligomers. This indicates that the observed ability of ENTH 
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domain to deform membranes and to form homo-oligomers are somehow connected and 
dependent on the loop region between helix 6 and helix 7, especially on the function of 
R114.  
Before we went on with analyzing the connection of oligomerization, membrane deformation 
and the loop region, we wanted to find out, if the mutation of the ENTH domain induced 
changes within structure and thus impaired the function of the ENTH domain. Therefore, we 
employed CD spectroscopy to compare the secondary structures of ENTH R114A and the 
ENTH domain WT (Figure 39).  
Purified ENTH domain WT and ENTH R114A were transferred into 10 mM potassium 
phosphate buffer (pH 7.4) and the protein concentrations were adjusted to 0.1 mg/ml. The 
CD spectroscopy analysis of the ENTH domain WT displayed a typical profile of a protein 
consisting of α-helices, indicating correct folding. In comparison, the CD profile of ENTH 
R114A displayed a nearly perfect overlay over the profile of the ENTH domain WT. We also 
measured the absorbance of the potassium phosphate buffer to show that it did not interfere 
the CD spectroscopy in the range of 190 nm to 260 nm. The CD data indicated that the 
mutation did not induce helix brakes or misfoldings within the structure of ENTH R114A. 
 
 
Figure 39: CD spectroscopic analysis of ENTHR114A in comparison to the ENTH domain WT. Proteins 
were rebuffered into 10 mM potassium phosphate buffer with a concentration of 0.1 mg/ml. A. CD spectroscopic 
profiles of ENTH R114A (purple) and the ENTH domain WT (cyan). B. Absorbance of the potassium phosphate 
buffer. 
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We already showed that the ENTH domain forms homo-oligomers in presence of 
PtdSer if the protein is recruited to the membrane and that ENTH 114A failed in forming 
similar oligomers under the same conditions. In order to resolve the formation of oligomers in 
a comparable quantitative manner, we employed the Förster resonance energy transfer 
(FRET) assay. The FRET assay enables us to analyze the ability of the proteins to form 
homo-oligomers, or at least of proteins close enough to each other, even at low protein 
concentrations. Therefore, we used the labeling mutants of the ENTH domain WT (ENTH 
C96A A155C) and of ENTH R114A (ENTH C96A R114A A155C) and generated two 
populations of labeled proteins: one population was labeled with Atto 488 maleimide and the 
other one was labeled with Atto 532 maleimide (Figure 40). To avoid a false FRET signal by 
protein crowding effects but still ensure full binding of the proteins, we used only 5 µM of 
total protein concentration and 2 mg/ml lipid concentration of LUVs as reaction mix. We 
prepared two LUV populations to compare just protein binding to formation of oligomers on 
the membrane:  
1. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 5) 
2. Lα-PtdCho, Lα-PtdEtn, Lα-PtdIns(4,5)P2 (65 : 30 : 5) 
 
 
 
Figure 40: Choice of fluorophores for the FRET assay. Absorption and emission profile of Atto 488 and Atto 
532 in comparison. 
 
The normalized spectra show that the ENTH domain WT indeed showed a FRET 
effect if LUVs with PtdSer were used and we observed an increase of acceptor emission at 
552 nm (Figure 41). In comparison, we observed strongly decreased acceptor emission if we 
used LUVs without PtdSer. If we used ENTH R114A instead we did not observe strong 
acceptor emission independent from the presence of PtdSer within the LUVs. With other 
words, the mutant also failed in this assay to form homo-oligomers. 
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Figure 41: Protein-protein FRET assay of ENTH R114A in comparison to the ENTH domain WT. Two 
differently labeled protein populations were generated of both proteins, one labeled with Atto 532 mal, the other 
one labeled with Atto 488 mal. Proteins were incubated with LUVs composed of PtdCho, PtdEtn, PtdSer 
PtdIns(4,5)P2 (+ PS - 45 : 30 : 20 : 5) and PtdCho, PtdEtn, PtdIns(4,5)P2 (- PS - 65 : 30 : 5). 
 
The protein FRET experiment shows that the formation of ENTH domain homo-
oligomers is concentration independent and dependent on the presence of PtdSer within the 
membrane. Furthermore, the loop between helix 6 and 7 and especially the arginine plays a 
central role in oligomerization. But still we did not know if this arginine directly interacts with 
PtdSer or if it has a distinct role from specific lipid interaction. Therefore, we designed a 
second FRET experiment in which we analyzed the lipid binding of the ENTH domain to 
PtdSer (Figure 42). Therefore, we used the ENTH domain C96A A155C and ENTH C96A 
R114A A155C (5 µM end concentration), only labeled with Atto488 maleimide as FRET 
donor. We used Atto 532 labeled PtdSer as FRET acceptor for our LUVs to determine the 
lipid binding. Atto 532 labeled PtdEtn was used as a control to the lipid binding specificity of 
the ENTH domain. Therefore, we used two LUV (2 mg/ml) compositions: 
1. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2, Atto 532 PtdSer (55 : 20 : 19.5 : 
5: 0.5) 
2. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2, Atto 532 PtdEtn (55 : 20 : 19.5 : 
5: 0.5) 
The FRET spectra show that the ENTH domain specifically binds to PtdSer, since we 
observed an increase of acceptor emission if we used Atto 532 PtdSer, but no increase if we 
used Atto 532 PtdEtn in our membranes. Surprisingly, we observed the same effect if we 
used labeled ENTH R114A indicating that PtdSer binding is independent from the arginine at 
position 114. The loop region seems to have an important role in oligomerization of the 
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ENTH domain, but not in selective binding of PtdSer. Still, oligomerization and PtdSer 
binding seem to be intertwined effects. 
 
 
Figure 42: Lipid-protein FRET assay of ENTH R114A in comparison to the ENTH domain WT. Proteins 
were labeled with Atto 488 mal and membranes contained Atto 532 PE or Atto 532 PS. Proteins were incubated 
on LUVs composed of Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2, Atto 532 PtdSer (55 : 20 : 19.5 : 5: 
0.5), or Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2, Atto 532 PtdEtn (55 : 20 : 19.5 : 5: 0.5). 
 
Since we observed the formation of ENTH domain homo-oligomers in dependency of 
the arginine 114, we wanted to find the localization of oligomerization. Thus, we employed 
an analysis strategy including chemical cross-linking, trypsin digest and MS/MS. ENTH 
domain WT and ENTH R114A (15 µM) were incubated with three populations of LUVs (2.5 
mg/ml lipid concentration): 
1. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 5) 
2. Lα-PtdCho, Lα-PtdEtn, Lα-PtdIns(4,5)P2 (65 : 30 : 5) 
3. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer (50 : 30 : 20) 
The incubation was performed, as described before, for 3 h at 30°C and subsequently 
cross-linked by using BS3 (Figure 43A). The analysis of the cross-linked proteins revealed 
that in all samples containing ENTH domain WT and ENTH R114A oligomerization occurred 
if the proteins were incubated with LUVs. The ENTH domain WT formed dimers, trimers and 
even higher order oligomers if incubated with LUVs containing PtdSer and PtdIns(4,5)P2, or 
PtdIns(4,5)P2 alone. The ENTH domain WT oligomer bands were fainter, if it was incubated 
with LUVs that did not contain PtdIns(4,5)P2. ENTH R114A formed oligomers with the same 
LUV compositions as ENTH domain WT, but they were fainter in comparison. Monomers, 
dimers and trimers were cut out of the gel und used for trypsin digest and MS/MS analysis 
(Figure 43B and Figure 43C). Proteins that were incubated with LUVs composed of PtdCho, 
PtdEtn, PtdSer showed weak signs oligomerization and the monomer bands remained more 
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pronounced. If the ENTH domain WT was incubated with LUVs containing PtdIns(4,5)P2 with 
or without PtdSer three positions on the amino acid sequence were cross-linked: the most 
abundant cross linking position was K117, but also position K149 was cross-linked. Notably, 
if ENTH R114 was used less inter-protein cross-links were observed in general. Cross-links 
only occurred abundantly at position K149 and no cross-links were detected at position 
K117, next to the mutated arginine. The data indicate that the ENTH domain oligomerizes at, 
or close to position K117 and that the single replacement of the arginine on position 114 to 
an alanine inhibits the formation of ENTH domain homo-oligomers. 
  
Table 7: Relative peptide fragment abundancy of inter-protein cross-links between K117. The ENTH 
domain WT and ENTH R114A were incubated with LUVs composed of PtdCho, PtdEtn, PtdSer PtdIns(4,5)P2 
(PC PE PS PIP2 - 45 : 30 : 20 : 5) and PtdCho, PtdEtn, PtdIns(4,5)P2 (PC PE PIP2 - 65 : 30 : 5). Only dimers 
and trimers were used for analysis.  
Protein ENTH WT ENTH R114A 
LUVs PC PE PIP2 PC PE PS PIP2 PC PE PIP2 PC PE PS PIP2 
Oligomer 2mer 2mer 3mer 2mer 2mer 3mer 
117-117 10% 18% 10% 0 0 0 
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Figure 43: Cross-linking and MS/MS analysis of ENTH domain oligomerization in comparison to ENTH 
R114A. LUVs were composed of Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 5), Lα-
PtdCho, Lα-PtdEtn, Lα-PtdIns(4,5)P2 (65 : 30 : 5) and Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer (50 : 30 : 20). These 
LUVs were incubated with ENTH domain WT and ENTHR114A. A. SDS-PAGE of the cross-linking experiment by 
BS3. B. MS/MS analyzes of trypsin digest ENTH domain WT and ENTH R114A incubated with LUVs composed 
of Lα-PtdCho, Lα-PtdEtn, Lα-PtdIns(4,5)P2 (65 : 30 : 5). C. MS/MS analyzes of trypsin digest ENTH domain WT 
and ENTH R114A incubated with LUVs composed of Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2 (45 : 
30 : 20 : 5).  
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4.4 Epsin1 recruits clathrin and tetraubiquitin to the membrane 
Epsin1 is described as an adaptor protein in endocytosis. It directly interacts with the 
main endocytic proteins clathrin and AP-2, and with the plasma membrane. Additionally, it 
interacts with endocytic nucleation proteins like intersectin and Eps15. Since the membrane 
deforming ability of the ENTH domain was characterized 116, the question arose if Epsins 
have more roles in endocytosis, apart from their adaptor functions. Epsins also have 
ubiquitin interaction motifs within their unstructured C-terminus indicating their possible 
function in cargo selection 122. CME is a highly regulated process and many functions are 
redundant in different proteins, like membrane deformation. But these abilities of membrane 
deformation coupled to clathrin recruitment and cargo selection display the potential of 
Epsin1 to drive endocytosis in a minimal system. 
We started to optimize our assays for the use of the full length Epsin1. Therefore, the 
membrane binding and the ability to deform vesicles was tested with three already 
established LUV compositions: 
4. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2 (45 : 30 : 20 : 5) 
5. Lα-PtdCho, Lα-PtdEtn, Lα-PtdIns(4,5)P2 (65 : 30 : 5) 
6. Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer (50 : 30 : 20) 
Epsin1 (8 µM) was incubated together with these three LUV populations (2 mg/ml 
lipid concentration) for 3 h at 30°C. Membrane binding was determined by the co-
sedimentation assay and membrane deformation was analyzed by EM and DLS. 
As expected, Epsin1 displayed the same binding phenotype as the ENTH domain 
(Figure 44A). The protein co-sedimented with liposomes containing PtdIns(4,5)P2, while it 
remained in the supernatant if incubated with LUVs without PtdIns(4,5)P2 or if it was 
incubated without any LUVs. Epsin1 also deformed the membranes only if PtdIns(4,5)P2 and 
PtdSer were present in the membrane and LUVs without one of these lipids remained 
spherical (Figure 44B). The DLS profiles also pronounced this results and liposomes 
containing PtdIns(4,5)P2 and PtdSer displayed the characteristic profile of membrane 
deformation, while LUVs containing just one of these lipid species remained spherical 
(Figure 44C).  
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Figure 44: Epsin1 displays the same phenotype as the ENTH domain in membrane binding and 
deformation. LUVs were composed of PtdCho, PtdEtn, PtdSer PtdIns(4,5)P2 (PS PIP2 - 45 : 30 : 20 : 5), 
PtdCho, PtdEtn, PtdIns(4,5)P2 (PIP2 - 65 : 30 : 5) and PtdCho, PtdEtn, PtdSer (PS - 50 : 30 : 20). Those LUVs 
were incubated with Epsin1. A. Co-sedimentation of Epsin1 with LUVs (P = pellet, Sn = supernatant). Epsin1 
without LUVs and LUVs without protein (Lipos) were used as control. B. Electron micrographs of Epsin1 
incubated with LUVs. Scale bars correspond to 200 nm C. Corresponding DLS analysis profiles to B. 
 
In the next step, we analyzed membrane binding as well as deformation by Epsin1 
employing the GUV assay (Figure 45). We used GUVs composed of Lα-PtdCho, Lα-PtdEtn, 
Lα-PtdSer, Lα-PtdIns(4,5)P2, Atto 647N PtdSer (44.5 : 30 : 20 : 5: 0.5) and incubated them 
with Atto 488 maleimide labeled Epsin1 C96A (5 µM) and incubated at 25°C. Shortly after 
addition, Epsin1 co-localized at the membrane and started to deform the GUVs until the 
GUV collapsed. Epsin1 also seemed to form clusters on the membrane. 
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Figure 45: Epsin1 binds to PtdIns(4,5)P2 containing membranes in the GUV assay. GUVs were composed 
of Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2, Atto 647N PtdSer (44.5 : 30 : 20 : 5: 0.5) and incubated 
with Epsin1. The signal of the membrane (Atto 647N) and the emission of Epsin1 (Atto 488) were recorded. 
Scale bars correspond to 8 µm. 
 
Next, we addressed if Epsin1 is able to recruit clathrin to LUVs using the liposome 
co-sedimentation assay. We modified the assay with a second protein incubation step: LUVs 
(2 mg/ml lipid concentration) composed of Lα-PtdCho, Lα-PtdEtn, Lα-PtdSer, Lα-
PtdIns(4,5)P2 (45 : 30 : 20 : 5) were at first incubated with 8 µM Epsin1 on ice for 1 h. 
Subsequently, purified and rebuffered clathrin triskelia (5 mg/ml) were added and the mix 
was incubated for 2 more h at room temperature. The analysis of membrane binding in the 
co-sedimentation assay was carried out by SDS-PAGE and also by western blot and 
immune staining (Figure 46A and 46B). The results displayed that Epsin1 alone was 
recruited to the membrane while clathrin alone remained in the supernatant. Both proteins 
were incubated together with LUVs clathrin indeed co-sedimented completely. The proteins 
remained in the supernatant if they were incubated without LUVs. Thereby, we established 
the co-recruitment of clathrin in our assay and showed that clathrin only bound to 
membranes if Epsin1 was present. Interestingly, Epsin1 also formed homo-oligomers, which 
were more pronounced if the protein was incubated with LUVs. 
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Figure 46: Epsin1 is able to recruit clathrin to LUVs. LUVs were composed of PtdCho, PtdEtn, PtdSer 
PtdIns(4,5)P2 (45 : 30 : 20 : 5), incubated with Epsin1 and subsequently with clathrin. The co-sedimentation was 
performed with Epsin1 and clathrin together with LUVs (P = pellet, Sn = supernatant). Epsin1 and clathrin without 
LUVs and LUVs without protein were used as control. The co-sedimentation was resolved by Coomassie staining 
(A) and by western blotting (B). 
 
To show clathrin recruitment to GUVs, we prepared GUVs composed of Lα-PtdCho, 
Lα-PtdEtn, Lα-PtdSer, Lα-PtdIns(4,5)P2, Atto 647N PtdSer (44.5 : 30 : 20 : 5: 0.5) (Figure 
47). First Atto 488 maleimide labeled Epsin1 C96A (2.5 µM) was added to the GUVs and 
incubated for 1 h at 10°C. Subsequently, Atto 390 NHS labeled clathrin triskelia (1 µM) were 
added and incubated at 25°C for 1 h. Clathrin indeed co-localized with membrane bound 
Epsin1. It is remarkable that a lot of clathrin agglomerated independently displaying the 
sensitivity of clathrin triskelia to crush out. 
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Figure 47: Clathrin co-localizes with Epsin1 on GUVs. GUVs were composed of Lα-PtdCho, Lα-PtdEtn, Lα-
PtdSer, Lα-PtdIns(4,5)P2, Atto 647N PtdSer (44.5 : 30 : 20 : 5: 0.5) and incubated with Epsin1 and clathrin. The 
signal of the membrane (Atto 647N), the emission of clathrin (Atto 390) and the emission of Epsin1 (Atto 488) 
were recorded. Scale bars correspond to 5 µm. 
 
Next, we wanted to find out if we can visualize the recruitment of ubiquitin by Epsin1 
in our GUV assay (Figure 48). Therefore, we used a linear tetraubiquitin construct connected 
by lysine 63 and labeled with Atto 390 NHS. We used the same GUVs as before and 
incubated them with Atto 488 maleimide labeled Epsin1 C96A (2.5 µM) at 10°C for 1 h to 
establish high membrane coverage without deformation. Next, tetraubiquitin was added and 
incubated at 25°C. Shortly after addition the tetraubiquitin construct co-localized at the 
membrane together with Epsin1. Epsin1 was able to recruit ubiquitin to the membrane. 
 
 
Figure 48: Tetraubiquitin is recuitied by Epsin1 to GUVs. GUVs were composed of Lα-PtdCho, Lα-PtdEtn, 
Lα-PtdSer, Lα-PtdIns(4,5)P2, Atto 647N PtdSer (44.5 : 30 : 20 : 5: 0.5) and incubated with Epsin1 and 
tetraubiquitin (ubiquitin
4
). The signal of the membrane (Atto 647N), the emission of tetraubiquitin (Atto 390) and 
the emission of Epsin1 (Atto 488) were recorded. Scale bars correspond to 4 µm. 
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5. Discussion 
 
 
Clathrin mediated endocytosis is an essential process for cell homeostasis in 
eukaryotes. During CME cargo molecules are transported across the plasma membrane 
from the outer cell surface into the cytosol. This pathway is mediated and regulated by 
numerous proteins that are recruited to the plasma membrane at specific timepoints. One of 
these proteins is Epsin1 which is highly conserved in eukaryotic evolution. The ENTH 
domain is the lipid interaction module of this protein and specifically binds to PtdIns(4,5)P2. 
Lipid binding is associated with the formation of an amphipathic helix at the N-terminal end 
of the protein which inserts into one leaflet of the membrane 45.  
 
5.1 PtdSer promotes ENTH domain induced membrane tubulation  
The ENTH domain membrane binding and amphipathic helix insertion is associated 
with the generation of local membrane curvature 45 which was extensively studied with 
different approaches. Experiments demonstrating the ENTH domain induced membrane 
deformation were classically performed with model membranes composed of a not 
completely defined lipid extract (Folch) enriched with PtdIns(4,5)P2 
45, 115, while the ENTH 
domain failed to deform model membranes composed of simple lipid composition like 
PtdCho, PtdEtn and PtdIns(4,5)P2, indicating that the generation of membrane curvature 
induced by the ENTH domain is dependent on additional lipid species.  
We addressed the questions which lipid species beside PtdIns(4,5)P2 play a role in 
ENTH domain mediated membrane deformation and how they affect this process. In the 
beginning we demonstrated that the ENTH domain binding to LUVs is only dependent on 
PtdIns(4,5)P2 (Figure 21A), while membrane deformation only occurred on LUVs composed 
of the brain lipid extract enriched with PtdIns(4,5)P2. LUVs composed of PtdCho, PtdEtn and 
PtdIns(4,5)P2 did not show any membrane deformation (Figure 21B and 21C). The 
dependency of ENTH domain membrane binding on the presence of PtdIns(4,5)P2 within the 
used model membrane systems was demonstrated by liposome co-sedimentation by Ford, 
M. G. J. et al 45. We observed the predominant generation of membranous tubules from 
LUVs as the ENTH domain phenotype of membrane deformation which is consistent with the 
observations of Ford, M. G. J. et al 45, but distant from the findings of Boucrot, E. et al, who 
determined the generation of SUVs with a diameter of approx. 25 nm as the predominant 
membrane deforming effect. Remarkably, two distinct brain lipid extract mixtures were used 
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in these two studies: Ford M. G. J. et al used 90% bovine brain lipid extract Type I, Folch 
Fraction I (Sigma-Aldrich Corp., St. Louis, USA) enriched with 10% PtdIns(4,5)P2, while 
Boucrot, E. et al used a mixture of 47,5% bovine brain lipid extract Type I, Folch Fraction I 
(Sigma-Aldrich Corp., St. Louis, USA) and 47.5 % porcine total brain lipid extract (Avanti 
Polar Lipids Inc., Alabaster, USA) enriched with 5% PtdIns(4,5)P2. The lipid compositions 
within the extracts are distinct from each other and the bovine brain lipid extract Type I is 
enriched in PtdIns and PtdSer, while the porcine total brain lipid extract is enriched in 
PtdEtn, PtdCho and PtdSer, but 58.7% of its lipid species are unknown. This might explain 
the distinct phenotypes for ENTH dependent membrane deformation in the two studies. Only 
phospholipids were determined in these lipid mixtures, but not other lipid species like 
sphingolipids and sterols that were demonstrated to have an effect on membrane rigidity and 
membrane shaping 190, 191, 192. The lipid composition of those extracts strongly depends on 
the species and the tissue they were derived from and can differ a lot 193. We used 95% 
Brain Polar Lipid Extract Porcine (Avanti Polar Lipids Inc., Alabaster, USA) enriched with 5% 
PtdIns(4,5)P2 that is also distinct in lipid composition from the two used extracts in the 
studies, but this seems to be more consistent with the findings of Ford M. G. J et al. We 
never observed the generation of SUVs from LUVs in our experiments, but by using the lipid 
composition PtdCho, PtdSer, Chol, PtdIns(4,5)P2 (45 : 30 : 20 : 5) we demonstrated the 
generation of segmented tubules by the ENTH domain, designated “beads-on-a-string” 
phenotype. Each segment was approx. 25 nm, consistent with the diameter of the SUVs 
characterized by Boucrot, E. et al. The addition of cholesterol to lipid compositions might 
govern the formation of small vesicles as main membrane deformation phenotype of the 
ENTH domain. We only used 20% cholesterol in our artificial model membranes, but 
mammalian cell membranes can contain up to 50% cholesterol. To determine if cholesterol 
has an effect on vesiculation it is necessary to repeat the deformation analysis by EM and 
DLS experiments with increasing cholesterol content in the lipid compositions of the model 
membranes and incubate them with the ENTH domain. 
Beside Epsin1, several proteins that are involved in CME contain characteristic 
membrane modules mediating their membrane binding and membrane deformation ability. 
The ANTH domain that can be found in CALM and AP180 for example is associated with 
membrane binding due to surface charge interactions, but not with membrane deformation 
194, 165. In contrast, N-BAR domains that are the membrane interaction modules of 
amphiphysin and endophilin for example, also bind membranes due to surface charge 
interactions, but induce and stabilize membrane curvature due to the scaffold mechanism 
195. The interaction of these domains with model membranes is well characterized. Thus, we 
used them in our membrane binding and deformation assays in comparison to the ENTH 
domain (Figure 22). As expected, all modules were recruited to LUVs, but only the BAR 
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domain and the ENTH domain induced membrane deformation. The tubules generated by 
the BAR domain appeared to be straight and rigid without kinks which is consistent to the 
BAR domain associated deformation mechanism; the scaffold mechanism. The BAR domain 
forms oligomers upon membrane binding, inducing and stabilizing high degrees of 
membrane curvature 114, 48. The ENTH domain generated membranous tubules appeared to 
be flexible with kinks. The mechanism of membrane deformation mediated by the ENTH 
domain is the hydrophobic insertion mechanism, in which the surface of one leaflet of the 
membrane is increased upon the insertion of the amphipathic helix, inducing membrane 
packing defects 45. However, Boucrot, E. et al demonstrated that the two mechanisms can 
be synergetically in one protein 115. For example, amphiphysin and endophilin possess 
amphipathic helices inside their BAR domains.  
Since ENTH domain induced membrane deformation was observed in LUVs 
composed of brain lipid extracts, but not of a simple lipid composition we started to screen 
for lipid species to include into our model membranes. The phospholipid profile of the Brain 
Polar Lipid Extract Porcine (Avanti Polar Lipids Inc., Alabaster, USA) shows that, beside 
PtdCho and PtdEtn, PtdSer is the most abundant lipid species (Table 6). Van Meer, G. et al 
also reviewed that PtdSer is enriched at the inner leaflet of the mammalian plasma 
membrane 4, where CME proteins bind. We demonstrated that PtdSer does not have any 
effect on ENTH domain recruitment to the LUVs and membrane binding is indeed only 
dependent on PtdIns(4,5)P2 
45. However, the presence of PtdSer governed the generation of 
membrane tubules mediated by the ENTH domain as the formation of tubules decreased 
with the decrease of the PtdSer content and in absence of this lipid species, no tubulation 
was observed (Figure 23 and 24). We also observed the same effect by changing the model 
membrane system from LUVs to GUVs and ENTH domain mediated membrane tubulation 
only occurred if PtdSer was present in the membrane (Figure 27, 28 and 29). Remarkably, 
the GUV assay showed that the ENTH domain is not equally distributed on the GUV 
membrane and small ENTH domain clustering spots appeared before membrane tubulation 
started (Figure 29). Stachowiak, J. C. et al showed that membrane deformation of GUVs 
induced by the ENTH domain is dependent on protein surface coverage, or in other words: 
the ENTH domain induces membrane deformation by a crowding effect on the membrane 
inducing lateral pressure by molecule collision 118. Our observations are distinct, since we did 
not see any membrane deformation on GUVs without PtdSer (Figure 28), but PtdSer 
tubulated after ENTH domain binding (Figure 27). Although we are not able to quantify the 
membrane bound protein so far, we assume that the ENTH domain membrane coverage of 
both GUV populations were similar, since we used the same conditions.  
Since PtdSer is negatively charged, we replaced it with PtdIns and tested if we can 
rescue ENTH domain induced membrane deformation (Figure 23 and 24). The co-
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sedimentation assay displayed that PtdIns had no effect on membrane binding, but no 
deformation was observed on LUVs by EM and DLS analysis. PtdIns is an abundant 
phospholipid in the membrane 4, but seemingly does not promote ENTH domain mediated 
membrane deformation. 
PtdSer is inversely conical shaped with a small headgroup compared to the area of 
the fatty acid chains 100. This shape might induce lipid packing defects, making the model 
membranes more favorable for deformation events. We tested this hypothesis by replacing 
PtdSer by additional PtdEtn which has a similar inverse conical shape, but is uncharged 
(Figure 25), so that LUVs were composed of PtdCho, PtdEtn and PtdIns(4,5)P2 (45 : 50 : 5). 
The ENTH domain was recruited to those LUVs, but failed to induce membrane deformation. 
The tests we performed indicate that ENTH domain induced membrane deformation 
depends specifically on the presence of PtdSer. Since we observed no tubulation by 
replacing PtdSer with a positively charged lipid (PtdIns) and an inverse conical shaped lipid 
(PtdEtn) we excluded that membrane deformation occurred only because PtdSer alters the 
physical properties of the membrane. As our assays just gave indications, it is necessary to 
determine physical properties of model membrane systems prepared of the lipid 
compositions we used. Gleisner, M. et al demonstrated that the membrane tension of GUVs 
with a defined lipid composition is altered by the addition of the ENTH domain 173. This 
experiment would be suitable to compare membrane tensions of GUVs prepared of lipid 
compositions containing PtdSer, or PtdIns, or an increased PtdEtn content and how the 
addition of ENTH domain would affect these GUVs.  
By solid state NMR experiments, we were able to demonstrate that the ENTH 
domain undergoes structural changes upon binding to PtdSer containing LUVs in 
comparison to LUVs composed of PtdCho, PtdEtn and PtdIns(4,5)P2. The data indicates that 
the ENTH domain becomes more rigid due to the interaction with PtdSer containing 
membranes. Since we observed that the ENTH also induces the generation of membranous 
tubuli it might be necessary to distinguish if these structural changes occur because of 
interaction to PtdSer, or due its localization on membrane tubules that have a high 
membrane curvature compared to LUVs. Goldstein, A. S. et al were able to prepare 
preformed membranous nanotubes by using the ceramide galactocerebroside, in their lipid 
composition 196. By repeating solid state NMR experiments with PtdIns(4,5)P2 containing 
membrane nanotubes without PtdSer we could determine if bound ENTH domain is affected 
in the same way as in NMR experiments with LUVs.  
Finally, we were able to partially rescue ENTH domain induced membrane tubulation 
by using the PtdSer headgroup O-phosphoserine together with LUVs composed without 
PtdSer (Figure 30) indicating that the ENTH domain interacts with PtdSer directly. To further 
examine the interactions of the ENTH we started to establish isothermal titration calometry 
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(ITC) experiments with liposomes composed with and without PtdSer. In further steps, we 
also want to titrate O-phosphoserine into LUVs composed of PtdCho, PtdEtn and 
PtdIns(4,5)P2 and saturated with ENTH domain so that we can examine energy changes by 
PtdSer headgroup binding to the ENTH domain. Busse, R. A. et al already characterized the 
membrane binding of PROPPIN, the peripheral membrane binding domain of Atg18, Atg21 
and Hsv2, successfully by using ITC establishing the feasibility of the method 197. Finally, 
Pérez-Lara, A. et al performed an interesting EPR experiment to determine the orientation 
and the membrane binding of synaptotagmin-1 on membranes containing PtdIns(4,5)P2 in 
absence and presence of PtdSer. They spin-labeled synaptotagmin-1 at the PtdIns(4,5)P2 
binding motif and also at amino acids that were supposed to touch the membrane surface. 
By doing so they demonstrated that synaptotagmin-1 orientates differently on PtdSer and 
PtdIns(4,5)P2 containing membranes than on membranes containing just one of these lipid 
species. EPR measurements were already performed with the ENTH domain to determine 
the insertion depth and orientation of the amphipathic helix within membranes 167, 168. We 
would like to find out by this approach if the orientation of the ENTH domain on the 
membrane changes in presence of PtdSer. 
Altogether, the results indicate that ENTH domain induced membrane deformation is 
dependent on the lipid composition. In addition to the presence of PtdIns(4,5)P2. We 
demonstrated that PtdSer promotes the generation of membrane tubules and that the 
presence of cholesterol changes the morphology of those tubules from a smooth surface to 
segmentations (beads-on-a-string). We were not able to find a defined lipid composition that 
governs the formation of SUVs from LUVs. 
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5.2 The ENTH domain induced membrane deformation is associated with the 
formation of homo-oligomers 
In addition the interaction of the ENTH domain with PtdSer we could observe 
formation of ENTH domain homo-oligomers whenever ENTH domain induced membrane 
deformation occured. Lai, C. et al performed CG MD simulations and identified two regions 
of the ENTH domain that might be involved in PtdSer binding (R114) and in ENTH domain 
inter-protein interactions (V50,51). 
ENTH V50,51A seemed to be a loss of function mutant. It sedimented together with 
any LUV population independently from the presence of PtdIns(4,5)P2 (Figure 32A), but not 
if it was incubated without liposomes. Although the concentrations of ENTH V50,51A were 
similar in each sample and control the LUVs occupy space within the samples. This may 
decrease the space between each protein molecule, leading to crowding and agglomeration 
effects. Agglomeration effects would also explain why the SDS-PAGE of ENTH V50,51A co-
sedimentation assays displayed higher order kDa bands in the supernatant. We also did not 
observe any membrane deformation induced by V50,51A. The exchange of the two valines 
in helix 3 to two alanines might induce helix breaks and influence the structural integrity of 
the protein.  
 Next, we used the mutant ENTH R114A in which an arginine within the loop between 
helix 6 and 7 was mutated to alanine. Lia, C. et al claim, that this arginine comes in close 
proximity to the membrane and might interact with negatively charged lipids 170. The 
interaction of peripheral membrane proteins to more than one distinct lipid species at the 
same time was shown with synaptotagmin-1 by Pérez-Lara, A. et al 198. This is consistent 
with the data we obtained, since we observed that the ENTH domain seems to interact with 
PtdSer. However, the mutant ENTH R114A had a distinct phenotype: although it was 
recruited to LUVs in a similar way as the ENTH domain WT it was not able to form homo-
oligomers on the membrane anymore (Figure 33) and it also failed to induce tubulation on 
LUVs containing PtdIns(4,5)P2 and PtdSer analyzed by EM, DLS experiments and flotation 
assays (Figure 34A, 34B, 35 and 36). In comparison to ENTH R114A the ENTH domain WT 
deformed LUVs which were produced of the same lipid composition. The flotation assay is a 
well- established technique to resolve membrane binding and deformation in the same 
assay. Barbot, M. et al demonstrated that LUVs incubated with the BAR domain of 
endophilinA1 and Mic10, both membrane deforming proteins, show a characteristic ladder 
because deformed liposomes migrate into all the interphases between the discontinuous 
density gradient 106. We only observed this characteristic deformation ladder with ENTH 
domain WT deformed LUVs containing PtdIns(4,5)P2 and PtdSer. The corresponding SDS 
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gel displays that the ENTH domain WT floated along these liposomes (Figure 36A) 
accompanied by the formation of homo-dimers. ENTH R114A bound to LUVs of the same 
composition, but did not deform them and both, LUVs and the protein migrated only into the 
interphase between 0% and 5% histodenz similar to LUVs composed without PtdSer (Figure 
36B). ENTH R114A failed to form homo-oligomers here.   
 Protein induced membrane deformation is often accompanied by the formation of 
homo-oligomers. For example, BAR domain containing proteins like endophilins and 
amphiphysins form homo-oligomer-scaffolds surrounding membranous tubules in a helical 
way 195, 52. Barbot, M. et al demonstrated that Mic10, an integral membrane protein involved 
in the formation of cristae junctions, forms homo-oligomers and that Mic10 induced 
membrane deformation is dependent on this process 106.  
Different studies also suggested that the ENTH domain forms homo-oligomers. 
Yoon, Y. et al proposed that ENTH domains interact with each other by lysine 23 (K23) and 
glutamic acid 42 (E42) 168. Lai, C. et al performed CG MD simulation and suggested that 
ENTH domains interact via V50,51 170. However, Boucrot et al demonstrated that ENTH 
domains act as monomers and induce membrane deformation independently from each 
other 115. However, we found evidence that ENTH domain induced membrane deformation is 
at least accompanied by the formation of homo-oligomers and that R114 plays a crucial role 
in both processes.   
Since ENTH R114A did not show the same phenotype as the ENTH domain WT we 
wanted to ensure that the mutant protein did not contain helix breaks. The CD spectrum of 
the ENTH domain WT and ENTH R114A displayed a nearly perfect overlay indicating that 
the mutation did not affected the secondary structures.  
Next, we used the FRET assay to determine if the ENTH domain WT, and ENTH 
R114A come in close proximity to PtdSer and to each other, indicating self-assembly. The 
ENTH domain self-assembles on LUVs only if PtdIns(4,5)P2 and PtdSer are present in the 
membrane (Figure 41) while ENTH R114A failed in all used conditions to induce a FRET 
effect. We also observed a FRET signal if we used labeled PtdSer together with ENTH 
domain WT and also ENTH R114A (Firgure 40). No FRET signal appeared if we used 
labeled PtdEtn. 
 To identify at which position of the amino acid sequence the ENTH domain 
oligomerizes we used a cross-linking approach coupled to trypsin digest and MS/MS 
analysis of the tryptic peptides (Figure 43). A similar approach was used to identify the 
binding motif of synaptobrevin to the complex of syntaxin1, SNAP25 and Munc18-1 to form a 
functional SNARE complex 199. In general, more inter-protein cross-links were identified with 
the ENTH domain WT than with ENTH R114A. K117-K117 was the most abundant cross-
link on LUVs composed with PtdIns(4,5)P2 and in presence and absence of PtdSer, beside 
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K149-K149 and K153-K149 (Table 7). The K117-K117 cross-link was not detected if ENTH 
R114 was used. Here, the most abundant crosslink was K149-K149. K117 is located within 
the loop between helix 6 and helix 7, while K149 and K153 are located within the unaligned 
helix 8. We claim that the loop between helix 6 and helix 7 might be the location of ENTH 
domain dimerization.  
The K117-K117 fragment was not identified at all by MS/MS analysis, if we used 
ENTH R114A. To receive a clearer picture about oligomerization of the ENTH domain in 
further analysis, we want to use 15N-labeled ENTH domain populations and incubate it 
together with unlabeled ENTH domain on LUVs as composed before. The nitrogen isotope 
would induce distinct mass shifts within the MS/MS profile and we would receive cross-link 
spectra for 15N-ENTH domain dimers, 15N-ENTH domain - ENTH domain and unlabeled 
ENTH domain dimers. This approach was shown before by Melchior, J. T. et al 200. 
The results so far indicate that membrane deformation is dependent on ENTH 
domain oligomerization. We identified that ENTH domain homo-dimerize by the loop 
between helix 6 and helix 7. Nevertheless, beside the occurrence of dimers we observed the 
formation of higher order homo-oligomers indicating that the ENTH domain has at least 
another inter-protein interaction site. However, the formation of higher order oligomers also 
depended on R114.  Recent studies demonstrated that the ENTH domain can interact with 
distinct proteins and has many different interaction sites. The ENTH domain of yeast Ent1 
interacts with the ANTH domain of Sla2 forming a regular, hetero-oligomeric coat 176. The 
interaction was inhibited by using the mutant ENTH T104A. Wang, J. et al demonstrated that 
ENTH domains of yeast Ent3 bind to the SNARE protein Vit1 due to an interface formed by 
the loop between helix 2 and helix 3, the loop between helix 4 and helix 5 and helix 8 itself 
177. Finally, the ENTH domain of yeast Ent1 and Ent2 interacts with the cell division protein 
Cdc42 201. We demonstrated that the loop between helix 6 and helix 7 is involved in the 
formation of ENTH domain dimers.  
To address the cellular endocytic consequence of ENTH domain oligomerization we 
want to start experiments with HeLa cells. Boucrot, E. et al used siRNAs to silence all three 
copies of Epsin inside such cells impairing endocytosis 115. By introducing their own Epsin1 
construct into silenced HeLa cells they could rescue CME. We want to use this system and 
follow the endocytic uptake of EGFR, which is an Epsin1 specific cargo. By using an Epsin1 
WT construct we aim to rescue the EGFR uptake. Furthermore, we want to visualize if the 
formation of ENTH domain homo-oligomers has an effect on CME by introducing an ENTH 
R114A construct. 
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5.3 Epsin1 interacts with clathrin and tetraubiquitin on the membrane  
 
The role of Epsin1 in CME is controversially discussed. It was discovered as an 
interaction partner for Eps15, and described as an adaptor protein interacting with clathrin, 
AP-2 and the membrane itself 120. It is still debated if Epsin1 is crucial for CME and if it is 
involved in cargo selection. Several studies demonstrate that Epsin1 is crucial for CCV 
maturation and its release from the plasma membrane 132, 115, while other studies 
demonstrate that CCVs do even form if only the unstructured part of Epsin1 was used 202. 
We addressed the potential of Epsin1 to drive clathrin mediated endocytosis in a 
minimal component system. Therefore, we examined the membrane binding and 
deformation behavior of Epsin1 with the same membrane systems, as we used for the ENTH 
domain. Epsin1 had the same binding and membrane deformation phenotype (Figure 44) as 
the ENTH domain (Figure 23) and was recruited to LUVs only in the presence of 
PtdIns(4,5)P2 and generated membrane tubules only in the additional presence of PtdSer. In 
comparison to the ENTH domain (12 µM for the assays) only 8 µM Epsin1 was necessary to 
observe similar results. Epsin1 was demonstrated to be more efficient in membrane 
deformation than its ENTH domain alone on LUVs and GUVs 175. The authors claim that 
Epsin1 is more efficient, due to its bigger hydrodynamic radius than the isolated ENTH 
domain in their molecular crowding model. The ENTH domain covers approx. 15 to 20 nm2 
on the membrane after binding, while Epsin1 covers approx. 70 to 100 nm due to its large 
disordered C-terminus. The larger hydrodynamic radius of the full-length protein might 
induce more lateral pressure due to collisions between the proteins than the small globular 
ENTH domain does. Interestingly, if we incubated GUVs with Epsin1, we observed the 
formation of small clusters on the membrane indicating that Epsin1 forms oligomers more 
efficient than the sole ENTH domain, although we did not observe this occurrence on SDS-
PAGEs after co-sedimentation assays (Figure 45). The reason might have been that Epsin1 
forms so large homo-oligomers that they don’t migrate through the separation gel during 
SDS-PAGE. The protein FRET assay might give more conclusive results if Epsin1 forms 
homo-oligomers on the membrane.  
To observe if Epsin1 is able to recruit clathrin to membranes we modified the co-
sedimentation assay with a second incubation cycle. The idea was to obtain a high 
membrane coverage of Epsin1 without membrane deformation and then start the incubation 
with clathrin 45. The analysis of the SDS gel and detection by Coomassie staining was 
inconclusive (Figure 46A). Here, we observed Epsin1 oligomers, but also in the control of the 
soluble protein without LUVs. In contrast, purified Epsin1 did not show higher order 
oligomers after size exclusion chromatography (Figure 18). We were also not able to detect 
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clathrin by this staining method. However, the detection by immunostaining showed a clearer 
result (Figure 45B). First, we detected that Epsin1 forms homo-oligomers and more 
pronounced if it is recruited to LUVs. Especially, if it was incubated with clathrin the Epsin1 
oligomer signal appeared to be more pronounced than the monomer signal. The second 
observation was that clathrin is indeed only recruited to the membrane if Epsin1 is present. 
This is consistent with several findings 45, 145. Nonetheless, we expected a stronger immune 
staining signal for clathrin. The reason for the weak signal might be the way clathrin was 
isolated and prepared for the assays. Clathrin triskelia are purified into a buffer that inhibits 
the self-assembly and transferred shortly before usage into HEPES buffer by dialysis and 
centrifuged to pellet agglomerated protein. The triskelia already start to agglomerate during 
the whole procedure and thus it is hard to determine the functional triskelia concentration 
efficiently. We were also able to label clathrin triskelia with Atto 390 NHS and use it in the 
GUV assay together with Epsin1. Although we detected clathrin recruitment to the 
membrane in dependency of Epsin1, we observed a lot of clathrin agglomerates, indicating 
that the additional labeling prodcedure had an adverse effect on on the stability of clathrin 
(Figure 47). Thus, we need to modify the preparations by decreasing the time between 
clathrin triskelia storage and usage for the assays. A solution might be to use desalting 
columns instead of dialysis and perform the labeling at room temperature for a shorter period 
instead of labeling at 4°C for 12 h. Nevertheless, the data we obtained are consistent with 
the general findings that clathrin is co-recruited by Epsin1 to membranous tubuli 145 and to 
LUVs 45. Still we did not answer the question if Epsin1 together with clathrin alone is able to 
form clathrin coated vesicles in our in vitro systems. Therefore, we need to modify the 
preparation of EM grids. It is possible to coat EM grids with a membrane monolayer and 
incubate it first with Epsin1 and clathrin and by this induce the formation of clathrin coated 
vesicles 45. Together with immune gold staining it might be a powerful technique to first 
observe the formation of CCVs and to analyze the localization of Epsin1 and clathrin in those 
vesicles.  
Besides the recruitment of clathrin we wanted to show that Epsin1 can bind to conjugated 
ubiquitin. It was demonstrated that the ubiquitinated EGFR is a specific cargo for Epsin1 
since its internalization depends on the function of Epsin1 149. It was also shown, that the 
UIMs of Epsin1 bind to higher order conjugated ubiquitins (at least tetraubiquitin) and 
ubiquitinated proteins derived from cytosolic fractions 122. Based on these reports we started 
to analyze the interaction of Epsin1 and an artificial cargo composed of tetraubiquitin labeled 
with Atto 390 NHS Using GUV assay as initial test, we clearly observed the recruitment of 
this cargo to the membrane in presence of Epsin1 (Figure 48). To further analyze the co-
recruitment of tetraubiquitin we want to employ the co-sedimentation assay and the flotation 
assay to resolve if ubiquitin also binds to Epsin1 in the deformation pattern. As before, EM 
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coupled with immunogold staining will be a powerful technique to resolve the co-localization 
of tetratubiquitin on Epsin1 generated membrane tubuli. Here we can also use Ni-NTA 
containing lipids (Ni-NTA DOGS) to first recruit hexa-his-tetraubiquitin to the LUVs and then 
incubate it with Epsin1 to induce deformation and analyze the localization of the ubiquitin 
cargo by immunogold staining. 
Our final goal is to detect ubiquitin sorting into clathrin baskets by Epsin1 as the only 
adaptor protein (Figure 49). Therefore, we must modify the assays we use with an additional 
incubation step. The co-sedimentation assay might resolve the co-recruitment of 
tetraubiquitin and clathrin to the membrane while EM coupled to immunogold staining will 
resolve if all proteins co-localize into CCVs. Furthermore, our GUV assay must be modified 
for the use of a fourth fluorophore. Atto 565 NHS seems to be the most suitable fluorophore 
because it has the least cross- Interaction to the fluorophores already in use.  
 
Figure 49: Schematic illustration of the in vitro cargo sorting of ubiquitin into clathrin baskets by Epsin1 
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Conclusion 
 
 
 In clathrin mediated endocytosis (CME), cargo molecules are transported across the 
plasma membrane from the outer cell surface into the cytosol. During this process, the 
plasma membrane undergoes massive local remodeling events which are mediated and 
regulated by a numerous number of proteins. One of these proteins is Epsin1 which is highly 
conserved across eukaryotic evolution. Epsin1 is composed of a tightly folded ENTH domain 
and an unstructured C-terminus containing several short interaction motifs for CME proteins. 
The ENTH domain is the lipid binding module of Epsin1 and binds specifically to 
phosphatidylinositol 4,5-bisphosphate. Membrane binding of the ENTH domain is associated 
with the folding of an additional, amphipathic helix, which inserts into one leaflet of the 
membrane. Helix insertion was demonstrated to be associated with membrane deformation 
but little is known about the mechanisms that drive the deformation process by the ENTH 
domain. 
In this thesis, molecular details of membrane deformation induced by the ENTH 
domain of Epsin1 were investigated. By using model membrane systems with defined lipid 
compositions we were able to identify the lipid species beside PtdIns(4,5)P2 playing a role in 
membrane deformation. Phosphatidylserine (PtdSer) promoted the generation of membrane 
tubles from model membranes, induced by the ENTH domain. This effect appeared lipid 
species specific since it was not possible to rescue ENTH domain induced membrane 
deformation by replacing PtdSer by lipid species with similar physical abilities, or by using 
the soluble headgroup O-phophoserine. By solid-state NMR we found that the presence of 
PtdSer within LUVs induced conformational changes and that the ENTH domain became 
more rigid than on membranes without PtdSer.   
 By using LUVs containing PtdIns(4,5)P2, PtdSer and cholesterol we were able to 
identify an additional phenotype of membrane deformation which appeared as segmented 
membrane tubuli which might be an intermediate between tubulation and vesiculation.  
 In addition, we demonstrated that ENTH domain induced membrane deformation is 
accompanied by the formation of homo-oligomers and that the mutant ENTH R114A failed in 
both, although it was recruited to LUVs in the same way as the ENTH domain WT in 
liposome co-sedimentation assays. FRET data indicate that the ENTH domain formation of 
homo-oligomers is dependent on PtdIns(4,5)P2 and PtdSer within the membrane and that 
ENTH 
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R114A was not able to form oligomers on those membranes. However, both the ENTH 
domain WT and R114A interacted with PtdSer in lipid-protein FRET assays and no FRET 
effect appeared if PtdSer was replaced by PtdEtn. Using a strategy combining cross-linking, 
trypsin digestion and MS/MS analysis we could identify the location of oligomerization within 
the loop between helix 6 and helix 7 which comes in close proximity to the membrane due to 
ENTH domain membrane recruitment. 
 Finally, we established the recruitment of clathrin to model membrane systems by 
Epsin1 in liposome co-sedimentation assays, as well as in GUV assays and demonstrated 
the interaction of tetraubiquitin with Epsin1 by GUV assays. 
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